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Background: Over 100,000 primary knee arthroplasty operations are undertaken annually in the UK.
Around 15–30% of patients do not report a good outcome. Better rehabilitation strategies may
improve patient-reported outcomes.
Objectives: To compare the outcomes from a traditional outpatient physiotherapy model with those
from a home-based rehabilitation programme for people assessed as being at risk of a poor outcome
after knee arthroplasty.
Design: An individually randomised, two-arm controlled trial with a blinded outcome assessment,
a parallel health economic evaluation and a nested qualitative study.
Setting: The trial took place in 14 NHS physiotherapy departments.
Participants: People identified as being at high risk of a poor outcome after knee arthroplasty.
Interventions: A multicomponent home-based rehabilitation package delivered by rehabilitation
assistants with supervision from qualified therapists compared with usual-care outpatient physiotherapy.
Main outcome measures: The primary outcome was the Late Life Function and Disability Instrument
at 12 months. Secondary outcomes were the Oxford Knee Score (a disease-specific measure of
function); Knee injury and Osteoarthritis Outcome Score; Quality of Life subscale; Physical Activity
Scale for the Elderly; EuroQol-5 Dimensions, five-level version; and physical function assessed using
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the Figure-of-8 Walk Test, 30-Second Chair Stand Test and Single Leg Stance. Data on the use of
health-care services, time off work and informal care were collected using participant diaries.
Results: In total, 621 participants were randomised. A total of 309 participants were assigned to
the COmmunity based Rehabilitation after Knee Arthroplasty (CORKA) home-based rehabilitation
programme, receiving a median of five treatment sessions (interquartile range 4–7 sessions). A total
of 312 participants were assigned to usual care, receiving a median of four sessions (interquartile range
2–6 sessions). The primary outcome, Late Life Function and Disability Instrument function total score at
12 months, was collected for 279 participants (89%) in the home-based CORKA group and 287
participants (92%) in the usual-care group. No clinically or statistically significant difference was found
between the groups (intention-to-treat adjusted difference 0.49 points, 95% confidence interval –0.89 to
1.88 points; p = 0.48). There were no statistically significant differences between the groups in any of the
patient-reported or physical secondary outcome measures at 6 or 12 months post randomisation. The
health economic analysis found that the CORKA intervention was cheaper to provide than usual care
(£66 less per participant). Total societal costs (combining health-care costs and other costs) were lower
for the CORKA intervention than usual care (£316 less per participant). Adopting a societal perspective,
CORKA had a 75% probability of being cost-effective at a threshold of £30,000 per quality-adjusted
life-year. Adopting the narrower health and social care perspective, CORKA had a 43% probability of
being cost-effective at the same threshold.
Limitations: The interventions were of short duration and were set within current commissioning
guidance for UK physiotherapy. Participants and treating therapists could not be blinded.
Conclusions: This randomised controlled trial found no important differences in outcomes when
post-arthroplasty rehabilitation was delivered using a home-based, rehabilitation assistant-delivered
rehabilitation package or a traditional outpatient model. However, the health economic evaluation
found that when adopting a societal perspective, the CORKA home-based intervention was cost-saving
and more effective than, and thus dominant over, usual care, owing to reduced time away from paid
employment for this group. Further research could look at identifying the risk of poor outcome and
further evaluation of a cost-effective treatment, including the workforce model to deliver it.
Trial registration: Current Controlled Trials ISRCTN13517704.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 24, No. 65. See the NIHR Journals Library website for further project information.
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BMI body mass index
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OKS Oxford Knee Score
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QoL quality of life
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SD standard deviation
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TKA total knee arthroplasty
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Knee replacement is a common treatment for knee osteoarthritis. Most people do well after surgery;however, a small group of people do not report a good outcome. One way we could try to improve
this is by considering the way that rehabilitation is offered after surgery.We identified people thought to
be at risk of a poor outcome after knee replacement.We compared a newly designed rehabilitation
programme that was undertaken in people’s own homes with physiotherapy as it is currently offered.
This new programme was delivered by rehabilitation assistants under the guidance of qualified therapists.
We assessed these treatments by measuring three functional tests: walking in a figure of eight, sitting and
standing from a chair in 30 seconds and standing on one leg. In addition, we asked people to complete
questionnaires about their knee, what activities they could perform, how physically active they were and
their quality of life.We also recorded the use of health-care services, time off work and any informal care
that people received. The results showed that both groups had improved by a similar amount at 6 months
and 12 months after surgery. The new rehabilitation programme that was designed for the study was
cheaper to deliver than standard physiotherapy, when all costs were considered.We think that future
research should look at developing better tools to predict who might be at risk of not doing well after
surgery, and to determine the ideal make-up of the rehabilitation team that delivers treatment after
knee replacement.
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Knee osteoarthritis is a common musculoskeletal condition that causes pain and loss of function. It is
the most common cause of disability in older people. Knee arthroplasty for end-stage osteoarthritis
of the knee is an established and effective treatment for patients. The number of knee arthroplasty
operations taking place in the UK is continuing to rise, as is the age of the patient and the American
Society of Anesthesiologists classification grade, a method of categorising patients’ fitness before
surgery. Although most patients achieve a satisfactory outcome, many patients continue to report poor
outcomes after knee arthroplasty. Given the rising number of these operations, the relatively limited
therapy resources available and the increasing age and frailty of patients receiving joint arthroplasty,
it is important to concentrate rehabilitation resources on those patients who need the most help to
achieve a good outcome.
Objectives
The objectives of the COmmunity-based Rehabilitation after Knee Arthroplasty (CORKA) trial were to:
1. design a prognostic screening tool based on an analysis of factors associated with a poor outcome
after knee arthroplasty to guide patient selection for the trial
2. evaluate whether or not a multicomponent rehabilitation programme delivered in patients’ homes
could improve their outcome compared with those receiving standard outpatient physiotherapy
rehabilitation over 12 months
3. undertake a nested qualitative study exploring patients’ and clinicians’ perceptions of the
community-based rehabilitation programme
4. undertake an economic analysis comparing the cost-effectiveness of the intervention with that of
usual care.
It was hypothesised that the CORKA intervention would produce improved outcomes over usual care
for participants identified as at risk using the CORKA screening tool.
Methods
The CORKA trial was a prospective, individually randomised, two-arm controlled trial with a blinded
outcome assessment for the clinical outcomes at baseline, and at 6 and 12 (primary outcome) months.
It aimed to determine whether or not a multicomponent rehabilitation programme that was provided
to patients following knee arthroplasty who were deemed at risk of a poor outcome using the CORKA
screening tool was better than usual care. The design included a parallel health economic evaluation
and a nested qualitative study.
Setting
The trial was run in 14 NHS trusts across England.
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Interventions
The CORKA home-based intervention
The CORKA home-based intervention was a multicomponent rehabilitation programme. Its aim was to
improve the function and the participation in activities of participants at risk of a poor outcome after
knee arthroplasty surgery. The primary component of the rehabilitation package was an individually
adapted exercise programme conducted in participants’ homes. Additional components consisted of
functional task practice, appropriate adherence approaches and, if required, the provision of appropriate
aids and equipment. The CORKA intervention started within 4 weeks of surgery. It comprised an initial
assessment appointment and up to six follow-up sessions. It was delivered by a mixture of qualified staff
and rehabilitation assistants.
Usual care
Those who were allocated to the usual-care arm received standard post-operative physiotherapy.
Usual care after knee arthroplasty surgery could vary considerably across the trial’s UK locations.
However, it was highly likely that usual care would include several of the following: between one and
six sessions of physiotherapy in an outpatient setting, class-based setting or hydrotherapy; written
advice on home exercise at discharge from hospital; and an assessment of any potential home
requirements for or barriers to discharge by an occupational therapist. To standardise usual care as
much as possible, participants were expected to attend a minimum of one session and a maximum of
six sessions of usual-care physiotherapy.
Recruitment
Patients were initially identified from clinic lists. Those who were scheduled to receive a knee
arthroplasty were sent the CORKA participant invitation letter and participant information sheet.
This pack was sent out by a member of the patient’s usual-care team before they attended their
pre-operative assessment clinic appointment. Patients who had been sent the information were
approached during their pre-operative assessment clinic appointment to determine whether or not
they were interested in the trial, and to give them the opportunity to discuss the trial further and ask
any questions. If the patient indicated that they were interested in taking part, the CORKA screening
tool was used to identify if they were at risk of a poor outcome. They were then checked for eligibility
into the trial. If they were deemed eligible, an appointment was made to gain informed consent and
to collect baseline outcome data with a member of the research team. This baseline appointment
took place in the hospital or in the patient’s home no more than 4 weeks before the date of the
surgery. Patients were not formally recruited to the trial or randomised until their eligibility had
been re-checked after surgery. Patients with serious peri-operative complications were excluded,
as they would not be able to complete routine post-operative rehabilitation. Patients who were still
eligible were then asked to confirm their consent verbally to a member of the research team before
being enrolled in the trial and randomised.
Randomisation, allocation and blinding
Participants were randomly allocated by a computer-generated system to either ‘usual care’ or
‘home-based exercise programme’ in a 1 : 1 ratio. Randomisation used permuted blocks of various
sizes (two, four and six) in a 1 : 2 : 1 ratio, and was stratified by recruitment site to account for any
site effects. Participants and those delivering the rehabilitation were aware of the treatment allocation
because of the nature of the intervention. Those carrying out follow-up outcome measurements
remained blinded to treatment allocation.
Sample size
The primary outcome was the Late Life Function and Disability Instrument overall function score at
12 months. No information had been published about the minimum clinically important difference at
the time of designing the trial, but it is a clinically relevant outcome in this population. The sample size
calculation was based on a moderately small standardised effect size of 0.275. This standardised effect
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size is, for example, equivalent to detecting a 3-point difference between treatment arms on the Late
Life Function and Disability Instrument overall function score, assuming a standard deviation of 10.91
and no clustering effect across sites. In total, 620 participants (310 per arm) were required to detect a
standardised effect size of 0.275 with 90% power and 5% (two-sided) significance, allowing for 10%
loss to follow-up based on previous experience of trials in a similar population.
Monitoring and ethics
Trial oversight was provided by a Trial Steering Committee and an independent Data Monitoring
Committee. The study protocol was approved by the South Central Research Ethics Committee
(reference 15/SC/0019). Ethics permission was obtained for all participating sites.
Outcomes and analysis
Baseline data were collected face to face no more than 4 weeks before surgery. Follow-up data collection
was carried out by face-to-face clinical assessments at 6 and 12 months following randomisation.Where
face-to-face assessment was not possible, postal and telephone data collection methods were used to
obtain self-reported core data.
Primary outcome
The Late Life Function and Disability Instrument was developed for community-dwelling older adults.
It assesses and responds to meaningful change in two distinct outcomes: a person’s ability to perform
discrete actions or activities using a 32-item function component and a person’s performance of
socially defined life tasks using a 16-item disability component.
Secondary outcomes
Secondary outcomes consisted of self-reported and physical measures. The self-reported measures
were the Oxford Knee Score, Physical Activity Scale for the Elderly questionnaire, Knee Injury and
Osteoarthritis Outcome Score, Quality of Life subscale and EuroQol-5 Dimensions, five-level version.
The physical measures were Figure-of-8 Walk Test, 30-Second Chair Stand Test and Single Leg Stance.
A health resource diary collected the exercises undertaken, medication taken, use of health-care
services and personnel, and falls.
Analysis
Two analysis populations were considered: the intention-to-treat population and the per-protocol
population. The intention-to-treat population included all randomised participants who were analysed
according to their allocated intervention. The per-protocol population included only participants who
received at least one session of their allocated intervention, did not receive more treatment than
intended (more than six sessions of usual care or seven sessions of home-based rehabilitation) and
provided follow-up data.
The Late Life Function and Disability Instrument function scores at 6 and 12 months post randomisation
were summarised by treatment group and analysed using a linear mixed-effects model with repeated
measures adjusted for baseline score and recruitment site (stratification factor). Time was treated as
categorical, and an interaction between the outcome measurement time point and the randomised
group was included to allow the treatment effect to be estimated at each time point, reported as the
adjusted mean difference in Late Life Function and Disability Instrument between groups with 95%
confidence interval and associated p-value. The underlying assumptions of this model were assessed.
The primary end point was considered to be 12 months post randomisation. The primary analysis was
performed for the intention-to-treat population using multiple imputation to impute missing data.
Health economic evaluation
The CORKA home-based intervention and usual care were compared in terms of quality-adjusted
life-years gained along with health and wider societal costs. Participants were asked to complete
two diaries reporting their use of health-care services, time off work and any informal care received
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because of their knee arthroplasty. The first diary ran between randomisation and 6 months, and the
second between 6 and 12 months. Participants were also asked to complete the EuroQol-5 Dimensions,
five-level version, questionnaire at randomisation (baseline), and at 6 and 12 months. Unit costs were
derived from national databases, reports and websites. All unit costs were inflated, where necessary,
to 2017–18 prices using the health-care and community health services inflation index.
Results
In total, 621 participants at 14 sites were randomised: 312 to usual care and 309 to the CORKA
intervention. Most participants scored 5 or 6 on the screening tool (494/621, 79.5%) and received a
total knee arthroplasty (460/621, 74.1%).
Primary outcome
The primary analysis of the Late Life Function and Disability Instrument function score demonstrated
no statistically significant difference between the two treatment groups at the primary time point of
12 months (adjusted difference 0.49, 95% confidence interval –0.89 to 1.88; p = 0.48). There was also
no statistically significant difference between the two groups at 6 months post randomisation or based
on any of the sensitivity analyses.
Secondary outcome
No statistically significant differences between the two treatment groups at 6 or 12 months were
identified for any of the secondary outcomes. Only one statistically significant difference was identified
by the sensitivity analyses of key secondary patient-reported outcome measures for the Late Life
Function and Disability Instrument disability limitation at 6 months using the intention-to-treat
population and multiple imputation. This effect only just reached significance (adjusted difference
2.67, 95% confidence interval 0.14 to 5.19; p = 0.04), and is likely to have been a chance effect.
No significant differences between the two groups were identified on the physical measures 30-Second
Chair Stand Test and Figure-of-8 Walk Test.
The health economic evaluation found a small, non-significant difference in quality-adjusted life-years
(0.003, 95% confidence interval –0.017 to 0.023) favouring the CORKA home-based intervention.
Post-operative physiotherapy (intervention) costs were lower, on average, in CORKA than usual
care (–£65, 95% confidence interval –£86 to –£44). However, the CORKA group reported higher
subsequent health-care resource use (primary care, outpatient care and hospitalisations) and costs
(£142, 95% confidence interval –£70 to £354). The total NHS costs at 12 months were higher in
the CORKA group (£77, 95% confidence interval –£138 to £291). By contrast, costs associated
with private health-care use (–£15, 95% confidence interval –£76 to £46), informal care (–£23, 95%
confidence interval –£210 to £164) and time away from paid employment (–£355, 95% confidence
interval –£820 to £110) were lower for the CORKA group than for the usual-care group at 12 months.
As a result, total societal costs (combining health-care costs and other costs) were lower for CORKA
than usual care (–£316, 95% confidence interval –£892 to £260). Adopting an NHS health and social
care perspective, CORKA compared with usual care was £28,372 per quality-adjusted life-year, close to
the standard threshold for cost-effectiveness in the UK. Adopting a societal perspective, CORKA was
cost-saving and more effective than usual care.
Qualitative study
As part of the main study, a nested qualitative study was conducted to obtain in-depth views about
the intervention and how it was delivered. Ten patient participants, five physiotherapists and six
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rehabilitation assistants were recruited. Semistructured interviews with participants were digitally
audio-recorded and transcribed.
The themes related to physiotherapists and assistants were seeing the person in their world;
developing people skills; thinking outside the cubicle; gaining personally from doing that bit extra;
there is a fine line between patient and friend; feeling outside my comfort zone; and needing a support
network. The themes related to patients were it was a relief not travel; I got an hour’s work done in
an hour; they can work with your surroundings; I didn’t want to let them down; there is nothing like
company; and I wouldn’t have done it on my own.
Conclusions
The CORKA trial was a rigorous, well-conducted multicentre randomised controlled trial targeting a
population at risk of a poor outcome following knee arthroplasty. This trial did not find an important
difference between usual care and home-based rehabilitation in terms of Late Life Function and Disability
Instrument function score at 12 months post randomisation. The key differences between the two
interventions were that one was usual care, whereas the CORKA home-based intervention was
multidisciplinary in content, delivered in participants’ homes, and used a staffing model of rehabilitation
assistants supervised by a qualified physiotherapist or occupational therapist. The data from the trial
suggests that the two treatments are similarly effective and appear safe in this population.
Future research questions
It is suggested that further research should focus on developing a screening tool that is more sensitive
to identifying those patients who will benefit from additional input. The CORKA screening tool was
developed to identify the population most at risk of a poor outcome after knee arthroplasty but could
be further developed to try to identify factors on an individual level or factors linked to engagement
with rehabilitation.
The CORKA home-based intervention was delivered by rehabilitation assistants supervised by qualified
therapists in a ratio of five sessions to two sessions. Considering these results in the context of workforce
shortages across the NHS, further research to examine different workforce models and interventions
solely using rehabilitation assistants could be explored.
Trial registration
This trial is registered as ISRCTN13517704.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 65.
See the NIHR Journals Library website for further project information.
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The COmmunity based Rehabilitation after Knee Arthroplasty (CORKA) trial was commissioned bythe National Institute for Health Research Health Technology Assessment (HTA) programme to
address the question ‘What is the clinical and cost-effectiveness of intensive rehabilitation programmes
following knee joint replacement for chronic osteoarthritis?’.1 The commissioning brief specified that
the intervention should be intensive rehabilitation that is likely to bridge between hospital and home
and should target older adults who have undergone elective knee arthroplasty (KA) who are considered
to be at risk of poorer functional outcomes.
The CORKA trial compared the effect of two rehabilitation approaches on a range of functional
outcomes: traditional clinic-based therapy and a rehabilitation package delivered by rehabilitation
assistants supported by qualified therapists in participants’ homes. This chapter provides background
information on KA and rehabilitation approaches.
Background to the problem
Knee osteoarthritis is a common musculoskeletal condition that causes pain and loss of function.
It is the most common cause of disability in older people,2 with painful osteoarthritis affecting 18.2%
of people over the age of 45 years in the UK.3 The use of KA for end-stage knee osteoarthritis is an
established and effective treatment for patients who have already completed all non-surgical options
but continue to experience significant pain and decreased function.
The number of KA operations taking place in the UK is continuing to rise. The 15th Annual National
Joint Registry Report (2018)4 showed that over 100,000 KA operations were performed in the UK
in 2017. This is an increase of over 3% from 2010. Part of the reason for this increase is that KA is
increasingly performed for patients who are older and who have other health conditions in addition
to their osteoarthritis. A further change relates to the increasing use of unicompartmental knee
arthroplasty (UKA). Approximately 90% of KAs are a total knee arthroplasty (TKA) and 10% are a
UKA or partial KA. In TKA, the entire tibiofemoral joint is replaced, whereas in UKA the affected
medial or lateral side of the tibiofemoral joint is replaced only. National outcome data have revealed
that patients’ age and American Society of Anesthesiologists (ASA) classification grades are increasing.
In the 15th National Joint Registry Report of 2018,4 15% of patients were aged 80–89 years and 1%
were over 90 years of age. The average ASA classification grade is also increasing, with 19% reported
as ASA classification grade 3 (severe systemic disease that limits activity).4
Age should not be a barrier to a good KA outcome, with reports of successful outcomes in patients
aged over 80 years.5,6
Data from patient-reported outcome measures (PROMs) have shown that most patients achieve a
satisfactory outcome following KA. However, between 15% and 30% of patients are unsatisfied or
report little or no improvement after KA.7 We do not yet know how to identify these patients or
target rehabilitation to improve their outcomes.
Predicting which patients will have poor outcomes
The existing literature has demonstrated that it is difficult to predict who will do well after KA. Any
prediction is complex and extends far beyond a simple linear relationship with factors such as age or
presurgical function. A number of studies have explored the influence of pre-operative predictors on
post-operative KA outcomes and have generally agreed that patients who have a higher pre-operative
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status, such as better pre-operative function or less pain, tend to have better post-operative
outcomes.8–12 However, no screening tool that can accurately identify and predict who is at risk of a
poor post-operative outcome currently exists, despite much previous work exploring this subject.13–15
Rehabilitation pathway
Many hospitals follow an accelerated or enhanced recovery protocol, mobilising patients for the
first time in the first 4 hours after surgery. Bohl et al.16 and Okamoto et al.17 demonstrated that early
mobilisation within the first 24 hours after surgery shortened length of stay, but did not affect longer-
term outcomes. Most hospitals have discharge criteria governing when patients are discharged from
hospital that are based on safe mobilisation, ability to perform self-care and attainment of a minimum
amount of knee flexion (commonly set at 90 degrees). Patients will have reached a minimal level of
function at discharge, but will continue to have rehabilitation needs to help restore muscle strength
and endurance, range of motion, walking distance and performance of higher-level functional activities.
Patients are commonly referred for further physiotherapy in an outpatient setting to assist with these
issues. The timing of this referral varies, with some hospitals advocating immediate commencement
of therapy after discharge from hospital and others waiting until the first post-operative review at
around 6 weeks before considering referral. The type of therapy also differs, with some sites using
self-directed home exercise and others advocating for more formal outpatient treatment using manual
therapy, individually progressed exercises and functional activities in an individual or group setting.
Outpatient rehabilitation approaches
We conducted a systematic review evaluating the effectiveness of exercise after KA. We found that
functional physiotherapy exercise interventions following discharge after elective primary TKA offered
short-term benefit.18 We found a small to moderate standardised effect size [0.33, 95% confidence
interval (CI) 0.08 to 0.58] in favour of functional exercise at 3–4 months post operatively, which
included small to moderate weighted mean differences of 2.90° (95% CI 0.61° to 5.20°) for range of
motion and 1.70 (95% CI –1.00 to 4.30) for quality of life, in favour of functional exercise. However,
the post-treatment benefits faded and were not carried through to 1 year post operation.
The review revealed the complexity that is involved in deciding the best rehabilitation after arthroplasty.
A growing number of studies have chosen to apply an intervention later in the rehabilitation pathway
(often between 6 weeks and 6 months after surgery), which suggests that a delay in starting the
intervention avoids the period of early post-operative pain, swelling and limited motion.19–21 Similarly,
assessing outcomes after arthroplasty is known to be complex and multifaceted.22,23 The lack of certainty
about what constitutes best physiotherapy practice has been recognised internationally, with considerable
variation in the post-operative rehabilitation protocols used. A recent Australian survey of physiotherapy
practice24 and an observational cohort study of US rehabilitation services25 have started to address this
knowledge gap. However, there are no published randomised controlled trials (RCTs) of occupational
therapy after KA. Other studies do not allow the occupational therapy input to be disaggregated from
the overarching rehabilitation package to assess its contribution.
Patients in the UK usually receive a short course of between four and six sessions of post-operative
physiotherapy after their surgery, usually in a physiotherapy outpatient clinic setting. Concern has
been raised that many exercise programmes lack adequate intensity to lead to optimal recovery.24,26
Internationally, where much longer courses of physiotherapy are often provided, research has indicated
that 12–18 hours of physiotherapy21 or a mean of 17 visits27 may be needed to produce benefit. These
levels of care are substantially higher than those provided in the UK and, in the current economic
climate, may be more than the NHS can afford given the rising number of KA operations that are
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performed each year. Patients are likely to have an occupational therapy assessment before surgery to
identify any potential issues on discharge, such as home layout. However, it is not usual for patients to
have further input from occupational therapists unless they have particular problems.
Given the rising number of KA operations, the relatively limited therapy resources available and the
increasing age and frailty of patients receiving this surgery, it is important that we concentrate our
rehabilitation resources on those patients who need the most help to achieve a good outcome. It is
important that exercise and functional rehabilitation is linked to demonstrable increases in function
and participation levels. Not all patients need physiotherapy to help them recover, and some patients
will recover fully using self-directed rehabilitation.28–31 It is, thus, pertinent to focus our resources on
those who are most likely to be at risk of a poor outcome, least likely to be able to engage with a
self-management approach and able to benefit from rehabilitation input.
It is clear that current rehabilitation strategies do not meet the needs of all patients, particularly those
who are socially isolated, do not have easy access to transport and are frail. This is a particular concern
given both the projected increased need for joint arthroplasty over the next decade to accommodate
an ageing population and the pressure of potential reductions in NHS funding. Evaluating the value
of treatment modalities offered to these patients is crucial because many more patients are being
discharged home earlier from the acute setting. There is less time available for acute physical recovery,
rehabilitation and education in hospital, which increases the potential burden of care for these patients
and their families.
Rationale for the CORKA trial
There is considerable variation in the quantity and content of rehabilitation received by patients after
KA. Previous evidence has shown that some patients do well with minimal input or self-directed exercise
programmes,30–33 but that many patients continue to experience pain and poor function after their
surgery and report dissatisfaction with the rehabilitation that they have received.
In the CORKA trial, we aimed to evaluate a different approach designed to cater to the needs of
an older, frailer population. We evaluated two strategies of rehabilitation after KA: a traditional
outpatient clinic-based model and a rehabilitation programme delivered in participants’ homes
by rehabilitation assistants supported by qualified therapists.
The programmes were designed to be acceptable to NHS physiotherapists and occupational therapists,
based on current available evidence, and affordable to UK commissioners. A parallel economic study
enabled conclusions to be made about cost-effectiveness. A nested qualitative study assessed the
acceptability of the interventions to participants and the therapists who delivered them.
Research objectives
The CORKA research objectives were published in the protocol paper in Trials in 2016:34
1. to design a prognostic screening tool based on an analysis of factors associated with poor outcomes
following KA to guide patient selection for the trial
2. to evaluate if a multicomponent rehabilitation programme delivered in patients’ homes could improve
their outcomes compared with those receiving standard outpatient rehabilitation over 12 months
3. to undertake a nested qualitative study exploring patients’ and clinicians’ perceptions of the
community-based rehabilitation programme
4. to undertake an economic analysis to compare the cost-effectiveness of the interventions.
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The protocol for the RCT was published in Trials in 2016.34 The trial was delivered as published withno changes to the protocol.
Trial design
The CORKA trial was a prospective, individually randomised, two-arm controlled trial with blinded
outcome assessment for the clinical outcomes at baseline, 6 months and 12 months. It aimed to
determine if a multicomponent rehabilitation programme provided to participants who were deemed
at risk of a poor outcome following KA by the CORKA screening tool (see Chapter 7) was better
than usual care. The trial took place in 14 NHS hospitals across the UK. The design included a parallel
health economic evaluation and a nested qualitative study. Figure 1 gives an overview of the flow of
participants through the trial and the timing of assessment procedures.
Randomised controlled trial
During the trial, people undergoing KA were screened for suitability during their pre-operative
assessment clinic appointment using the screening tool that had been developed for the trial. Once
informed consent was gained, participants were enrolled in the trial and baseline data were collected.
After surgery, participants’ eligibility was confirmed and randomisation took place. Participants were
allocated to receive one of two rehabilitation options: ‘usual care’ or the ‘home-based intervention’.
Randomisation
Knee arthroplasty carried out
Eligible participants highlighted using
CORKA algorithm and contacted 
for consent
Baseline data collected no more than
4 weeks preoperatively
Trial research clinician to conf irm
eligibility before discharge
Physiotherapy (minimum of one session,
up to six sessions, over 12 weeks)
A home-based functional rehabilitation
programme (seven sessions over 12 weeks)
Follow-up assessment at 12 months
Usual-care rehabilitation CORKA intervention arm
Follow-up assessment at 6 months
FIGURE 1 Flow of participants through the trial.
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Both participants and those delivering the rehabilitation were aware of the treatment allocation owing
to the nature of the interventions.
Participants remained in the trial until data relating to their 12-month follow-up were collected.
The trial had two follow-up time points: 6 and 12 months after randomisation. The physiotherapists
carrying out the follow-ups remained blinded to the participants’ allocation.
Economic analysis
Once all participants completed their 12-month follow-up appointment, an economic analysis comparing
the community-based rehabilitation programme with usual care was conducted (described in Chapter 5).
Qualitative study
As part of the main study, a nested qualitative study was conducted with 10 participants who
undertook the community-based rehabilitation programme and 11 clinical staff who provided the
treatment (five therapists and six rehabilitation assistants). We conducted one-to-one interviews with
these participants to obtain their in-depth views about the intervention and how it was delivered
(described in Chapter 6).
Participants
Inclusion criteria
Participants were included in the trial if they met all of the following inclusion criteria:
l was willing and able to give informed consent for participation in the trial
l was male or female, aged ≥ 55 years
l was scheduled to have a primary UKA procedure
l was deemed by the study screening tool to be at risk of a poor outcome
l was willing to allow therapists to visit their home to deliver the community-based rehabilitation
programme if randomised to the intervention arm.
Exclusion criteria
Participants were excluded from the study if they met any of the following exclusion criteria:
l had any absolute contraindications to exercise
l had severe cardiovascular or pulmonary disease (New York Heart Association III-IV)35
l had severe dementia, assessed using the hospital dementia screening tool
l had rheumatoid arthritis
l had further lower limb surgery planned within 12 months
l had serious perioperative complications.
Screening and recruitment
Patients were initially identified from clinic lists. Those who were scheduled to receive a KA were sent
the CORKA participant invitation letter and participant information sheet. This pack was sent out by a
member of the patient’s usual-care team before they attended their pre-operative assessment clinic
appointment. Patients who had been sent the information were approached during their pre-operative
assessment clinic appointment to determine if they were interested in the trial, and were given the
opportunity to discuss the trial further and ask any questions. If the patient indicated that they were
interested in taking part, the CORKA screening tool was used to identify if they were at risk of a poor
outcome. They were also then checked for eligibility into the trial. Once they were deemed eligible, an
appointment was made to gain informed consent and collect baseline outcome data with a member of
the research team. This baseline appointment took place either in the hospital or in the patient’s own
home no more than 4 weeks before the date of surgery.
METHODS
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Patients were not formally recruited into the trial or randomised until their eligibility had been
re-checked on day three after surgery. Patients with serious peri-operative complications were
excluded, as they would not be able to complete routine post-operative rehabilitation. Those
participants who were still eligible were then asked to confirm their consent verbally to a member
of the research team before being enrolled into the trial and randomised (described in Intervention
monitoring and support).
Settings and locations
The trial was run in 14 NHS sites (names correct at time of participation):
l Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust
l Horton Hospital – Banbury
l The Royal Orthopaedic Hospital NHS Foundation Trust
l Ashford and St Peter’s Hospitals NHS Foundation Trust
l Northumbria Healthcare NHS Foundation Trust
l Southern Health NHS Foundation Trust
l Dorset County Hospital NHS Foundation Trust
l Dorset Healthcare University NHS Foundation Trust
l Royal United Hospitals Bath NHS Foundation Trust
l Countess of Chester Hospital NHS Foundation Trust
l Central Manchester NHS Foundation Trust
l Medway NHS Foundation Trust
l Medway Community Healthcare
l Epsom and St Helier University Hospitals NHS Trust.
Interventions
Full details of the interventions are provided in Chapter 3, but are described briefly here. This trial
tested physiotherapy and occupational therapy in a multicomponent package of rehabilitation that
was delivered by a generic rehabilitation therapist. The occupational therapy element focused on
assessment of and adaptations to participants’ homes to enable a safe environment for home exercise
and everyday functional tasks. The physiotherapy element included a home-based intervention with an
emphasis on functional, activity-based rehabilitation. We tested whether or not the intervention could
be delivered by generic rehabilitation assistants rather than uni-professionally.
Usual care can vary geographically, including the number of sessions of physiotherapy given post
discharge.36 To standardise the usual-care arm without changing it significantly, we set a minimum and
maximum number of sessions allowed for usual care. Participants were expected to attend at least one
and a maximum of six sessions of outpatient physiotherapy.
Data collection
Baseline assessments: pre surgery
Baseline data were collected on paper questionnaires and most measures were participant reported.
Baseline assessments were carried out either in the participant’s home or in the hospital. Wherever
the baseline assessment took place, the 6- and 12-month follow-ups were conducted in the same
location. All sites were given a research clinician manual that gave detailed instructions on how to
complete all baseline and follow-up measures.
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In addition to the battery of primary and secondary outcome measures, the following data were
collected at baseline: name, contact details, age, surgery, ASA classification rating, review of medical
notes and Functional Co-morbidities Index. The Functional Co-morbidities Index is a measure of
comorbidity and was completed because comorbidities affecting physical outcome are likely to be
present in this more frail population.35 Table 1 shows the measures collected at each time point.
Follow-up visits
The trial had two follow-up time points at 6 and 12 months post randomisation. Local site staff
organised follow-up and liaised directly with the participants to organise home-based follow-ups.
In addition to the outcome measures, the following data were collected at the two follow-up
time points:
l complications/adverse events, including any apparent KA-related complications since discharge
l falls, including time to first fall.
Outcomes
Follow-up data collection was carried out at face-to-face clinical assessments at 6 and 12 months
following randomisation. Where face-to-face assessment was not possible, postal and telephone data
collection methods were used to obtain self-reported core data. Table 1 shows the measures collected
at each time point.
Primary outcome
The primary outcome was the Late Life Function and Disability Instrument (LLFDI) overall function
score. This outcome instrument was developed specifically for community-dwelling older adults. It
assesses and responds to meaningful change in two distinct outcomes: a person’s ability to do discrete
actions or activities (function) and a person’s performance of socially-defined life tasks (disability).37
The overall function score consists of 32 items. Scores range from 0 to 100, with higher scores indicating
better function. The summary of the outcomes measured has previously been published in the protocol
paper by the authors.34
TABLE 1 Measures collected at each time point
Measure Baseline 6 months 12 months
Demographics ✗
Medical history ✗
Late Life Function and Disability Instrument ✗ ✗ ✗
Oxford Knee Score ✗ ✗ ✗
Quality-of-life subscale of the Knee Osteoarthritis Outcome Score ✗ ✗
Physical Activity Scale for the Elderly ✗ ✗ ✗
Health economics using EQ-5D-5L ✗ ✗ ✗
30-Second Chair Stand Test ✗ ✗ ✗
Figure-of-8 Walk Test ✗ ✗ ✗
Single Leg Stance test ✗ ✗ ✗
Participant diarya ✗ ✗
EQ-5D-5L, EuroQol-5 Dimensions, five-level version.
a Completed daily/as required at home for 6 weeks, then weekly. This measures exercises undertaken, medication
taken and use of health-care services and personnel.
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Secondary outcomes
l LLFDI disability frequency and limitation total dimension scores. These scores each consist of
16 items. They have a total score ranging from 0 to 100, with higher scores indicating higher
frequency and better capability of participation in life tasks.
l Oxford Knee Score (OKS). The OKS is a disease-specific measure to assess function and allow
comparison with data from large epidemiological cohort studies. It is a 12-item PROM that is
designed to measure pain and function after KA surgery.38 Each item is scored from 0 to 4, and
total scores are calculated as a sum across the individual items. Scores range from 0 (least severe
symptoms) to 48 (most severe symptoms).
l Knee injury and Osteoarthritis Outcome Score (KOOS) – Quality of Life subscale. This is a specific
instrument for knee osteoarthritis, which can also be analysed to calculate the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC). It is a self-reported questionnaire consisting
of five subscales: pain, other symptoms, function in daily living, function in sport and recreation,
and knee-related quality of life (QoL). The quality-of-life subscale of KOOS consists of four
self-reported questions.39 Total scores range from 0 (extreme problems) to 100 (no problems).
l Physical Activity Scale for the Elderly (PASE) questionnaire. This is a self-reported scale designed
to measure the physical activity level of those aged ≥ 65 years. It consists of three subscales:
leisure time activity, household activity and work-related activity. It is a short, self-administered
questionnaire to assess activity in the past week.40 Time spent participating in each activity is
weighted by the difficulty of that activity to calculate a total score. Higher scores indicate greater
levels of physical activity.
l Health economics using EuroQol-5 Dimensions, five-level version (EQ-5D-5L). This is a self-reported
outcome measure consisting of five dimensions: mobility, self-care, usual activity, pain and discomfort,
and anxiety and depression. Each dimension has five categories of response. It is designed to provide
a generic measure of health status for clinical and/or economic evaluation.41 Responses are converted
into multi-attribute utility scores, where 1 represents perfect health, 0 represents death and scores
< 0 represent a QoL worse than death.
l Physical measures. Physical measures included measures of balance, mobility and physical activity,
which are all affected by KA. Each test is reliable and valid, has been used with older, community-
dwelling adults and has been shown to be responsive in previous rehabilitation studies. Physical
function was measured by three physical performance tasks:42–44
¢ Figure of 8 Walk Test (F8WT). In the F8WT, participants are asked to walk in a figure of eight
around two cones. Their walk is timed, the number of steps taken counted and their accuracy in
performing the task (ability to stay within the test boundary) recorded.
¢ 30-Second Chair Stand Test (30SCST). The participant starts in a seated position on a chair with
a seat height of 17 inches. They are asked to complete as many full stands in 30 seconds as
possible, sitting down after each stand. The number of full stands they can complete is recorded.
¢ Single Leg Stance (SLS). The participant is asked to stand and lift one leg off of the ground
without using any other support. They are timed standing on one leg. The participant stands with
a chair in front of them should they require support. They are timed three times on each leg, for
a maximum of 45 seconds for each trial.
l Health resource diary. On discharge, participants were given a diary to regularly record:
¢ daily exercises undertaken (completed daily for 6 weeks and weekly thereafter)
¢ medication taken, including dose and frequency
¢ use of health-care services and personnel
¢ falls
¢ adverse events.
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Intervention monitoring and support
Quality assurance checks took place at all CORKA research sites. They included fidelity checks, during
which assessment and treatment delivery were observed. All aspects of the intervention were checked
against a predefined fidelity checklist that was created in line with the study protocol. Following checks,
feedback was given and any training needs or action points identified. The investigator site file was also
reviewed and any necessary changes were recorded. Staff at research sites were assured that support
could be provided as required, not just during a monitoring visit. Staff were encouraged to contact the
central CORKA trial team in Oxford if they had any questions or concerns about any aspect of the trial.
Randomisation
Randomisation took place using the Registration/Randomisation and Management of Product website
provided by the Oxford Clinical Trials Research Unit randomisation service.
Allocation
Participants were randomly allocated by a computer-generated system to either ‘usual care’ or
‘home-based exercise programme’ in a 1 : 1 ratio. Randomisation using permuted blocks of various
sizes (2, 4 and 6) in a 1 : 2 : 1 ratio was stratified by recruitment site to account for any site effects.
Blinding
Participants and those delivering the rehabilitation were aware of the treatment allocation owing to
the nature of the intervention. The therapists who carried out the follow-up visits remained blinded.
Sample size
We chose the LLFDI as the primary outcome using the overall function subscore at 1 year. The sample
size calculation was based on a moderately small standardised effect size of 0.275. This standardised
effect size is, for example, equivalent to detecting a three-point difference between treatment arms on
the LLFDI overall function score, assuming a standard deviation (SD) of 10.91 and no clustering effect
across sites.45
A total of 558 participants (279 per arm) would be required to detect a standardised effect size of
0.275, with 90% power and 5% (two-sided) significance. A 10% loss to follow-up was chosen based
on previous experience of trials in a similar population, which resulted in the planned sample size of
620 participants (310 per arm).
An internal pilot study was conducted at one site (Oxford) to review recruitment feasibility and
confirm the intervention package. Fifteen participants were randomised during this pilot study. These
participants are included in the final analysis, as the interventions were not changed between the pilot
and the main trial.
Data analysis
General analysis principles
Two analysis populations were considered: the intention-to-treat (ITT) population and the per-protocol
(PP) population. The ITT population, which was the primary analysis set, included all randomised
participants who were analysed according to their allocated intervention. Analyses of the primary
and key secondary outcomes were repeated for the PP population, which included participants who
received at least one session of their allocated intervention, did not receive more treatment than
METHODS
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intended (more than six sessions of usual care or seven sessions of home-based rehabilitation) and
provided follow-up data. The statistical significance level used throughout was 0.05, and 95% CIs are
reported. All analyses were undertaken using Stata® 15 (StataCorp LP, College Station, TX, USA).
The statistical analysis plan for this trial was prespecified and was approved by the trial Data Safety
Monitoring Committee and the Trial Steering Committee in October 2017. The agreed statistical
analysis plan was then published in Trials.46
Descriptive analyses and availability of data
The flow of participants through the trial from screening, through randomisation, allocation and
follow-up, to analysis was summarised using a Consolidated Standards of Reporting Trials (CONSORT)
patient-reported outcomes extension flow chart (see Figure 4).47 The baseline comparability of the
two treatment groups was summarised using numbers with percentages for binary and categorical
variables, and means and SDs or medians and interquartile ranges (IQRs) for continuous variables,
as appropriate, in terms of (1) risk factors for a poor outcome after KA according to the CORKA
screening tool,48 (2) baseline characteristics and (3) primary and secondary outcomes. Losses to
follow-up and withdrawals before 6-month follow-up and 12-month follow-up were reported by
intervention arm with reasons. Absolute risk differences were tested to ensure that there were no
differential losses between the two groups. The availability of all primary and secondary outcomes
from baseline to 12 months post randomisation was also summarised by intervention arm.
Treatment
Compliance with home-based rehabilitation was defined as completing at least four treatment sessions,
and with usual care as completing at least one treatment session. The number and percentage of
compliers in each treatment group was calculated. The average (median and IQR) number of treatment
sessions received in each treatment group was summarised overall and by site. Details of what the
treatment sessions involved were also summarised by treatment site for each intervention.
Analysis of the primary outcome
The LLFDI function scores at 6 and 12 months post randomisation were summarised by treatment group
and were analysed using a linear mixed-effects model with repeated measures adjusted for baseline
score and recruiting site (stratification factor). Time was treated as categorical and an interaction
between the outcome measurement time point and the randomised group was included so that the
treatment effect at each time point could be estimated, reported as the adjusted mean difference in
LLFDI between groups with 95% CI and associated p-value. The underlying assumptions of this model
were assessed. The primary time point was 12 months post randomisation. The primary analysis was
performed for the ITT population using multiple imputation to impute missing data. The multiple
imputation model included type of KA (TKA or UKA), gender, whether or not the participant had had
previous lower limb surgery, Charnley Classification score49 (whether the participant had single knee
arthropathy, bilateral knee arthropathy or multiple joint disease), whether or not a walking aid was
currently used, recruiting site and baseline score. Imputation was performed separately for each treatment
group, and 10 data sets were imputed (approximately equal to the percentage of missing data).
To examine the robustness of conclusions of different assumptions about missing data and departure
from randomised allocation, this analysis was repeated for the ITT population using available cases
only and for the PP population using available cases. A complier-average causal effect analysis was
undertaken using an instrumental variable approach.50,51
Analysis of secondary outcomes
Linear mixed-effects models with repeated measures, similar to those described for the primary outcome,
were used to analyse each of the secondary PROMs (LLFDI disability limitation, LLFDI disability frequency,
OKS, KOOS QoL, PASE, EQ-5D-5L utility and visual analogue scale), 30SCST (number of stands) and
F8WT (time and steps). These analyses were performed for the ITT population using available cases only.
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For the key secondary outcomes (LLFDI disability limitation, LLFDI disability frequency, OKS and KOOS
QoL), these analyses were repeated for the ITT population using multiple imputation (imputation model
as outlined for the primary outcome) and the PP population using available cases. A complier-average
causal effect analysis was also undertaken.
Average SLS test times were summarised using medians and IQRs for each treatment group at each
time point. Differences between the two groups were tested using a Wilcoxon rank-sum test, and
p-values were reported owing to the substantial floor and ceiling effects observed in this outcome.
These analyses were unadjusted and carried out separately at each time point.
Analysis of safety data
The number of adverse events and the number and percentage of participants experiencing adverse
events up to 6 months post randomisation, and between 6 and 12 months post randomisation, were
reported by treatment group. The number of participants with an adverse event was compared across
treatment groups using risk differences. Similar methods were used to analyse serious adverse events.
Monitoring and approvals
Formal approvals
The CORKA trial was approved by the National Research Ethics Service Committee South Central –
Oxford B in February 2015 (Research Ethics Committee reference 15/SC/0019) and by the Research
and Development department of each participating site. The Clinical Trials and Research Governance
office at the University of Oxford confirmed sponsorship in December 2014.
The first substantial amendment was submitted and approved in August 2015, in which the sample size
was recalculated using a consistent description of the clinically important standardised mean difference, a
45-minute travel inclusion zone was added and the KOOS was added to the questionnaire pack. A second
substantial amendment was granted in December 2015, which added the internal pilot participants to
the sample size, increasing the sample size from 620 to 635, and sought approval to send appointment
reminder letters to participants. A third substantial amendment was requested in February 2017 to
reduce the sample size back to 620.
Trial Steering Committee
A Trial Steering Committee was responsible for monitoring and supervising the progress of the CORKA
trial throughout its duration. The committee consisted of three independent experts, a lay member and
leading members of the trial management group.
Data Safety Monitoring Committee
The Data Safety Monitoring Committee was independent of the trial and was tasked with monitoring
progress, conduct, participant safety and data integrity. The trial statistician provided data and analyses
requested by the committee at each meeting.
Trial management group
A trial management group was responsible for the day-to-day management of the trial, consisting
of the chief investigator, research physiotherapist, statistician and trial manager. They ensured the
overall integrity of the trial, compliance with the protocols, welfare of all participants and appropriate
reporting of the trial.
METHODS
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Chapter 3 Intervention development
This chapter describes the steps taken by the CORKA trial team to produce the CORKA home-basedintervention. It describes the development process and each component of the intervention. The
CORKA home-based intervention was developed with consideration of the Medical Research Council’s
guidelines for developing and evaluating complex interventions52 and the Template for Intervention
Description and Replication checklist.53 A recent systematic review54 of intervention development
approaches has categorised differing approaches in a taxonomy. Although the CORKA home-based
intervention was developed before this taxonomy was published, we can classify the development
approach as a combined approach, with parts of the development aligning with the ‘target population
centred’, ‘theory and evidence-based’, and ‘intervention-specific’ taxonomy categories.
Overview of the development process
The CORKA home-based intervention development drew on a number of sources, including reviewing
the relevant evidence base on post-arthroplasty rehabilitation, identifying appropriate exercise guidelines
and seeking the views of relevant stakeholders. An intervention development day was organised that
was attended by research staff, physiotherapists and occupational therapists. During the day, potential
intervention approaches were discussed and refined, and factors associated with the design, content and
intervention delivery were discussed. A draft intervention was presented.
The draft intervention was reviewed and refined, then tested in a clinical NHS setting as part of a pilot
phase, which included participant and clinician feedback.
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FIGURE 2 Intervention development considerations.
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Health Technology Assessment programme brief
The first step in developing the CORKA home-based intervention was considering the HTA commissioning
brief. This brief called for an intensive and, if possible, multidisciplinary rehabilitation intervention in the
community setting that was designed for older adults who were at risk of poorer functional outcomes
following elective knee joint arthroplasty surgery that could be compared with usual care.
Evidence base
Before designing a draft intervention, we undertook a systematic search of the literature on
rehabilitation post-KA, and a wider search on the field of rehabilitation following arthroplasty. This
process identified a number of papers that were used in the design of the intervention. These papers
are outlined in Table 2 and are described in more detail in the following section on the rationale
underlying the CORKA home-based intervention.
TABLE 2 Key papers used to develop the CORKA home-based intervention
Authors and year
of publication Design Conclusion or key considerations
Relevant intervention
component
Bade et al. 201055 Cohort Impairments can persist 6 months after TKA. More




Cohort High-intensity early rehabilitation after TKA may




Review Higher-intensity rehabilitation programmes using
progressive resistance strengthening produce
long-term strength and functional gains
Functional task practice
Strengthening
Bhave et al. 200558 Cohort Functional limitations can be present after knee






RCT Improvements in the 6-minute walk test were




Coulter et al. 200959 Cohort Strengthening exercises delivered during one-to-one
physiotherapy or class-based physiotherapy after joint










Harmer et al. 200961 RCT Similar outcomes were demonstrated with land-
based and water-based rehabilitation after TKA
Graduated walking
programme
Heiberg et al. 201062 Cohort Difficulty can be experienced with strenuous




Kearns et al. 200863 Cohort Falling was reported by 78 out of 1341 consecutive
patients after TKA
Balance
Knoop et al. 201164 Narrative
review
People with knee osteoarthritis have decreased knee
proprioception
Balance




Liao et al. 201366 RCT Significant changes in the 10-metre walk test and
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TABLE 2 Key papers used to develop the CORKA home-based intervention (continued )
Authors and year













Altered gait patterns are observed following TKA Gait skills
Meier et al. 200869 Review Quadriceps muscle impairment can contribute to
functional limitations after total knee replacement
Functional task practice
Strengthening




Functional physiotherapy exercises resulted in
short-term benefit after total knee replacement
Functional task practice
Mizner et al. 200570 Cohort Functional performance was highly correlated with
quadriceps strength
Strengthening
Moffet et al. 200421 RCT Short- and mid-term functional ability was improved
by intensive functional rehabilitation
Strengthening
Naylor and Ko 201271 Mixed methods
study (nested
within a RCT)
Patients were able to exercise at moderately




Noble et al. 200572 Cross-section Significant functional impairments were experienced
by TKA patients
Functional task practice




Philbin et al. 199574 Cross-section Those with end-stage osteoarthritis of the lower
extremity can be severely deconditioned
Graduated walking
programme
Piva et al. 201019 Pilot RCT Balance training after TKA is feasible, as supported
by high adherence and a low dropout rate
Balance
Piva et al. 201175 Cross-section Physical function after arthroplasty can be influenced
by hip abduction strength
Strengthening
Pozzi et al. 201376 Systematic
review
Strengthening and intensive functional exercises should
be included in optimal physiotherapy programmes
Strengthening
Functional task practice
Ries et al. 199677 Cohort There can be improvements in cardiovascular fitness
at 1 or 2 years after TKA
Graduated walking
programme
Rowe et al. 200078 Cohort A suitable goal for knee rehabilitation is to reach
110° of knee flexion
Range of movement
exercises
Stratford et al. 201079 Cohort The first 12 weeks post arthroplasty is when




Stevens et al. 200380 Cohort Reduced quadriceps strength was observed in those
with knee osteoarthritis. This weakness persisted
post surgery
Strengthening
Su et al. 201081 Review Stiffness is a frequent complication after TKA Range of movement
exercises





Walsh et al. 199883 Cohort Physical impairments and functional limitations may
persist at 1 year after TKA
Strengthening
Wiik et al. 201384 Cohort Gait parameters were much closer to normal after
unicompartmental knee replacement than total knee
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Rationale underlying the CORKA intervention
The different components of the CORKA home-based intervention were informed by a review of
existing trials. The intervention primarily consists of a functional exercise programme. The rationale for
the following sections of this exercise programme is given below:
l range of movement exercises
l strengthening exercises
l balance exercises
l gait and aerobic exercise
l functional exercise.
Range of movement
Both flexion and extension can be limited after KA surgery.58,79 Stiffness is a common complication
after surgery,78 with as many as 60% of those undergoing KA experiencing stiffness.73 Many functional
activities require a knee joint range of 0–110°,80 and a significant proportion of this range is likely to
be attained within the first 12 weeks after surgery.79 A number of studies have, therefore, included
range of movement exercises in their post-arthroplasty interventions.56,66,75
Strengthening
Decreased quadricep strength is a common finding in people with knee osteoarthritis,80 and these
strength deficits can persist for a long time after KA.76 One year after arthroplasty, both knee flexor
and extensor peak muscle torque are lower in those who have undergone surgery than age-matched
controls.83 As there is a close link between muscle strength and functional performance, strength is
an important consideration for the population in question. For example, the ability to change position
from sitting to standing and the ability climb stairs have been linked to quadriceps strength.70 The
ability to get up from a chair, climb-up stairs, walk and change direction have been linked with hip
abduction strength.75 Hip and calf strength also perform a significant role in gait and balance.65,73
Strengthening exercises have formed part of previous interventions following lower limb arthroplasty,
targeting muscle groups such as the quadriceps, hamstrings, hip abductors and calf muscles.21,56,59,75
Balance
As KA surgery can affect gait, balance and stability,67 it is not surprising that falling has been reported as a
problem after KA.63 In a pilot study, Piva et al.19 gave participants functional training or functional training
enhanced by a balance training programme after KA. The pilot study’s design was underpowered to detect
changes between groups but showed that the balance training group had high adherence, had a low dropout
rate and reported no adverse events. A RCT66 that investigated the effect of adding a balance programme
to functional training after KA reported that those in the balance training group had significantly better
outcomes, including on the Timed Up and Go, 10-metre walk, 30SCST and Stair Climb tests.
Gait skills and aerobic exercise
McClelland et al.68 conducted a systematic review that studied gait analysis following KA and
concluded that patients exhibit altered gait patterns after surgery. Gait problems after KA include
specific gait deficits linked to underlying problems, such as reduced range of movement or pain,
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and general problems, such as decreased walking speed and endurance.62,68,83 Such gait problems may
continue to persist 1 year after surgery. Patients undergoing UKA are more likely to exhibit a gait
pattern closer to normal than patients undergoing TKA.84 It is important to consider gait in patients
who have undergone KA, as gait outcomes influence patient satisfaction.82
Bruun-Olsen et al.20 undertook a RCT comparing a walking skills intervention with usual physiotherapy.
They reported that the walking skills group demonstrated better short-term and long-term functional
mobility. Walking can also be considered from a wider cardiovascular perspective. People with end-
stage lower limb osteoarthritis are likely to be physically deconditioned,74,77 which can be exacerbated
immediately after surgery owing to reduced mobility. Naylor and Ko71 found that moderate-intensity
exercise was tolerable and safe following KA. Later studies have included aerobic exercise using cycling
on a static bike or walking on a treadmill.59,61
Functional exercise
Functional limitations can persist after the immediate post-operative period following KA.57,69 One year
post KA surgery, it is common for patients to be significantly slower with activities, such as walking or
stair climbing, and have more functional impairments with tasks that involve kneeling or squatting than
matched controls.72,83 Measurements of function, such as the Timed Up and Go, 6-minute walk, Stair
Climb and SLS tests, have been found to be worse in participants following KA at 1, 3 and 6 months
after surgery than in healthy participants.55 A 2007 systematic review18 investigating the effectiveness
of post-KA exercise advocated for the use of functional physiotherapy exercise interventions to achieve
short-term benefits. It found that the interventions had a small to moderate effect on functional
outcomes, QoL and joint range of movement at 3 to 4 months after surgery; however, these benefits
were not found 1 year after surgery. A later study explored function after KA57 and a 2013 systematic
review76 of exercise after KA recommended that physiotherapy interventions include strengthening and
functional exercise.
Guidelines
Currently, there are no specific exercise guidelines for patients after KA. We considered two relevant
guidelines for patients following KA when developing the CORKA home-based intervention:
l Physical activity and public health in older adults: recommendation from the American College of
Sports Medicine and the American Heart Association.85
l Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal,
and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise.86
These guidelines cover exercise guidelines for adults aged 65 years or older and aged 50–64 years
with functional limitations or a chronic condition,85 and apparently healthy adults of all ages.86 On the
basis of these guidelines, it is recommended that participants accumulate five sessions of 30 minutes
of moderate-intensity physical activity per week, which is accumulated in at least 10-minute bouts.
Intervention development day and workshop
An intervention development day was attended by researchers, physiotherapists and occupational
therapists. A draft intervention developed using the evidence base and guidelines outlined above was
presented at the workshop. The proposed intervention programme, strategies for exercise progression
and patient materials were discussed and reviewed. Feedback was given on all aspects of the proposed
intervention, leading to changes in the content of the intervention and patient materials.
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Pilot phase
Following the workshop, a final version of the CORKA home-based intervention was compiled. It was
then tested in a pilot phase with 15 participants. Three participants and two clinicians were interviewed
after the participants had completed their treatment sessions to get feedback on the intervention
content and the mode of delivery. As a result, changes were made to the participant materials and
intervention procedures. These modifications included retaking some of the photographs used in the
participant exercise sheets to make them brighter and more vibrant, and providing a space on the sheets
for participants to make comments.
The CORKA intervention arms
The CORKA trial had two intervention arms:
l usual care
l the CORKA home-based intervention.
The intervention arms are described in the following sections.
Usual care
Those who were allocated to the usual-care arm received standard post-operative physiotherapy, as
offered by their local physiotherapy department. It was recognised that usual care after KA could
vary considerably across the trial’s UK locations.36 However, there was a reasonable likelihood that
it would include some of the following: one to six sessions of physiotherapy in an outpatient setting,
class-based setting or hydrotherapy; written advice on home exercise at discharge from hospital;
and an assessment of any potential home requirements and barriers to discharge by an occupational
therapist. To standardise usual care as much as possible, participants were expected to attend at least
one and no more than six sessions of usual-care physiotherapy.
The CORKA home-based intervention
The CORKA home-based intervention was an individually tailored, multicomponent rehabilitation
programme that could be adapted for each participant. The intervention’s aim was to improve the
function and participation of participants who were at risk of a poor outcome post KA. The primary
component was an individually adapted exercise programme that was conducted in the participant’s
own home, with additional components consisting of functional task practice, appropriate adherence
approaches and, if required, the provision of appropriate aids and equipment.
The CORKA home-based intervention started within 4 weeks of surgery. It comprised an initial home
assessment appointment, followed by up to six follow-up sessions. It was designed to be delivered
by a mixture of qualified occupational therapy and physiotherapy staff, and rehabilitation assistants.
The CORKA home-based intervention is outlined further in Figure 3.
Home exercise programme
The CORKA home-based intervention exercise programme comprised groups of possible exercises that
were arranged into the following categories:
l knee flexion range of movement
l knee extension range of movement
l basic quadriceps strengthening
l strengthening – quadriceps
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l strengthening – hamstrings
l strengthening – hip abductors
l strengthening – calf
l balance
l gait skills.
The programme included a range of exercises in each category, and at least one exercise from each
category was to be selected for a participant’s exercise programme. This allowed the intervention to
cover a range of exercises and be tailored to each participant.
Functional task practice
A functional task practice component was also included. During a participant’s first appointment, the
therapist focused on tasks that the participant had identified as being potentially problematic. The
exercise programme was, therefore, tailored to the specific needs, goals and functional problems of
the individual. As necessary, different techniques were used as part of a problem-solving approach,
including breaking the task down and identifying any specific components for practice. Each task could
also be demonstrated and practised during the intervention sessions. To reinforce the importance of
practising the selected tasks during their daily life, participants were encouraged to follow the written
advice in the exercise diary.
Graduated walking programme
The graduated walking programme was included as it was deemed the most practical and relevant
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FIGURE 3 Components of the CORKA home-based intervention exercise programme. ROM, range of movement.
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exercise programme. It was considered likely that participants would have a wide range of mobility
levels at entry into the trial. The aim of the graduated walking programme was to increase walking
distance and/or time. During session 3 of the CORKA home-based intervention, participants were
asked about their walking and how far or how long they were currently able to walk. They were then
asked to gradually increase this distance and/or time, giving consideration to any pain or swelling.
Walking was reviewed at subsequent follow-up sessions.
Prescription and progression
Therapists and assistants were asked to use treatment algorithms and decision aids to prescribe and
progress participants’ exercises, which are outlined and described in Table 3. The Rating of Perceived
Exertion scale87 that is mentioned is an 11-point scale that allows participants to rate how hard they
feel they are working during exercise.
TABLE 3 Prescription and progression of exercise













l RPE of ≥ 5




l Increase in pain
lasting longer than
2 hours post exercise
l Significant increase
in swelling
l RPE of 3–4
l Able to complete
6–12 repetitions
with good form
l RPE of < 3









l Participant at risk
of falling
l Pain lasting longer
than 2 hours
post exercise
l A significant increase
in swelling
l Exercise is challenging
for the participant but
does not put them at
risk of falling























the exercise is not
being performed
correctly





l Exercise is too
challenging for the
participant, putting
them at risk of falling
l Exercise is challenging
for the participant but
does not put them at
risk of falling
l Exercise is not
challenging for
the participant





l RPE of ≥ 5
l Pain lasting longer
than 2 hours
post exercise
l A significant increase
in swelling
l RPE of 3–4 l RPE of < 3
Task practice l Practice one to three
tasks as required
during daily life
l Task practice is too
challenging for the
participant, putting
them at risk of falling
l Task practice is
challenging for the
participant but does
not put them at risk
of falling
l Task practice is
not challenging
for the participant
Reps, repetitions; RPE, rating of perceived exertion.
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Exercise duration and frequency
It was envisaged that the whole exercise programme would take 15–25 minutes to complete. Participants
were advised that their exercise programme could be performed as one block or spread throughout the
day. They were asked to perform the exercise programme daily, although it was recognised that this
would not be possible for everyone.
Modifications
The therapists and rehabilitation assistants delivering the CORKA home-based intervention were
encouraged to use their clinical reasoning skills when assessing and treating participants. If at any time
they felt that it would be unsafe or inappropriate to give a participant an exercise from one or more of
the intervention’s categories, then they were advised not to do so. If they decided that a participant
needed additional exercises from an intervention category, for example if they felt that a participant
had a particular problem with knee flexion and needed to be given more than one exercise from the
knee flexion range of movement category, then they were encouraged to do so. Clinicians were asked
to record any modifications that they made on the treatment logs that were returned to the central
CORKA trial team.
Information booklet
Participants were given an information booklet that contained information about topics relevant to
patients after KA, such as wound management, pain and swelling, expected symptoms, scar massage,
walking, slips, trips and falls, kneeling, stairs, driving, returning to work, and returning to leisure
activities or sports.
Adherence approaches
A number of adherence strategies were used within the intervention to encourage participants to
adhere to their exercise programme, including an exercise diary, a behavioural contract and goal-setting.
Participants recorded their exercises, repetitions and sets in an exercise diary so that they could monitor
their own progress.
The CORKA trial participant materials included a behavioural contract. Participants were asked when
they would be able to perform their exercises, whether or not there was a specific location where they
could perform their exercises and if there was anyone who could help them undertake their exercise
programme. The therapists and participant signed this contract to encourage adherence.
The therapist and participant took time to discuss the goals that were important to the participant.
These goals were written in the appropriate section in the participant materials, along with the
steps that the participant would follow to meet the goals: (1) practice tasks related to the goals,
(2) undertake their tailored exercise programme and (3) record their exercise progress in the exercise
diary provided. Each participant was given opportunities to review and set new goals as required in
follow-up treatment sessions.
Intervention materials
Trial sites were given at least one copy of the treating therapists’ manual. This manual gave a detailed
overview of the intervention and a point-by-point guide for each intervention session, including how to
select the initial exercise level for each section of the exercise programme. It also included copies of all
of the paperwork needed for the intervention and the contact details for the central CORKA team.
The CORKA website (https://corka.octru.ox.ac.uk/) was a further resource for staff at research sites.
It contained a section for site staff that sites gained access to once they had signed up for the trial.
This section included digital copies of all trial documents needed for that site.
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Intervention providers and setting
The CORKA home-based intervention was undertaken using qualified therapists and rehabilitation
assistants. The initial appointment consisted of a home assessment that was conducted by a therapist
and a rehabilitation assistant. Subsequent rehabilitation sessions were undertaken by the rehabilitation
assistant, except for one session midway through the treatment that was undertaken by the qualified
therapist. Clear channels of communication were encouraged, and rehabilitation assistants were asked
to feed back to the qualified staff member after all treatment sessions. All of the therapists that
delivered the intervention were UK-registered physiotherapists or occupational therapists, with
NHS banding ranging from 5 to 7. The rehabilitation assistants were NHS bands 3 or 4.
Training
All members of staff who were involved in delivering the CORKA home-based intervention received a
2- to 3-hour training session that was delivered by the central CORKA trial team. The training included
instructions on how to assess and treat CORKA participants, prescribe and progress the different
categories within the exercise programme, and complete the trial paperwork, in line with the trial
protocol. None of the intervention components was beyond the normal scope of practice for the staff
who delivered the intervention.
Safety and serious adverse events
The safety of participants and therapists was paramount and was considered as part of the CORKA
home-based intervention. All trial site staff members delivering the intervention were encouraged to
consider their and their patients’ safety. One of the significant considerations for a community-based
trial like CORKA is that staff are by themselves when visiting participants in their homes. All staff
members at all sites were, thus, asked to adhere to their organisation’s lone-working policy. They were
also asked to report anything that they felt might constitute a serious adverse event. To make this
process as easy as possible for clinicians involved in the treatment sessions, they were encouraged to
discuss any questions or concerns with the central CORKA team in Oxford.
INTERVENTION DEVELOPMENT




The trial opened for recruitment on 17 March 2015, and the first participant was randomised on 27
March 2015. As recruitment was slower than predicted in the first year, the funder (HTA programme)
requested a recovery plan be put in place. The recovery plan was reviewed by the Trial Steering Committee
on 16 June 2016 and submitted to the HTA programme on 8 July 2016. In February 2017, a funding
extension was agreed with the HTA programme with a revised trial end date of 31 December 2019.
The final randomisation took place on 26 January 2018. In total, 2788 patients were screened and
621 participants were recruited to the trial. The 12-month follow-up was completed in February 2019.
The CONSORT flow chart (Figure 4) summarises the flow of participants through the trial, including
details of the number of participants randomised and the numbers allocated to and receiving at least
one session of each treatment. The number of participants followed up at 6 and 12 months and providing
the primary outcome measure is summarised by treatment group. Reasons why participants were not
followed up are also included. The numbers of participants included in the ITT and PP populations are
summarised by treatment group.
Available data
The data available at baseline and at each follow-up time point (6 and 12 months) are summarised by
treatment group in Table 4. These data include which participants returned a case report form (CRF) at
each time point and which participants returned a questionnaire. Reasons for data not being available
are also summarised. The proportion of available data is high at both 6 and 12 months; approximately
90% for each treatment group. There were no significant differences in data availability between the
two groups (Table 5).
Withdrawals
Thirty-four participants (5.5%) withdrew from follow-up during the course of the trial. Most withdrawals
were because of participants withdrawing their consent (n = 28), with the rest a result of a clinical
decision (n = 6). Most of the withdrawals happened before the 6-month follow-up (n = 24) and the
remainder happened between the 6-month and the 12-month follow-up (n = 10). Three participants
died between the 6-month and the 12-month follow-up.
Baseline characteristics
Randomisation in the CORKA trial was stratified by recruiting site. The number and proportion of
participants randomised to each treatment group at each site are summarised in Table 6. Participants
were well balanced between the two groups at each site.
A screening tool was used to identify participants at higher risk of a poor outcome following KA for
inclusion in the CORKA trial (see Chapter 7). The key features of the screening tool were body mass
index (BMI), pain, health status and anxiety or depression.
Table 7 summarises the number and proportion of people satisfying each of the criteria, which combine to
give the total screening tool score. These appear well balanced across the two treatment groups. The slight
apparent imbalance in BMI may have been because this variable was treated as categorical (see Table 8).
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Table 7 also included the contribution of each characteristic to the total score, the number of participants
with each score and the constituent parts that make up that score. All participants met the moderate to









• ITT population,b n = 312 (100.0%)
• PP population,c n = 235 (75.3%)
• ITT population,b n = 309 (100.0%)
• PP population,c n = 280 (90.6%)
• Ineligible, n = 591 (21.2%)
• Declined, n = 794 (28.5%)
• No surgery, n = 151 (5.4%)
• Missed, n = 616 (22.1%)
• Ineligible after surgery, n = 15 (0.5%)
Excluded
• ≥ 1 session, n = 297 (95.2%)
• LLFDI function, n = 309 (99.0%)
Usual care
(n = 312)
• ≥ 1 session, n = 299 (96.8%)
• LLFDI function, n = 307 (99.4%)
Home-based rehabilitation
(n = 309)
• LLFDI function, n = 283 (90.7%)
• Withdrew consent, n = 11 (3.6%)
• Clinical withdrawal,a n = 1 (0.3%)
• LTFU, n = 4 (1.3%)
• Missed, n = 8 (2.6%)
Followed up
(n = 288) (92.3%)
Data not available
(n = 24) (7.7%)
• LLFDI function, n = 276 (89.3%)
• Withdrew consent, n = 8 (2.6%)
• Clinical withdrawal,a n = 4 (1.3%)
• LTFU, n = 5 (1.6%)
• Missed, n = 11 (3.6%)
Followed up
(n = 281) (90.9%)
Data not available
(n = 28) (9.1%)
• LLFDI function, n = 287 (92.0%)
• Withdrew consent, n = 14 (4.5%)
• Clinical withdrawal,a n = 2 (0.6%)
• LTFU, n = 5 (1.6%)
• Died, n = 1 (0.3%)
• Missed, n = 2 (0.6%)
Followed up
(n = 288) (92.3%)
Data not available
(n = 24) (7.7%)
• LLFDI function, n = 279 (90.3%)
• Withdrew consent, n = 14 (4.5%)
• Clinical withdrawal,a n = 4 (1.3%)
• LTFU, n = 8 (2.6%)
• Died, n = 2 (0.6%)
• Missed, n = 1 (0.3%)
Followed up
(n = 280) (90.6%)
Data not available
(n = 29) (9.4%)
FIGURE 4 The CONSORT flow chart. LTFU, lost to follow-up. a, Clinical withdrawals include those who withdrew owing
to an adverse event, serious adverse event or medical contraindication; b, missing follow-up data in the ITT population
were imputed using multiple imputation for the primary outcome analysis; c, analysis of the PP population was based on
available data only.
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The descriptive characteristics of all randomised participants are summarised by treatment group, and
overall, in Table 8. These values are presented as numbers and percentages for binary and categorical
factors, and as means and SDs or medians and IQRs, as appropriate, for continuous variables. These
variables appear well balanced across the two treatment groups.
The PROMs and physical measure baseline values are summarised by treatment group, and overall,
in Table 9, and are all similar across the two treatment groups.
TABLE 4 Data available at each time point by treatment group
Data
Usual care
(N= 312), n (%)
Home-based rehabilitation
(N= 309), n (%)
Baseline
Data available 312 (100.0) 309 (100.0)
Completed CRF 312 (100.0) 309 (100.0)
Completed questionnaire 312 (100.0) 309 (100.0)
6 months
Data available 288 (92.3) 281 (90.9)
Completed CRF 280 (89.7) 276 (89.3)
Completed questionnaire 284 (91.0) 278 (90.0)
Data not available 24 (7.7) 28 (9.1)
Withdrawna 12 (2.8) 12 (3.9)
Missingb 12 (3.8) 16 (5.2)
12 months
Data available 288 (92.3) 280 (90.6)
Completed CRF 282 (90.4) 276 (89.3)
Completed questionnaire 287 (92.0) 279 (90.3)
Data not available 24 (7.7) 29 (9.4)
Withdrawna 16 (5.1) 18 (5.8)
Missingb 7 (2.2) 9 (2.9)
Died 1 (0.3) 2 (0.6)
a Data not available owing to being withdrawn includes participants who withdrew consent or were withdrawn for a
clinical reason.
b Data not available owing to being missing includes participants who were marked as lost to follow-up or who did
not provide data at the specified time point.
Note
Case report forms included the data collected by the clinical team (e.g. physical measures), whereas questionnaires
were used to record the patient-reported outcomes.
TABLE 5 Testing difference in missing data
Time point Risk difference (95% CI) p-value
6 months –0.01 (–0.06 to 0.03) 0.54
12 months –0.02 (–0.06 to 0.03) 0.45
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(N= 312), n (%)
Home-based
rehabilitation
(N= 309), n (%) Total (N= 621), n (%)
Site 1 33 (10.6) 34 (11.0) 67 (10.8)
Site 2 38 (12.2) 38 (12.3) 76 (12.2)
Site 3 4 (1.3) 4 (1.3) 8 (1.3)
Site 4 8 (2.6) 7 (2.3) 15 (2.4)
Site 5 8 (2.6) 7 (2.3) 15 (2.4)
Site 6 1 (0.3) 1 (0.3) 2 (0.3)
Site 7 3 (1.0) 2 (0.6) 5 (0.8)
Site 8 1 (0.3) 2 (0.6) 3 (0.5)
Site 9 2 (0.6) 2 (0.6) 4 (0.6)
Site 10 15 (4.8) 14 (4.5) 29 (4.7)
Site 11 30 (9.6) 30 (9.7) 60 (9.7)
Site 12 99 (31.7) 100 (32.4) 199 (32.0)
Site 13 65 (20.8) 63 (20.4) 128 (20.6)
Site 14 5 (1.6) 5 (1.6) 10 (1.6)
TABLE 7 The CORKA trial screening tool details by treatment group
Screening tool details
Usual care
(N= 312), n (%)
Home-based
rehabilitation




Normal (0) 11 (3.5) 7 (2.3) 18 (2.9)
Overweight (1) 121 (38.8) 138 (44.7) 259 (41.7)
Obese (2) 180 (57.7) 164 (53.1) 344 (55.4)
Usual pain from knee
Moderate or severe (4) 312 (100.0) 309 (100.0) 621 (100.0)
Health status
Fit and healthy (0) 296 (94.9) 298 (96.4) 594 (95.7)
Severe systemic disease (2) 16 (5.1) 11 (3.6) 27 (4.3)
Limited
None, a little or some of the time (0) 248 (79.5) 248 (80.3) 496 (79.9)
Most or all of the time (2) 64 (20.5) 61 (19.7) 125 (20.1)
Screening tool scores and constituent parts
5 – Overweight 87 (27.9) 104 (33.7) 191 (30.8)
6 – Obese 150 (48.1) 135 (43.7) 285 (45.9)
6 – Severe systemic disease 1 (0.3) 0 (0.0) 1 (0.2)
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TABLE 7 The CORKA trial screening tool details by treatment group (continued )
Screening tool details
Usual care
(N= 312), n (%)
Home-based
rehabilitation
(N= 309), n (%)
Total (N= 621),
n (%)
6 – Limited most/all of the time 10 (3.2) 7 (2.3) 17 (2.7)
7 – Overweight and severe systemic disease 4 (1.3) 6 (1.9) 10 (1.6)
7 – Overweight and limited most/all of the time 26 (8.3) 27 (8.7) 53 (8.5)
8 – Obese and severe systemic disease 6 (1.9) 3 (1.0) 9 (1.4)
8 – Obese and limited most/all of the time 23 (7.4) 25 (8.1) 48 (7.7)
9 – Overweight and severe systemic disease
and limited most/all of the time
4 (1.3) 1 (0.3) 5 (0.8)
10 – Obese and severe systemic disease and
limited most/all of the time
1 (0.3) 1 (0.3) 2 (0.3)
Numbers in brackets indicate the contribution that each element makes to the total screening tool score.
Limited refers to being limited in usual activities owing to feeling anxious or depressed.
TABLE 8 Descriptive characteristics at baseline by treatment group
Characteristic Usual care (N= 312)
Home-based
rehabilitation
(N= 309) Total (N= 621)
Gender, n (%)
Male 125 (40.1) 125 (40.5) 250 (40.3)
Female 187 (59.9) 184 (59.5) 371 (59.7)
Age (years), mean (SD) 70.18 (8.14) 70.67 (8.01) 70.42 (8.07)
BMI (kg/m2), mean (SD) 31.65 (4.99) 31.34 (4.48) 31.50 (4.74)
Side of operation, n (%)
Right 169 (54.2) 169 (54.7) 338 (54.4)
Left 142 (45.5) 139 (45.0) 281 (45.2)
Not recorded 1 (0.3) 1 (0.3) 2 (0.3)
Knee arthroplasty type, n (%)
TKA 229 (73.4) 231 (74.8) 460 (74.1)
UKA 82 (26.3) 77 (24.9) 159 (25.6)
Not recorded 1 (0.3) 1 (0.3) 2 (0.3)
ASA classification grade, n (%)
Healthy 38 (12.2) 55 (17.8) 93 (15.0)
Mild systemic disease 218 (69.9) 202 (65.4) 420 (67.6)
Severe systemic disease 43 (13.8) 44 (14.2) 87 (14.0)
Not recorded 13 (4.2) 8 (2.6) 21 (3.4)
continued
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TABLE 8 Descriptive characteristics at baseline by treatment group (continued )
Characteristic Usual care (N= 312)
Home-based
rehabilitation
(N= 309) Total (N= 621)
Falls in the last year
Yes, n (%) 77 (24.7) 89 (28.8) 166 (26.7)
No, n (%) 235 (75.3) 220 (71.2) 455 (73.3)
If yes, number of falls, median (IQR) 1 (1, 3) 2 (1, 3) 2 (1, 3)
Previous lower limb surgery, n (%)
Yes 200 (64.1) 189 (61.2) 389 (62.6)
No 112 (35.9) 120 (38.8) 232 (37.4)
Screening tool score, median (IQR) 6 (5, 6) 6 (5, 6) 6 (5, 6)
Charnley ABC, n (%)
A: single KA 134 (42.9) 138 (44.7) 272 (43.8)
B: both knees affected 140 (44.9) 145 (46.9) 285 (45.9)
C: multiple joint disease/other disability 38 (12.2) 26 (8.4) 64 (10.3)
Stairs mobility, n (%)
Normal 19 (6.1) 19 (6.1) 38 (6.1)
One step at a time 34 (10.9) 39 (12.6) 73 (11.8)
Down with rail 18 (5.8) 19 (6.1) 37 (6.0)
Up/down with rail 225 (72.1) 216 (69.9) 441 (71.0)
Unable down 2 (0.6) 3 (1.0) 5 (0.8)
Unable 14 (4.5) 12 (3.9) 26 (4.2)
Missing 0 (0.0) 1 (0.3) 1 (0.2)
Support mobility, n (%)
None 178 (57.1) 178 (57.6) 356 (57.3)
Stick outdoors 83 (26.6) 78 (25.2) 161 (25.9)
Stick always 34 (10.9) 31 (10.0) 65 (10.5)
Two sticks 6 (1.9) 7 (2.3) 13 (2.1)
Two crutches 5 (1.6) 7 (2.3) 12 (1.9)
Walking frame 6 (1.9) 8 (2.6) 14 (2.3)
Functional comorbidity index,a n (%)
0 189 (60.6) 176 (57.0) 365 (58.8)
1–3 112 (35.9) 125 (40.5) 237 (38.2)
4–6 8 (2.6) 6 (1.9) 14 (2.3)
7 or more 2 (0.6) 0 (0.0) 2 (0.3)
Missing 1 (0.3) 2 (0.6) 3 (0.5)
a The functional comorbidity index88 counts the number of comorbidities experienced by each patient, giving more
weight to more severe conditions. This was categorised in four groups: (1) no comorbidities (0), (2) small number of
comorbidities (1–3), (3) medium number of comorbidities (4–6), and (4) high number of comorbidities (7 or more).
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Treatment compliance
Participants were defined as complying with usual-care if they attended at least one treatment session.
Compliance with home-based rehabilitation was defined as receiving at least four treatment sessions.
Table 10 summarises the number and percentage of compliers in each treatment group, the number of
participants who attended no sessions and the average number of treatment sessions received.
Compliance was high in both groups. The median number of treatment sessions was higher in the
home-based rehabilitation arm than in the usual-care arm. However, there was significant variability
in the number of sessions of usual care received, ranging from 0 to 27 sessions. Participants who
underwent UKA and TKA attended similar average (median, IQR) numbers of sessions. Figure 5 shows
how many participants in each treatment group received each number of sessions.
TABLE 9 Primary and secondary outcomes at baseline by treatment group
Outcome Usual care (N= 312)
Home-based
rehabilitation
(N= 309) Total (N= 621)
LLFDI function, mean (SD) 51.21 (7.09) 51.68 (7.17) 51.45 (7.13)
LLFDI disability (frequency), mean (SD) 51.28 (7.25) 51.55 (7.46) 51.42 (7.35)
LLFDI disability (limitation), mean (SD) 66.26 (11.96) 66.25 (12.48) 66.26 (12.21)
EQ-5D-5L utility, median (IQR) 0.59 (0.39, 0.70) 0.59 (0.39, 0.70) 0.59 (0.39, 0.70)
EQ-5D-5L VAS, median (IQR) 70.0 (58.0, 80.0) 75.0 (55.0, 80.0) 70.0 (55.0, 80.0)
OKS,a mean (SD) 20.59 (7.50) 20.81 (7.31) 20.70 (7.40)
PASE, median (IQR) 114.4 (62.2, 160.0) 98.5 (62.2, 149.6) 108.2 (62.2, 157.4)
KOOS, median (IQR) 25.0 (12.5, 37.5) 25.0 (12.5, 37.5) 25.0 (12.5, 37.5)
30SCST number of stands, median (IQR) 8 (6, 10) 8 (6, 11) 8 (6, 10)
30SCST adaptations, n (%)
None 211 (67.6) 214 (69.3) 425 (68.4)
Uses hands on legs 94 (30.1) 90 (29.1) 184 (29.6)
Uses walking aid 2 (0.6) 4 (1.3) 6 (1.0)
Not tested: unable 5 (1.6) 1 (0.3) 6 (1.0)
F8WT
Time (seconds), median (IQR) 10.3 (8.6, 13.0) 10.9 (9.0, 14.0) 10.6 (8.8, 13.5)
Steps, median (IQR) 16.0 (13.0, 19.0) 16.0 (14.0, 19.0) 16.0 (14.0, 19.0)
Stayed within cones, n (%) 303 (97.1) 304 (98.4) 607 (97.7)
F8WT smoothness score, n (%)
0 9 (2.9) 11 (3.6) 20 (3.2)
1 73 (23.4) 87 (28.2) 160 (25.8)
2 50 (16.0) 56 (18.1) 106 (17.1)
3 180 (57.7) 155 (50.2) 335 (53.9)
SLS test average time (seconds), median (IQR)
KA side 5.3 (2.6, 13.0) 4.5 (1.9, 14.5) 5.1 (2.2, 14.0)
Other side 7.2 (3.6, 22.0) 6.3 (2.6, 18.0) 6.9 (3.2, 19.8)
VAS, visual analogue scale.
a Includes scores imputed as per the handbook.
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The time from randomisation to first treatment session is also summarised in Table 10. Most
participants received their first session within 4 weeks, as per the protocol. Similar numbers of
participants received their first treatment within 4 weeks in the two treatment arms.
The average (median and IQR) and minimum and maximum number of treatment sessions received
were calculated separately by treatment group for each recruiting site (Table 11). The ‘other’ category
for recruiting sites includes all sites that recruited < 15 participants. Sites 4 and 5 provided follow-up
care jointly and are, therefore, combined in this table.
Substantial variability by site in the number of treatment sessions received was identified. The median
number of sessions of usual-care treatment ranged from just two sessions at site 13 to six sessions at
site 1. Similarly, the median number of sessions of home-based rehabilitation varied from four sessions
at site 1 to seven sessions at sites 4 and 5 and site 10. Site 1 participants who were allocated to usual
care received more treatment sessions, on average, than those allocated to home-based rehabilitation.
TABLE 10 Compliance with treatment by allocated treatment group




Minimum number of sessions for compliance 1 4
Compliers, n (%) 297 (95.2) 269 (87.1)
Participants with no treatment logs, n (%) 12 (3.8) 10 (3.2)
Number of sessions, median (IQR) 4 (2, 6) 5 (4, 7)
Number of sessions (minimum, maximum) (0, 27) (0, 8)
Number of sessions by replacement type, median (IQR)
TKA 4 (2, 6) 5 (4, 7)
UKA 3 (3, 4) 5 (4, 6)
Time to first session, n (%)
≤ 4 weeks 273 (87.5) 276 (89.3)
4–8 weeks 15 (4.8) 20 (6.5)
> 8 weeks 7 (2.2) 2 (0.6)
Did not start 13 (4.2) 10 (3.2)
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FIGURE 5 Comparison of number of treatment sessions received in the two treatment groups.
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Details of the usual care delivered by each site are summarised in Table 12. Again, the ‘other’ sites
are grouped together and sites 4 and 5 are combined. The total number of sessions provided, the
number of participants recruited and the average number of sessions are given for each site. The
number and proportion of sessions taking place in each location (home and hospital) are summarised
by site. Although > 80% of sessions took place in hospital at most sites, only 21.6% of sessions took
place in hospital at site 13, with the rest of the usual-care patients seen in a community setting.
The number and proportion of sessions of individual therapy provided at each site are summarised.
The sites can be separated into two groups. At sites 1 and 11 and the ‘other’ sites, the sessions were
split relatively evenly between individual therapy (40% to 60% of participants) and group therapy.
At the remaining sites, > 80% of the sessions were individual therapy. Most sessions at all sites were
exercise therapy (> 85%).
Details of the home-based rehabilitation treatment delivered by each site are summarised in Table 13.
The number of participants and the total number of treatment sessions given are included in this table.
The number and proportion of treatment sessions, including each type of exercise, appear similar across
sites, with some notable exceptions. A smaller proportion of sessions delivered by site 1 than the rest of
the sites included flexion, extension and basic quadriceps exercises, and a smaller proportion of sessions
delivered by site 13 than the rest of the sites included static balance and gait skills exercises.
Primary outcome analyses
Trends in LLFDI function scores over time are plotted for each treatment group in Figure 6. There was
a substantial improvement between baseline and 6 months in both groups, with minimal additional
difference between 6 and 12 months post randomisation. No substantial differences between the two
groups are visible at either time point.
The primary analysis of the LLFDI function score was carried out for the ITT population using multiple
imputation. There was no statistically significant difference between the two treatment groups at the
primary time point of 12 months post randomisation (adjusted difference 0.49, 95% CI –0.89 to 1.88;
p = 0.34) or at 6 months (Table 14).
TABLE 11 Number of treatment sessions by site for each treatment group
Site
Usual care Home-based rehabilitation
Median (IQR) (Min, max) n Median (IQR) (Min, max) n
Site 1 6 (4, 8) (0, 12) 33 4 (4, 6) (0, 7) 34
Site 2 4 (3, 6) (1, 15) 38 5 (4, 6) (1, 8) 38
Sites 4 and 5a 4 (3, 5.5) (2, 9) 16 7 (6, 7) (3, 7) 14
Site 10 3 (0, 4) (0, 7) 15 7 (5, 7) (0, 7) 14
Site 11 4 (4, 5) (0, 8) 30 4 (4, 6) (0, 7) 30
Site 12 4 (3, 6) (0, 23) 99 5 (4, 6) (0, 7) 100
Site 13 2 (2, 4) (0, 12) 65 6 (5, 7) (0, 8) 63
Other sitesb 3.5 (1, 7) (0, 27) 16 4 (2.5, 7) (0, 8) 16
Max, maximum; min, minimum.
a Sites 4 and 5 are reported together as they provided follow-up care jointly.
b ‘Other’ sites are those that recruited fewer than 15 participants (Sites 3, 6, 7, 8, 9 and 14).
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TABLE 12 Usual-care treatment details by site
Site Sessions (n) Participants (n)
Sessions/participant Location, n (%)
Individual,a n (%)
Exercise therapy,b
n (%)Median (IQR) Min, max Hospital Community Home
Site 1 186 33 6 (4, 8) 0, 12 181 (97.3) 0 (0.0) 5 (2.7) 108 (58.1) 186 (100.0)
Site 2 182 38 4 (3, 6) 1, 15 178 (97.8) 4 (2.2) 0 (0.0) 173 (95.1) 171 (94.0)
Sites 4 and 5c 72 16 4 (3, 5.5) 2, 9 67 (93.1) 0 (0.0) 5 (6.9) 61 (84.7) 69 (95.8)
Site 10 37 15 3 (0, 4) 0, 7 31 (83.8) 0 (0.0) 5 (13.5) 30 (81.1) 33 (89.2)
Site 11 121 30 4 (4, 5) 0, 8 114 (94.2) 3 (2.5) 4 (3.3) 58 (47.9) 119 (98.3)
Site 12 467 99 4 (3, 6) 0, 23 466 (99.8) 1 (0.2) 0 (0.0) 424 (90.8) 438 (93.8)
Site 13 208 65 2 (2, 4) 0, 12 45 (21.6) 1 (0.5) 162 (77.9) 179 (86.1) 201 (96.6)
Other sitesd 89 16 3.5 (1, 7) 0, 27 73 (82.0) 12 (13.5) 4 (4.5) 50 (56.2) 79 (88.8)
Max, maximum; min, minimum.
a The remaining participants received group-based therapy.
b The remaining participants received a variety of other treatments including manual therapy.
c Sites 4 and 5 are reported together as they provided follow-up care jointly.




























TABLE 13 Home-based intervention treatment details by site











Site 1 150 34 104 (69) 80 (53) 97 (65) 145 (97) 147 (98) 140 (93) 140 (93) 130 (87) 115 (77) 27 (18)
Site 2 192 38 189 (98) 190 (99) 189 (98) 186 (97) 169 (88) 169 (88) 167 (87) 150 (78) 140 (73) 49 (26)
Sites 4 and 5a 90 14 82 (91) 74 (82) 71 (79) 89 (99) 88 (98) 80 (89) 81 (90) 84 (93) 81 (90) 13 (14)
Site 10 80 14 79 (99) 79 (99) 79 (99) 80 (100) 79 (99) 78 (98) 78 (98) 79 (99) 75 (94) 16 (20)
Site 11 134 30 133 (99) 130 (97) 125 (93) 132 (99) 128 (96) 121 (90) 129 (96) 113 (84) 124 (93) 97 (72)
Site 12 523 100 511 (98) 510 (98) 510 (98) 510 (98) 493 (94) 489 (93) 491 (94) 487 (93) 472 (90) 257 (49)
Site 13 355 63 330 (93) 343 (97) 315 (89) 310 (87) 314 (88) 233 (66) 292 (82) 188 (53) 204 (57) 122 (34)
Other sitesb 66 16 55 (83) 60 (91) 59 (89) 64 (97) 57 (86) 53 (80) 49 (74) 54 (82) 51 (77) 15 (23)
a Sites 4 and 5 are reported together as they provided follow-up care jointly.















































































































































































































































































































































Sensitivity analyses were carried out considering the ITT population using available cases only, the
PP population using available cases and a complier-average causal effects analysis. No significant
differences between the two treatment groups at either time point were identified (see Table 14).
Additional sensitivity analyses of the primary outcome included unadjusted models; models with no
treatment-by-time interaction, including time as a continuous rather than categorical predictor; and
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FIGURE 6 The LLFDI function score from baseline to 12 months post randomisation for each treatment group.
TABLE 14 Comparison of LLFDI function between the two treatment groups
Time point
Usual care Home-based rehabilitation
Adjusted difference (95% CI) p-valueMean (SD) Total Mean (SD) Total
ITT multiple imputation
Baseline 51.20 (7.07) 312 51.64 (7.19) 309 – –
6 months 59.07 (8.58) 312 59.73 (8.65) 309 0.66 (–0.70 to 2.03) 0.34
12 months 59.97 (8.70) 312 60.47 (8.60) 309 0.49 (–0.89 to 1.88) 0.48
ITT available cases
Baseline 51.21 (7.09) 309 51.68 (7.17) 307 – –
6 months 59.37 (8.22) 282 60.01 (8.21) 276 0.64 (–0.72 to 2.01) 0.36
12 months 60.29 (8.25) 286 60.76 (8.24) 279 0.47 (–0.89 to 1.83) 0.50
PP available cases
Baseline 51.07 (7.10) 242 51.81 (7.23) 293 – –
6 months 59.85 (8.17) 222 60.00 (8.19) 270 0.15 (–1.31 to 1.60) 0.84
12 months 60.86 (8.22) 228 60.74 (8.20) 270 –0.13 (–1.58 to 1.32) 0.86
CACE
Overall – – – – 0.62 (–0.79 to 2.03) 0.39
CACE, complier-average causal effect.
Note
LLFDI function scores range from 0 to 100, with higher scores indicating better function.
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Subgroup analyses
Consistency of the treatment effect across sites was explored by including an interaction between
treatments and recruiting site in the model. A forest plot of treatment effects for each recruitment site
is provided in Figure 7. The treatment effects varied across sites, from an effect of 9 points in favour of
home-based rehabilitation at site 10 (95% CI 2.95 to 15.10 points) to 1 point in favour of usual care
at site 1 (95% CI –4.80 to 2.86 points). This variability appears to be at least in part related to the
amount of treatment received at each site, with participants in site 1 receiving more sessions of usual
care and less sessions of home-based rehabilitation than those in site 10.
Similar analyses were used to explore the relationship between treatment effect and age, gender,
number of falls, screening tool score and the constituent parts of the screening tool (BMI category,
health status and anxiety/depression). No clear patterns were identified. A forest plot of treatment
effects by screening tool score is provided in Appendix 1.
The Late Life Function and Disability Instrument function subscales
The LLFDI function component is made up of three subscales: upper extremity function, basic lower
extremity function and advanced lower extremity function. The values of each subscale are summarised
from baseline to 12-month follow-up by treatment group in Table 15. The trends in each subscale were
similar for the two treatment groups, with most of the observed improvement seen by 6 months post
randomisation. The improvements in upper extremity function were more modest than those in basic
and advanced lower extremity function, as would be anticipated.
Secondary outcome analyses
Patient-reported outcome measures
Trends over time for each of the key secondary PROMs are plotted in Figure 8. Although there was
only a small improvement over time in the two LLFDI disability variables, the OKS and KOOS both
showed similar substantial improvement between baseline and 6 months in both treatment groups.
There was little additional improvement between 6 and 12 months for either variable.
Trends over time are plotted for the PASE and EQ-5D-5L secondary outcomes in Figure 9, showing
small improvements over time.
Site Effect (95% CI) N
Site 1
Site 2
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–0.28 (–3.76 to 3.19)
–0.77 (–7.06 to 5.52)
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   2.41 (–1.52 to 6.34)
–0.26 (–2.41 to 1.90)
   1.17 (–1.66 to 3.99)
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FIGURE 7 Forest plot of treatment effects by recruiting site. Sites 4 and 5 provided follow-up jointly, so are reported
together. ‘Other’ sites include all those that recruited fewer than 15 participants.
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TABLE 15 The LLFDI Function subscales from baseline to 12 months post randomisation
LLFDI subscales
Usual care Home-based rehabilitation
Baseline 6 months 12 months Baseline 6 months 12 months
Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n
Upper 76.0 (15.0) 311 82.8 (16.0) 284 83.2 (15.7) 287 76.5 (15.8) 307 82.9 (16.2) 277 83.8 (15.3) 279
Basic lower 59.8 (10.8) 312 71.2 (15.6) 284 72.5 (15.9) 287 60.9 (11.3) 307 73.5 (15.2) 277 73.9 (15.0) 279
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FIGURE 8 Key secondary participant-reported outcome measures from baseline to 12 months post randomisation by
treatment group. (a) LLFDI disability frequency; (b) LLFDI disability limitation; (c) OKS; and (d) KOOS. (continued )
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FIGURE 8 Key secondary participant-reported outcome measures from baseline to 12 months post randomisation by
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FIGURE 9 Additional secondary participant-reported outcome measures from baseline to 12 months post randomisation
by treatment group. (a) PASE; (b) EQ-5D-5L utility; and (c) EQ-5D-5L visual analogue scale. (continued )
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The primary analysis for each of the secondary PROMs was conducted for the ITT population using
available cases only. No significant differences between the two treatment groups at either time point
(6 and 12 months) were identified for any of the secondary outcomes (Table 16).
For the key secondary PROMs (LLFDI disability frequency and limitation, OKS and KOOS QoL),
sensitivity analyses were performed for the PP population using available cases and for the ITT
population using multiple imputation, and complier-average causal effects were calculated. Only one
significant difference was identified, which was for the LLFDI disability limitation at 6 months using
the ITT population and multiple imputation (Table 17). This effect only just reached significance
(adjusted difference 2.67, 95% CI 0.14 to 5.19; p = 0.04) and is probably a chance effect.
Physical measures
Trends over time in the physical measures are summarised in Figure 10. There were small
improvements over time in each measure, but none was substantial.
The physical measures are summarised by treatment group over time in Table 18. No statistically
significant differences between the two groups were identified in the 30SCST or F8WT. There was a
statistically significant difference in the SLS test between the stance time at baseline and the stance
time at 12 months on the contralateral leg (p = 0.03). However, it is difficult to see how this change
could be related to the treatment received, and is likely to have been because of improved overall
fitness and strength.
Details of adaptations used to perform the 30SCST are summarised by treatment group and follow-up
time point in Table 19. Fewer participants required an adaptation as time went on. This table also
summarises the proportion of participants who stayed within the cones in the F8WT (high throughout)
and the F8WT smoothness scores, which improved over time.
Safety
The number of adverse events and serious adverse events experienced are summarised by treatment group
in Table 20. Overall, the number of such events was low, with 7.8% of participants experiencing an adverse
event in the first 6 months post randomisation, 4% experiencing an adverse event between 6 and 12 months
post randomisation and 5.2% of participants experiencing a serious adverse event. The System Organ
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FIGURE 9 Additional secondary participant-reported outcome measures from baseline to 12 months post randomisation
by treatment group. (a) PASE; (b) EQ-5D-5L utility; and (c) EQ-5D-5L visual analogue scale.
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TABLE 16 Comparison of treatment groups for secondary outcomes (intention-to-treat population using available cases)
Time point
Usual care Home-based rehabilitation
Adjusted difference
(95% CI) p-valueMean (SD) Total Mean (SD) Total
LLFDI disability (frequency)
Baseline 51.28 (7.25) 311 51.55 (7.46) 308 – –
6 months 54.27 (6.86) 283 54.91 (6.85) 275 0.64 (–0.50 to 1.78) 0.27
12 months 54.13 (6.87) 287 55.05 (6.87) 279 0.93 (–0.21 to 2.06) 0.11
LLFDI disability (limitation)
Baseline 66.26 (11.96) 312 66.25 (12.48) 305 – –
6 months 72.33 (15.25) 284 74.72 (15.24) 275 2.39 (–0.14 to 4.92) 0.06
12 months 74.10 (15.27) 287 74.75 (15.28) 277 0.65 (–1.87 to 3.18) 0.61
OKS
Baseline 20.59 (7.50) 312 20.81 (7.31) 308 – –
6 months 35.69 (7.69) 284 36.23 (7.69) 277 0.54 (–0.73 to 1.81) 0.40
12 months 37.34 (7.71) 287 37.80 (7.71) 278 0.46 (–0.81 to 1.73) 0.48
KOOS – QoL subscale
Baseline 25.50 (16.58) 301 25.50 (15.89) 300 – –
6 months 61.26 (22.31) 273 62.47 (22.29) 269 1.21 (–2.55 to 4.97) 0.53
12 months 65.53 (22.37) 277 65.26 (22.36) 271 –0.27 (–4.02 to 3.47) 0.89
PASE
Baseline 121.24 (73.90) 302 115.11 (72.95) 297 – –
6 months 150.62 (66.72) 259 149.41 (66.46) 245 –1.22 (–12.86 to 10.42) 0.84
12 months 156.58 (66.82) 263 154.63 (66.73) 251 –1.95 (–13.51 to 9.61) 0.74
EQ-5D-5L utility
Baseline 0.52 (0.22) 308 0.52 (0.23) 308 – –
6 months 0.75 (0.18) 277 0.75 (0.18) 275 0.00 (–0.03 to 0.03) 0.85
12 months 0.76 (0.18) 282 0.76 (0.18) 278 –0.00 (–0.03 to 0.03) 0.99
EQ-5D–5L VAS
Baseline 68.53 (19.46) 312 68.03 (19.13) 308 – –
6 months 75.81 (14.55) 283 75.51 (14.54) 275 –0.30 (–2.71 to 2.11) 0.81
12 months 76.80 (14.57) 287 77.05 (14.58) 278 0.24 (–2.16 to 2.65) 0.84
VAS, visual analogue scale.
Notes
Each LLFDI disability scale ranges from 0 to 100, with higher scores indicating less disability. OKS scores range from
0 to 48, with lower scores indicating better knee function. KOOS ranges from 0 to 100, with higher scores indicating
better QoL. For PASE, higher scores indicate greater levels of physical activity. EQ-5D-5L utility scores range from
–0.594 to 1, and the EQ-5D-5L visual analogue scale ranges from 0 to 100, in both cases higher scores indicate
better QoL.
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TABLE 17 Sensitivity analyses of key secondary participant-reported outcome measures
Time point
Usual care Home-based rehabilitation
Adjusted difference
(95% CI) p-valueMean (SD) Total Mean (SD) Total
Per-protocol population using available cases
LLFDI disability (frequency)
Baseline 51.22 (7.41) 243 51.74 (7.50) 293 – –
6 months 54.39 (6.96) 223 55.03 (6.96) 269 0.63 (–0.60 to 1.87) 0.32
12 months 54.37 (6.97) 229 55.09 (6.97) 270 0.72 (–0.51 to 1.95) 0.25
LLFDI disability (limitation)
Baseline 65.87 (11.25) 244 66.30 (12.39) 291 – –
6 months 73.12 (15.35) 224 74.73 (15.37) 269 1.60 (–1.13 to 4.33) 0.25
12 months 74.44 (15.38) 229 74.99 (15.38) 268 0.55 (–2.17 to 3.27) 0.69
OKS
Baseline 20.57 (7.41) 244 20.98 (7.32) 293 – –
6 months 36.23 (7.53) 224 36.34 (7.56) 271 0.11 (–1.22 to 1.45) 0.87
12 months 37.96 (7.57) 229 37.82 (7.56) 269 –0.14 (–1.48 to 1.19) 0.83
KOOS – QoL subscale
Baseline 25.53 (16.67) 235 25.66 (15.83) 285 – –
6 months 63.14 (22.00) 215 62.70 (22.05) 263 –0.44 (–4.41 to 3.54) 0.83
12 months 67.40 (22.08) 220 65.76 (22.06) 262 –1.64 (–5.60 to 2.32) 0.42
Intent-to-treat population using multiple imputation
LLFDI disability (frequency)
Baseline 51.28 (7.24) 312 51.52 (7.46) 309 – –
6 months 53.954 (7.284) 312 54.58 (8.09) 309 0.63 (–0.54 to 1.79) 0.29
12 months 53.81 (7.13) 312 54.63 (7.73) 309 0.82 (–0.32 to 1.96) 0.16
LLFDI disability (limitation)
Baseline 66.26 (11.96) 312 66.19 (12.49) 309 – –
6 months 71.97 (15.88) 312 74.51 (15.62) 309 2.67 (0.14 to 5.19) 0.04
12 months 73.80 (16.63) 312 74.51 (15.62) 309 0.71 (–1.88 to 3.30) 0.59
OKS
Baseline 20.59 (7.50) 312 20.82 (7.30) 309 – –
6 months 35.51 (8.69) 312 36.05 (8.42) 309 0.54 (–0.80 to 1.89) 0.43
12 months 37.18 (8.50) 312 37.80 (8.04) 309 0.62 (–0.70 to 1.94) 0.35
KOOS – QoL subscale
Baseline 25.49 (16.33) 312 25.66 (15.70) 309 – –
6 months 61.09 (23.51) 312 62.50 (24.60) 309 1.41 (–2.36 to 5.18) 0.46
12 months 65.22 (23.64) 312 65.24 (23.59) 309 0.02 (–3.62 to 3.66) 0.99
continued
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TABLE 17 Sensitivity analyses of key secondary participant-reported outcome measures (continued )
Time point
Usual care Home-based rehabilitation
Adjusted difference
(95% CI) p-valueMean (SD) Total Mean (SD) Total
Complier-average causal effect
LLFDI disability (frequency)
Overall – – – – 0.87 (–0.22 to 1.97) 0.12
LLFDI disability (limitation)
Overall – – – – 1.69 (–0.79 to 4.17) 0.18
OKS
Overall – – – – 0.56 (–0.76 to 1.88) 0.41
KOOS – QoL subscale
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FIGURE 10 Physical measures from baseline to 12-month follow-up by treatment group. (a) 30SCST number of stands;
(b) F8WT time in seconds; (c) F8WT number of steps; (d) arthroplasty side stance time; and (e) contralateral side
stance time. (continued )
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FIGURE 10 Physical measures from baseline to 12-month follow-up by treatment group. (a) 30SCST number of stands;
(b) F8WT time in seconds; (c) F8WT number of steps; (d) arthroplasty side stance time; and (e) contralateral side
stance time.
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TABLE 18 Comparison of physical measures between treatment groups at follow-up time points
Time point
Usual care (N= 312) Home-based rehabilitation (N= 309)
Adjusted difference
(95% CI) p-valueSummary n Summary n
30SCST number of stands, mean (SD)
Baseline 8.2 (3.5) 312 8.4 (3.7) 309 – –
6 months 11.1 (3.1) 278 11.0 (3.1) 275 –0.06 (–0.58 to 0.46) 0.82
12 months 11.7 (3.1) 279 11.5 (3.1) 276 –0.22 (–0.74 to 0.3) 0.41
F8WT time (seconds), mean (SD)
Baseline 11.8 (5.4) 312 12.1 (4.9) 309 – –
6 months 10.2 (3.6) 277 9.6 (3.6) 275 –0.57 (–1.17 to 0.04) 0.07
12 months 9.3 (3.6) 280 9.1 (3.6) 274 –0.17 (–0.78 to 0.43) 0.58
F8WT steps, mean (SD)
Baseline 16.4 (4.5) 312 17.3 (5.0) 309 – –
6 months 15.5 (3.2) 277 15.2 (3.2) 275 –0.36 (–0.91 to 0.18) 0.19
12 months 15.2 (3.2) 280 14.9 (3.3) 274 –0.23 (–0.77 to 0.31) 0.40
KA leg SLS average time (seconds), median (IQR)
Baseline 5.3 (2.6, 13.0) 310 4.5 (1.9, 14.5) 308 – –
6 months 10.0 (3.9, 30.3) 279 10.0 (3.6, 26.8) 276 – 0.57
12 months 13.3 (5.9, 31.1) 280 11.7 (3.4, 31.1) 276 – 0.14
Contralateral leg SLS average time (seconds), median (IQR)
Baseline 7.2 (3.6, 22.0) 310 6.3 (2.6, 18.0) 308 – –
6 months 10.9 (4.2, 30.8) 279 9.8 (3.5, 29.7) 276 – 0.43
12 months 14.7 (5.6, 30.7) 280 11.0 (3.2, 29.7) 276 – 0.03
The 30SCST records the number of stands in 30 seconds, with higher scores indicating better function. For the F8WT a
quicker time and fewer steps indicate better function. In the SLS, stance time is averaged over three trials at standing
on the same leg, with a maximum score of 45 seconds and higher scores indicate better function.
TABLE 19 Further details on the 30SCST and F8WT
Usual care (N= 312), n (%) Home-based rehabilitation (N= 309), n (%)
Baseline 6 months 12 months Baseline 6 months 12 months
30SCST adaptations
None 211 (67.6) 224 (80.6) 231 (82.8) 214 (69.3) 229 (83.3) 223 (80.8)
Uses hands on legs 94 (30.1) 50 (18.0) 47 (16.8) 90 (29.1) 44 (16.0) 49 (17.8)
Uses walking aid 2 (0.6) 2 (0.7) 1 (0.4) 4 (1.3) 1 (0.4) 1 (0.4)
Not tested: unable 5 (1.6) 1 (0.4) 0 (0.0) 1 (0.3) 1 (0.4) 3 (1.1)
Not tested: refused – 1 (0.4) – – 0 (0.0) –
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TABLE 20 Adverse events and serious adverse events by treatment group
Adverse events and serious adverse events Usual care
Home-based
rehabilitation Risk difference (95% CI) p-value
0–6 months post randomisation
Number of adverse events 24 34 – –
Participants with adverse events, n (%) 22 (7.1) 27 (8.7) 1.7% (–2.6% to 5.9%) 0.44
6–12 months post randomisation
Number of adverse events 12 15 – –
Participants with adverse events, n (%) 10 (3.2) 15 (4.9) 1.6% (–1.4% to 4.7%) 0.30
0–12 months post randomisation
Number of serious adverse events 18 20 – –
Participants with serious adverse events,
n (%)
14 (4.5) 18 (5.8) 1.3% (–2.1% to 4.8%) 0.45
System Organ Classes codes, n
Blood/lymphatic 2 2 – –
Cardiac 3 1 – –
Endocrine 1 0 – –
Gastrointestinal 2 3 – –
Immune system 0 1 – –
Infections/infestations 2 4 – –
Musculoskeletal 2 6 – –
Nervous system 0 1 – –
Renal/urinary 3 0 – –
Respiratory/thoracic 0 1 – –
Skin 1 0 – –
Social circumstances 1 0 – –
Vascular 1 0 – –
Unknown 0 1 – –
TABLE 19 Further details on the 30SCST and F8WT (continued )
Usual care (N= 312), n (%) Home-based rehabilitation (N= 309), n (%)
Baseline 6 months 12 months Baseline 6 months 12 months
F8WT
Stayed within cones? 303 (97.1) 274 (98.9) 273 (97.8) 304 (97.4) 273 (98.6) 270 (96.8)
F8WT smoothness score
0 9 (2.9) 5 (1.8) 2 (0.7) 11 (3.6) 5 (1.8) 4 (1.5)
1 73 (23.4) 26 (9.4) 33 (11.8) 87 (28.2) 32 (11.6) 26 (9.5)
2 50 (16.0) 35 (12.6) 22 (7.9) 56 (18.1) 29 (10.5) 27 (9.9)
3 180 (57.7) 211 (76.2) 222 (79.6) 155 (50.2) 209 (76.0) 217 (79.2)
Higher smoothness scores indicate better performance.
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Additional analyses
The Trial Steering Committee and Data Safety Monitoring Committee met jointly to review the results
on 13 June 2019. At this meeting they requested that additional analyses be performed that explored
further the definition of the PP population. The committees queried whether or not the key part of
the new intervention might be the home-based nature of the treatment, rather than the exact number
of sessions. They requested that the analysis of the primary outcome be repeated using two more
definitions of the PP population:
1. excluding those who received a session of usual-care treatment at home
2. excluding all participants randomised at site 13, at which the delivery of usual care differed
significantly from other sites.
These additional analyses were performed and the results are presented here.
Sensitivity to per-protocol population definition
In view of the recommendations made by the trial committees, the following definitions of the PP
population were considered:
1. PP population – no home-based care: participants were excluded from this population if they had
received a treatment session at home (usual-care group only), had not received any treatment
sessions (either group) or had not provided any follow-up data (either group).
2. PP population – no site 13 participants: participants were excluded from this population if they
were randomised at site 13, had not received any treatment sessions or had not provided any
follow-up data.
The analysis of the primary outcome was repeated for each of these populations using a repeated
measures mixed-effects model, as in the primary analysis. The results of these analyses were similar
to those for the other populations considered for the primary outcome (Table 21). No significant
differences between the two treatment groups were identified for either of the populations at either
of the time points.







(95% CI) p-valueMean (SD) Total Mean (SD) Total
PP – no home-based
usual care
Baseline 51.41 (7.00) 226 51.75 (7.21) 298 – –
6 months 59.61 (8.59) 216 60.05 (8.51) 274 0.43 (–1.12 to 1.99) 0.58
12 months 60.92 (8.57) 215 60.78 (8.51) 274 –0.14 (–1.70 to 1.42) 0.86
PP – no site 13
participants
Baseline 51.18 (7.11) 231 51.56 (7.33) 238 – –
6 months 59.30 (8.46) 220 59.90 (8.42) 222 0.60 (–0.98 to 2.17) 0.46
12 months 60.64 (8.44) 219 60.50 (8.42) 221 –0.15 (–1.73 to 1.43) 0.85
ROH, Royal Orthopaedic Hospital.
Note
LLFDI function scores range from 0 to 100, with higher scores indicating better function.
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Chapter 5 Health economics
This chapter reports the methods and results of a within-trial cost-effectiveness analysis of theCORKA trial. The CORKA trial randomly allocated 621 adults aged ≥ 55 years with a primary
unilateral KA scheduled who were at risk of a poor outcome following surgery to usual care (i.e.
outpatient physiotherapy) or to a bespoke community-based multidisciplinary rehabilitation programme
(the CORKA home-based intervention). Participants were followed up for 1 year after randomisation.
Information on recruitment, including inclusion and exclusion criteria, is presented in more detail in
Chapter 2. Participant characteristics at recruitment and clinical results are presented in Chapter 4.
We compared usual care with the CORKA home-based intervention in terms of quality-adjusted
life-years (QALYs) gained, health and wider societal costs and calculated incremental cost-effectiveness
ratios (ICERs).
Methods
Resource use and costing
Participants were asked to complete two diaries reporting their use of health-care services, their time
off work and any informal care received because of their knee, between randomisation and 6 months
post randomisation and from 6 months to 12 months post randomisation. Participants were asked to
complete the diary daily at home for 6 weeks, and weekly thereafter. Data are reported on visits to
health-care practitioners, admissions to hospital, medication use, equipment provided or purchased,
informal care received and time away from paid employment. Each of these components of resource
use is described in greater detail below. Participants’ receipt of the allocated intervention was also
recorded in treatment logs. Participants were also asked to complete the EQ-5D-5L questionnaire at
baseline and at 6 and 12 months post randomisation.
Unit costs were derived from national databases,90–96 reports,97,98 or websites99 (see Appendix 2, Tables 35–39).
All unit costs are inflated, where necessary, to 2017–18 prices using the health-care and community health
services inflation index.91
The location of care (clinic, home or community) and type of contact (one to one or group) were recorded in
the treatment log for those allocated usual care, and costs are attached accordingly. In cases where location
or type of contact data were missing (n= 32), the most frequent response was used. No information about
the staff member(s) delivering each treatment session was recorded for those allocated to the CORKA
home-based intervention. In accordance with the protocol, these participants had seven home visits: two
delivered by a qualified physiotherapist and five by a rehabilitation assistant. The average cost applied per
home visit reflects this expected staff-mix (see Appendix 2, Table 35).
In question 1 of the resource use diary, participants were asked to record their attendances with a
general practitioner (surgery, home or telephone), practice nurse (surgery), district nurse (home visit),
physiotherapist (clinic or home), occupational therapist (clinic or home), hospital accident and emergency
department, fracture clinic, outpatient clinic (not physiotherapy or occupational therapy), counsellor or
psychologist, and were asked to record their receipt of hydrotherapy, social services home care, a falls
prevention programme, acupuncture or other complimentary therapies. They were invited to report
other types of health care received as free text, which were allocated to existing resource use categories
or additional categories where possible. If participants provided any response to this question, we
assumed that the diary was complete. We excluded physiotherapy visits that were part of usual care or
the CORKA intervention up to the number of visits recorded in the treatment logs. Unit costs for each
type of health-care visit are reported in Appendix 2, Table 36.
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Participants were asked to report the duration of, and reason for, any hospital admissions. A cost per
day in accordance with whether the patient was in an ordinary ward or critical care was applied to
hospitalisations (see Appendix 2, Table 36). Participants were asked to record contacts with private
physiotherapists, occupational therapists, chiropractors or osteopaths, and record the receipt of
acupuncture or complimentary therapies. These were also valued using the unit costs reported in
Appendix 2, Table 36.
Participants were asked to report any medications taken in relation to their knee, whether they
were purchased or prescribed, and the dosage, duration and frequency of said medication. Data on
dosage, duration and frequency were often missing. Each self-reported medication was categorised
according to its chemical name where possible. Using all data from the 2018 Prescription Cost
Analysis,92 the most frequent medication within each chemical name was identified and the cost
per item prescribed extracted. Each medication was classified as likely to be a one-off or long-term
prescription. For those drugs considered long term, we identified the typical number of prescriptions
per year based on recommended use and standard pack sizes from the British National Formulary.100 We
assumed that drugs recorded in the 0- to 6-month diary were taken from baseline to 6 months, or up
to exit from the trial (if this happened before 6 months). We assumed that drugs recorded in the 6- to
12-month diary were taken from 6 months to exit from the trial. Appendix 2, Table 37, lists medication
costs. Where data on whether a drug was purchased or prescribed were missing, they were imputed
using the more common of the two in fully reported entries with the same chemical.
Participants were asked to report details of any equipment purchased or provided after surgery.
Self-reported equipment types were allocated to one of 43 categories, and costs were attached to
each category (see Appendix 2, Table 38). The same unit costs were assumed regardless of whether
the equipment was purchased or provided.
Participants were asked to report whether or not they had received unpaid care from family or friends,
the number of weeks that any care was received and the number of hours of care provided per week.
Unit costs per hour of unpaid care were attached to reported activity (see Appendix 2, Table 39).
Where data on weeks or hours per week of care were missing but care was reported to have been
received, mean imputation was used.
Participants were asked to report whether or not they had to take time off from paid employment and,
if so, how many days. This was converted to weeks off work and costed using data on average gross
wages and hours worked per week (see Appendix 2, Table 39).
Quality-adjusted life-years
Responses to EQ-5D-5L questionnaires were converted into utility scores using the cross-walk to the
three-level version101 and valued using the UK set.102 QALYs were calculated using the area under the
curve approach, which involved estimating the average EQ-5D-5L utility between each follow-up time
point and weighting it by survival time.
Methods for dealing with missing data
We followed best-practice methods for addressing missing data in cost-effectiveness studies.103 Missing
data on participant characteristics at baseline were imputed using unconditional mean imputation. As
data on the receipt of allocated interventions and deaths were considered to be complete, no imputation
was performed. For components of resource use where participants provided responses to any questions
in the resource diary, we imputed missing values as zero.
We used multiple imputation by chained equations to impute missing data on EQ-5D-5L utility scores
and cost components (except costs related to the allocated intervention) at each follow-up time point.
Each missing value was imputed as a function of follow-up period, sex, age, BMI, recruitment site,
LLFDI function score (baseline and 6 and 12 months), baseline EQ-5D-5L score, updated EQ-5D-5L
HEALTH ECONOMICS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
48
score and components of costs. We used predictive mean matching to create 40 imputed data sets.
We imputed annual costs and EQ-5D-5L utility scores in each period, adjusting if death was observed
in that period. We assumed that costs were incurred linearly over time; if a participant died halfway
through a period, they incurred half of the predicted costs. For QALYs, we assumed that the imputed
utility score prevailed until the time of death. Imputation was performed separately in subgroups
by treatment allocation and follow-up period (0–6 months and 6–12 months).
Analysis
We report descriptive statistics (means and SDs) for resource use, costs and EQ-5D-5L utilities at each
follow-up time point using complete data only. Differences between arms were estimated using linear
regression controlling for follow-up period, treatment allocation, an interaction between follow-up time
and treatment allocation, recruitment site, and baseline utility score for EQ-5D-5L. Standard errors
were adjusted for multiple observations within individuals.
Following multiple imputation, we estimated total costs and QALYs for all 621 participants in the
CORKA trial from the date of trial recruitment to the earliest date of death or withdrawal from the trial,
or the end of follow-up at 1 year by treatment allocation. On each imputed data set we estimated mean
costs (by type) and QALYs using separate linear regression models controlling for treatment allocation,
recruitment site and for QALYs baseline EQ-5D-5L utility. Estimates derived from each imputed data
set were combined using Rubin’s rule to estimate the adjusted mean difference and standard error for
each outcome. As a sensitivity analysis, we explored using a complete-case analysis that included only
individuals who provided complete data over the 12-month trial duration. In the preliminary analysis,
we also considered using linear regression in imputation models rather than predictive mean matching.
We calculated the ICER by dividing the mean cost differences (total NHS costs and total societal costs)
between the CORKA home-based intervention and usual care by the mean QALY difference.
We estimated the joint uncertainty around incremental total costs and QALYs (i.e. the difference
between the CORKA home-based intervention and the usual-care arm) and in the cost-effectiveness
by bootstrapping 200 times from each of our 40 imputed data sets (creating 8000 bootstraps), running
the estimation model on each bootstrapped data set and extracting the estimated treatment effects.
From these bootstrapped results, we calculated the probability that the CORKA home-based intervention
was more cost-effective than usual care for different threshold values per QALY gained,104 by estimating
the proportion of bootstrap replicates with a net monetary benefit of above zero for each threshold
value. The net monetary benefit was given by the product of the mean difference in QALYs and the
threshold value minus the mean difference in costs.
All analyses were conducted using R version 3.4 (The R Foundation for Statistical Computing,
Vienna, Austria).
Results
Study participant follow-up time
Out of the 621 trial participants, 3 died and 34 withdrew from the trial.
Table 22 presents the percentage of missing data observations for resource use and EQ-5D-5L utility
at each follow-up point by treatment allocation. Overall, the number of missing data was fairly low.
Missing data were more common for resource use than EQ-5D-5L, and marginally more common in
those allocated to the CORKA home-based intervention than those allocated to usual care. Patterns of
missing data were very similar for these two outcomes in both treatment arms and at each follow-up
time point.
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Resource use and costs during follow-up
Appendix 3, Tables 40–45, provides comprehensive data on resource use and responses to the EQ-5D-5L
questionnaire by treatment allocation and follow-up period. Table 23 presents the mean costs for each
cost type and totals by treatment allocation and follow-up period, and adjusted mean differences. Period
costs for all cost types and differences between treatment groups were substantially greater between
baseline and 6 months than between 6 months and 1 year. Average intervention costs were lower and
subsequent NHS costs were higher (reflecting higher costs associated with hospital admissions) in those
allocated to the CORKA home-based intervention than those allocated to usual care. Private health-
care costs and differences by treatment allocation were substantially lower than those for NHS costs.
Between 6 months and 1 year the average costs associated with informal care and time away from paid
employment were substantially lower for the CORKA home-based intervention than for the usual-care
arm, and were larger than the differences in health-care costs.
EuroQol-5 Dimensions, five-level version, utility
Table 24 presents EQ-5D-5L utility scores and differences by treatment allocation at each time point.
EQ-5D-5L scores were very similar in the two treatment groups at all follow-up time points, improving
similarly between baseline and 6 months. The distribution of responses to each EQ-5D-5L domain at
each follow-up time point is presented by treatment allocation in Appendix 3, Table 44.
Main analysis
Table 25 shows the main analysis results at 1 year. Appendix 3, Table 45, shows descriptive statistics
for the costs and QoL at each follow-up time point after multiple imputation. There was a small,
non-significant difference in QALYs (0.003, 95% CI –0.017 to 0.023) favouring the CORKA
home-based intervention.
Post-operative physiotherapy (intervention) costs were lower on average in the CORKA trial arm
than in usual care (–£65, 95% CI –£86 to –£44). However, as the CORKA trial arm reported higher
subsequent health-care costs (£142, 95% CI –£70 to £354), the total NHS costs at 12 months were
higher in CORKA (£77, 95% CI –£138 to £291). By contrast, costs associated with private health-care
use (–£15, 95% CI –£76 to £46), informal care (–£23, 95% CI –£210 to £164) and time away from paid
employment (–£355, 95% CI –£820 to £110) were lower in the CORKA trial arm than usual care at
12 months. As a result, total societal costs (adding health care and other costs) were lower for CORKA
than for usual care (–£316, 95% CI –£892 to £260).
Adopting an NHS health and social care perspective, the ICER for the CORKA home-based intervention
versus usual care was £28,372, which is close to the standard threshold for cost-effectiveness in the UK.
Adopting a societal perspective, the CORKA home-based intervention was cost-saving and more effective
than, and thus dominant over, usual care.
TABLE 22 Missing data on resource use and EQ-5D-5L utility by treatment allocation in each follow-up period
Time point






Baseline – – 4 (1.3) 1 (0.3)
6 months 48 (15.4) 46 (14.9) 31 (9.9) 34 (11.0)
12 months 39 (12.5) 36 (11.7) 26 (8.3) 31 (10.0)
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TABLE 23 Period costs by follow-up and treatment allocation
Cost categories









rehabilitation vs. usual care)
Number of respondents, n 264 263 – 273 273 –
Total NHS costs £823 (£898) £776 (£1008) £–43 (–£206 to £120) £189 (£441) £268 (£871) £86 (–£31 to £204)
Intervention costsb £250 (£183) £184 (£60) £–66 (–£87 to –£45) – – £0 (–£3 to £3)
Total subsequent NHS costs £563 (£868) £587 (£1005) £28 (–£133 to £188) £189 (£441) £268 (£871) £85 (–£33 to £202)
Primary care £67 (£83) £81 (£132) £14 (–£5 to £33) £15 (£40) £18 (£50) £4 (–£4 to £12)
Physiotherapy £87 (£136) £46 (£128) £–41 (–£63 to –£19) £15 (£81) £20 (£85) £4 (–£10 to £18)
Outpatient care £100 (£146) £116 (£209) £14 (–£14 to £43) £36 (£124) £33 (£123) £–3 (–£24 to £18)
Medications £26 (£68) £24 (£57) £–1 (–£10 to £8) £23 (£75) £19 (£54) £–3 (–£13 to £7)
Hospital admissions £172 (£772) £204 (£850) £36 (–£103 to £175) £83 (£378) £153 (£818) £72 (–£36 to £181)
Equipment £45 (£141) £39 (£57) £–6 (–£23 to £12) £5 (£20) £6 (£18) £1 (–£3 to £5)
Other NHS care £67 (£172) £77 (£222) £10 (–£22 to £43) £13 (£62) £19 (£90) £8 (–£6 to £22)
Total private health care £74 (£464) £44 (£205) £–30 (–£92 to £32) £11 (£49) £27 (£157) £16 (–£4 to £35)
Physiotherapy £14 (£69) £18 (£89) £4 (–£9 to £18) £6 (£34) £7 (£40) £1 (–£5 to £7)
Equipment £51 (£458) £22 (£185) £–29 (–£89 to £31) £1 (£7) £14 (£148) £13 (–£5 to £31)
Other £9 (£41) £4 (£27) £–5 (–£11 to £1) £4 (£34) £6 (£37) £1 (–£5 to £8)
Informal care £428 (£1332) £347 (£1003) £–79 (–£279 to £121) £20 (£129) £55 (£290) £52 (£9 to £95)
Time off work £980 (£2692) £601 (£1916) £–384 (–£786 to £17) £100 (£987) £109 (£1012) £18 (–£148 to £185)
Total societal costs £2305 (£3387) £1767 (£2521) £–537 (–£1049 to –£25) £321 (£1167) £459 (£1397) £172 (–£46 to £390)
Values are mean (SD) or mean (95% CI).
a Based on linear regression of treatment allocation on costs adjusted for follow-up period, recruitment site and an interaction between follow-up period and recruitment site.
Cluster robust standard errors were used to account for multiple observations per participant.















































































































































































































































































































































Figure 11 presents the cost-effectiveness scatterplot that illustrates differences in mean total costs
and QALYs for the CORKA home-based intervention versus usual care, adopting the NHS health care
and social care (blue dots) and societal (red dots) perspective. Figure 12 presents the cost-effectiveness
acceptability curve that gives the probability that the CORKA home-based intervention is cost-effective
compared with usual care for different threshold values for a QALY (from £0 to £50,000 per QALY) for
each costing perspective. Adopting an NHS or a health-care cost perspective, the probability that the
CORKA home-based intervention is cost-effective is around 25% when the willingness to pay for an
additional QALY is £0. As the willingness to pay for an additional QALY increases the probability of
cost-effective increases, reaching around 43% at a threshold value of £30,000 per QALY. Adopting a
societal perspective, the probability that the CORKA home-based intervention is cost-effective decreases
with a higher willingness-to-pay threshold. The probability of cost-effectiveness is 75% at a threshold of
£30,000 per QALY.







vs. usual care)N Mean (SD) N Mean (SD)
Baseline 308 0.52 (0.22) 308 0.5 (0.23) –0.00 (–0.0 to 0.04)
6 months 281 0.75 (0.19) 275 0.76 (0.19) 0.00 (–0.03 to 0.03)
12 months 286 0.76 (0.20) 278 0.768 (0.23) 0.004 (–0.03 to 0.04)
a Based on linear regression of treatment allocation on costs adjusted for the follow-up period, recruitment site and
an interaction between follow-up period and recruitment site. Cluster robust standard errors were used to account
for multiple observations per participant.
Unadjusted means are reported for each treatment group at each time point.






rehabilitation vs. usual care)
N 312 309 –
Life-years 1.000 (0.000) 1.000 (0.053) 0.000 (–0.001 to 0.000)
QALYs 0.696 (0.402) 0.698 (0.411) 0.003 (–0.017 to 0.023)
Total NHS costs £1015 (£38) £1088 (£51) £77 (–£138 to £291)
Intervention costsb £250 (£14) £184 (£8) –£65 (–£86 to –£44)
Total subsequent NHS costs £765 (£38) £904 (£51) £142 (–£70 to £354)
Total private health care £103 (£22) £88 (£18) –£15 (–£76 to £46)
Informal care £441 (£41) £413 (£37) –£23 (–£210 to £164)
Time off work £1105 (£86) £744 (£66) –£355 (–£820 to £110)
Total societal costs £2664 (£97) £2332 (£82) –£316 (–£892 to £260)
ICERb
NHS costs only – – £28,372
Total societal costs – – Dominant (more effective
and less costly)
Values are mean (standard error) or mean (95% CI).
a Based on a linear regression model of each treatment allocation against each outcome adjusted for recruitment site
and, for QALYs, baseline utility score.
b Estimated as the difference in costs divided by the difference in QALYs.
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Sensitivity analysis
Table 26 presents the complete-case analysis results at 1 year. Data were contributed to the complete-
case analysis by 489 (79%) participants (usual care, 78%; CORKA home-based intervention, 80%). The
results of the complete-case analysis were similar to those from the multiple imputation analysis. There
was no evidence of a difference in QALYs by treatment allocation. NHS costs were higher and societal
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FIGURE 12 Cost-effectiveness acceptability curves.
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Adopting an NHS health and personal social care perspective, the CORKA home-based intervention
was more costly and less effective than usual care and, thus, dominated by usual care. Adopting a
societal perspective, the ICER for the CORKA home-based intervention versus usual care was
£224,210, which is considerably higher than the standard threshold for cost-effectiveness in the UK.
As usual care was more effective, the CORKA home-based intervention was, therefore, cost-effective,
as higher ICER values indicate greater cost-effectiveness for CORKA.







N 243 246 –
QALYs 0.706 (0.155) 0.704 (0.166) –0.002 (–0.023 to 0.020)
Total NHS costs £1034 (£1068) £1016 (£1380) £12 (–£208 to £231)
Intervention costsb £262 (£186) £189 (£50) –£67 (–£91 to –£44)
Total subsequent NHS costs £773 (£1040) £827 (£1380) £79 (–£139 to £297)
Total private health care £92 (£491) £74 (£327) –£20 (–£94 to £55)
Informal care £471 (£1385) £400 (£1091) –£26 (–£241 to £190)
Time off work £1046 (£3131) £717 (£2390) –£308 (–£806 to £189)
Total societal costs £2644 (£3911) £2207 (£3156) –£342 (–£972 to £288)
ICERb
NHS costs only – – Dominated (less effective
and more costly)
Total societal costs – – £224,210
Values are mean (standard error) or mean (95% CI).
a Based on a linear regression model of each treatment allocation against each outcome adjusted for recruitment site
and, for QALYs, baseline utility score.
b Estimated as the difference in costs divided by the difference in QALYs. Because the mean difference in QALYs is
negative, where the ICER is positive, higher values indicate greater cost-effectiveness for CORKA.
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Chapter 6 Qualitative study
Introduction and objective of the study
This qualitative study was carried out to explore the experiences of the patients participating in the
CORKA home-based intervention and the physiotherapists and rehabilitation assistants delivering the
intervention. We aimed to explore barriers to and facilitators of adherence and gain insight into
experiences that might influence trial outcomes.
Methods
Approaching and recruiting participants
Potential patients, physiotherapists and rehabilitation assistants were identified by the trial co-ordinator
and were contacted by the qualitative researcher to arrange a convenient time and venue. All those
who were approached were given a participant information sheet and given at least 24 hours to decide
if they wanted to take part. Those who were willing to participate were given a consent form to
complete and sign.
Sample
We anticipated that approximately 10 patients from the intervention group and 10 clinicians, around
20 people in total, would provide rich insight. Eventually, 10 participants, five physiotherapists and six
rehabilitation assistants were recruited. Recruitment was halted when a wide range of views had been
obtained and no new topic areas were being raised. Female participants (n = 4) ranged in age from
64 to 90 years, and male participants (n = 6) from 65 to 89 years. The participant screening tool
score ranged from 6 to 7 out of 10. The physiotherapists had worked for a range of 1 to 32 years
post qualification and the assistants for a range of 1 to 30 years.
Interviews
The same experienced qualitative researcher completed all of the interviews (FT). Written consent was
obtained at the start of visits before interviews commenced. Although an interview guide was developed
after discussion with the trial team, it was not followed rigidly. Follow-up questions were used to help the
interview flow, which ensured that relevant areas were covered and allowed participants to introduce
new relevant areas. Participant interviews took place in their own homes at a convenient time for them,
usually at the weekend. Two rehabilitation assistant interviews took place on the telephone and were
recorded. The rest of the physiotherapist and rehabilitation assistant interviews took place in a quiet
room at work. All interviewees were encouraged to discuss any areas that they felt were relevant.
Interviews were digitally audio-recorded and transcribed.
Data analyses
Audio-recordings were listened to and transcripts read. Transcript data were broken down into discrete
units, making concerted efforts to remain close to the data and continually explore meaning. The first
three transcripts were independently coded by two researchers (FT and JR). As similar coding units
were identified by both researchers, FT coded subsequent transcripts. All transcripts were coded by
one researcher who then grouped together units with a shared essence into categories (FT) using
NVivo 11 (NVivo 11, QSR, Portsmouth, UK). Two researchers (JR and KB) checked each unit, the unit
descriptor and the data supporting each unit to make sure that the category was grounded in the
primary data. Data, codes and categories were constantly compared with each other, and the team met
regularly to discuss the data and analysis. Rigour was, therefore, promoted through collaboration.
DOI: 10.3310/hta24650 Health Technology Assessment 2020 Vol. 24 No. 65
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Barker et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
55
Findings
Physiotherapists and rehabilitation assistants
Using thematic analysis, we developed seven themes that cut across participants (Figure 13). We illustrate
these ideas below with narrative exemplars.
Seeing the person in their world
This theme describes the value of seeing the person as a whole, not just a body part, in their own
world. The home setting enhanced a holistic approach, rather than a biomedical approach:
I think that holistic approach is really, really important, so yes we’re there to get their knee bending . . .
but in the bigger picture, I want them to be able to go outside and use their knee . . . to be able to go and
see friends, or kind of do dancing and things like that . . . [In outpatients] it would have been very much
focused on the knee.
Physiotherapist
Clinicians compared the clinical encounter, which tended to focus on the body part, with the more
relational home encounter:
[Being at home] sort of takes it out of that context where the mindset of you’re just there just to fix you
. . . you’re with that chance to be able to talk with people, they’re able to see you as being human . . .
they were a lot more relaxed . . . They’re more open . . . they may well talk about and what their social


























FIGURE 13 Physiotherapist and rehabilitation assistant themes.
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In the home environment, the balance of power shifts. Entering a person’s home was described as a
privilege in which you see the patient on their own terms: it is less paternalistic and the patient
becomes a person:
It was very much on the patients’ terms whereas I can imagine kind of in a hospital setting, it’s a bit more
kind of like on our terms.
Assistant
You’re in there and it’s a privilege to be in someone’s home. They’ve let you in. You’re not just seeing
them; you’re seeing everything really . . . it’s quite invasive into their world.
Physiotherapist
Clinical staff reflected on the benefits of seeing the person in their environment and the changes that
they would make to their future clinical practice to ‘see the person’:
I would say that I’d strive now to see the person as an individual . . . strive more to try and just
understand where that person’s coming from, because even with something that you think is as simple
as a knee replacement . . . in terms of the impact on that one person’s life . . . You don’t just know that
stuff instinctively . . . you’ve gotta find out a bit about them, and so I think that’s hugely important.
Physiotherapist
Developing people skills
This theme describes the need to develop ‘people skills’ to effectively enter a person’s world. These
skills are integral to effective treatment and develop with experience:
To be truthful they [clinicians] need to have good people skills to be able to talk to people and not talk
down to them . . . don’t make ‘em feel like they’re on detention . . . it’s the way you go about it . . . personal
skills count a lot . . . You’ve sort of got to win their confidence and once you do that . . . it’s amazing what
you can get out of them once you get their confidence.
Assistant
Good ‘people skills’ meant that you had to get to know the person in their world and flexibly respond
to their needs:
The reality is that things change quickly, you have to be pragmatic . . . real life is wonderfully, beautifully
messy . . . you can’t know a thing that’s gonna come up.
Physiotherapist
Thinking outside the cubicle
This theme explores the way in which seeing a person in their own world fosters creative thinking and
enhances positive outcomes. Clinical staff described the world in situ as the real world:
In a sort of sterile clinic or environment where the floor’s totally flat, there’s no obstacles . . . it doesn’t
bear that much resemblance to somebody’s house . . . I think seeing people in their own home, it’s just
different . . . being able to relate more to what the patient’s saying ‘cause you can see it, it’s not just a
theoretical problem . . . they can show you.
Physiotherapist
Clinical staff enjoyed the freedom to be creative:
I enjoyed being able to give the people the realisation that you can do some exercise; you don’t need any
fancy equipment . . . it’s sort of utilising the equipment that they’ve got, so their chairs, their stairs . . .
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to make use of, like, towels or, I don’t know, a bit of rope that the husband has got in the shed . . .
It was taking it away from just ‘here’s a sheet with some exercises on it’.
Assistant
This creative approach was compared with the clinical space with its associated time constraints:
I think in the very time-pressured nature of outpatients, you probably can’t build up as much of a picture,
and you can’t see the home environment that you’re working with, so it’s really great that we’re able to
kind of walk through a day in the life of a, rather than just kind of talk through it . . . I think [we] probably
get a bit trapped in the cubicle thinking.
Physiotherapist
I gained personally from doing that bit extra
This theme describes the personal gain from working holistically and recognising the impact that one
can have:
I definitely gained a professional insight . . . but also personally as well: building those relationships, being
able to gain more of an insight into human beings . . . this has been really, really important to me to be
able to spend the time talking to people and understanding what makes them tick . . . I want to take on
the stories; I want to learn more about people, (a) to help them, but (b) to kind of develop as well . . .
personally and professionally . . . I take satisfaction from doing the little bit extra: from talking to the
patient . . . I think if I wasn’t doing that, I wasn’t taking on the patients’ stories, I’d be less satisfied –
and more likely to burn out . . . that’s the bit that I enjoy the, the above and beyond.
Physiotherapist
Clinical staff described the satisfaction that comes from having a positive impact on people’s lives:
I had this other chap, he lost his wife . . . I said to him, ‘What is your main goal?’ he said, ‘Walking to the
grave’ . . . I said, ‘Well how far is it?’ he said, ‘Well I need to drive my car first’ . . . I said, ‘Well that’s not
impossible . . . we’ll get there’ . . . I think it was about on the fifth time . . . he said, to me, ‘. . . I actually got
to the cemetery . . . but I couldn’t quite do the walk.’. I said, ‘Well that’s an achievement, you must be
really proud of yourself . . . and on the seventh time he said, ‘I’ve done it . . . I’ve actually gone to the grave’
. . . and I thought that was fantastic . . . it just feels such an achievement . . . It makes me feel so happy then.
Assistant
There is a fine line between patient and friend
This theme describes the challenge of managing the boundary between getting to know someone in their
own world and remaining professional. These challenges were exacerbated in the home environment:
I think you always have to realise that the patient who you’re going out to see is a patient and not a
friend . . . there is that fine line. I think it’s always being clear to them that you’re here to rehab them . . .
I mean, some patients want to have a laugh and a joke with you but I wouldn’t say that’s unprofessional
. . . that’s just making the patient feel comfortable . . . it’s polite to have that 5-minute conversation, how
are you doing, how have you been, what have you been up to? And then once that’s out the way, get on
with the treatment.
Assistant
Clinical staff described individual cases for which it was more challenging to remain professional.
For example, there were those whom you ‘clicked with’:
They’re the patient and not friends. Some people you do sort of click with . . . so, I was almost like trying
to be, sort of not friends, but be professional.
Assistant
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I think the most tricky people are perhaps someone like, I’m treating a guy that’s a similar age to me . . .
it’s just trying to maintain that you’re coming at things from an angle as a professional . . . maybe it’s
more challenging when they’re, like, ‘Did you enjoy the pub the other night?’. [Laughter] . . . it’s again
trusting [achieving] balance between the importance on knowing that person and building a relationship
versus maintaining a professional identity.
Physiotherapist
Clinicians described a tension between having to develop good rapport to build their confidence and
get the job complete and the need to maintain boundaries:
Building rapport is really, really important to get the patient engaged, but it’s managing the professional
relationship is the difficult bit, I think . . . You do get to you know their family, you meet their kids, you
know their dogs’ names . . . and you obviously share your own life stories as well . . . I found it kind of
difficult to negotiate that barrier sometimes.
Physiotherapist
Clinicians described a ‘middle area of closeness’, in which you enter a person’s world far enough to be
able to use your knowledge effectively, but not so far that you become ineffective:
There was one man [who] had other issues that he wanted to talk about . . . kind of brought [the
assistant] into the drama of his neighbourhood. I think there is kind of a middle area of closeness . . .
it’s not the more you get into their lives, the more help you can offer . . . there’s a threshold that helps,
and then maybe as you get too far, you’re not objective . . .
Physiotherapist
Feeling outside my comfort zone
This theme describes times of discomfort for rehabilitation assistants working alone in a person’s home.
Some described how they could feel vulnerable and on the spot as an unqualified health-care worker:
They were sort of under the impression that I was a physio[therapist], and then I say, “Well, I’m not a
physio[therapist],” then they’re sort of, “What do you mean, you’re not a physio[therapist]?” . . . There was
a couple of times where that’s sort of happened, and it just sort of made me feel a little bit, uncomfortable.
Assistant
Rehabilitation assistants described occasions where they asked for physiotherapist input, for example
when patients exhibited severe pain, swelling or lack of expected progress, or when things just ‘didn’t
look right’:
It was just mainly with the people who weren’t progressing as much . . . the lady who wasn’t getting
beyond 30 degrees of movement . . . I felt I’d sort of done everything that I could. So, of course, I’d go
back and touch base with [the physiotherapist] . . . even [the physiotherapist] was a bit baffled . . . he said,
‘Well . . . you’ve gone by the book . . . she’s doing what she can, she’s not progressing – she needs the MUA
[manipulation under anaesthetic]’.
Assistant
Physiotherapists recognised that this sort of situation could be extremely challenging for rehabilitation
assistants and emphasised the need for clear lines of communication:
I think the important thing would be just to emphasise openness and communication . . . ‘Don’t sit on
something if you’re worried about something, tell me . . . I might be worried about it as well, and I’ll tell
someone else’. [Laughter] . . . that wasn’t necessarily a formalised part of the training in the same way that
we laid out how to deal with the exercises . . . but actually, probably just as important.
Physiotherapist
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Needing a support network
This theme describes the need for peer support and effective two-way communication. Assistants
described an effective support network in which someone had ‘tabs on them’; they did not feel abandoned:
I worked very closely with [the physiotherapist] . . . we did have a patient that was very tearful and rehab
was quite difficult, and I called [the physiotherapist] as soon as I finished the appointment and we had a
chat on the telephone and the next morning straightaway, we had a meeting to discuss how it was going
on . . . which I think was really helpful because sometimes you just need that qualified [person] there just
to cast their eye over it and just make sure everything’s going OK.
Assistant
This ongoing support was not only important on a personal level for the assistant, but also important in
maintaining the patient’s confidence in the rehabilitation assistant:
If I ever [felt worried] I wouldn’t do it. Or I would get someone to come . . . I would always say, if you’re
not sure of something just say . . . ‘I will find out’ . . . because it’s hard to change it when you go next time
. . . then they could lose their confidence in you . . . Don’t put myself in a position where I say . . . ‘do that,
do that’ and think, ‘oh my god no that could be wrong’.
Assistant
Physiotherapists described the challenge of balancing the need for support and fostering an
environment of independence. Assistants described the need to feel trusted, yet also supported:
It’s quite nice from a physio[therapist] assistant point of view to feel like you’re making an impact
independently and [the physiotherapist] trust[s] you . . . But at the same time, it’s nice to have that
support . . . I didn’t feel at all like I was kind of abandoned or deserted . . . I think if the physio[therapist]
was coming in every single time they’d be pressure . . . are they kind of judging [me]? . . . it was a really
nice balance.
Assistant
This collaborative partnership between physiotherapist and rehabilitation assistant provided a safe
place to learn new skills:
So, it is nice to have that bit of encouragement from a physio[therapist] . . . I took on a lot of skills and
I learnt a lot about myself, I learnt a lot more about how to present myself to a patient because I was
independent and I was learning from the [physiotherapists] . . . so I was pitching the best skills from
everybody and putting them into, to what I want to become, so that was really good.
Assistant
Patients
We aimed to explore patients’ experience of being part of the CORKA trial. Using thematic analysis we
developed themes that fell into three main categories:
1. the benefits of having treatment at home
2. the challenges of CORKA
3. factors that might have an impact on the treatment outcome.
The benefits of having treatment at home
Participants described five main benefits: it was a relief not travel; I got an hour’s work done in an
hour; they can work with your surroundings; I wouldn’t have done it on my own; and there is nothing
like company (Figure 14).
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It was a relief not to travel
Participants described the difficulty that they would have in getting to the hospital and the great relief
that it was to have been allocated to the home exercises. Often they would rely on other people to get
them to the hospital:
I would have had to ask people to take me . . . we were having really bad traffic works at the time and it
could take anything up to 2 or 3 hours to get in . . . you never knew how long it was gonna take you and
the thought of having to make a physio[therapy] appointment . . . you’ve got somebody to take you and
they’ve got to wait around and bring you back again . . . It’s exhausting doing those exercises . . . and then
having to sit in the car and drive back . . . sitting in that car is exhausting when you got a bad knee,
I can’t tell you, you’d never believe it, you really wouldn’t.
Female 29
It was a relief [to have treatment at home] . . . we’re fairly au fait with the bus services now but at the
time I hadn’t been out so it was very much a sort of case of whenever I went anywhere it was calling a
taxi to get there . . . because my partner has health problems as well, so what with that and the eye
problems, and that we’re sort of permanently backwards and forwards.
Female 32
I got an hour’s work done in an hour
Participants felt that doing exercise at home made the best use of time, and described health-care
experiences where their time had been wasted:
We did an hour’s work and we got on with it . . . it just worked all the time and that was good . . . I got
an hour’s work done . . . [in hospital] I should think I got quarter of an hour’s work done in an hour . . .
I prefer just to get on with the work and get it done with . . . it was just being kept waiting . . . it seemed
to drag out a long time, over an hour, and you’d get very little done . . . you’re standing there thinking,
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FIGURE 14 Participant themes: the benefits of home therapy.
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One woman described the need to consider the time cost to the patient and their employers
(and family), not just the health-care costs:
I think sometimes it’s a matter of looking at the larger picture, because it’s not just the cost to the NHS
it’s the cost to everybody isn’t it . . . you have to cost what it’s costing you for sending someone to the
home, what it’s costing the individual, what it’s costing their employers . . . if you’re taking time off work
to go to a hospital appointment and then you’re spending half the day there for what is essentially a
10-minute or a half-hour session . . . I know it’s expensive for the hospitals but it’s expensive for the patients
as well . . . it is normally half a day isn’t it, instead of maybe half an hour of your appointment at home.
Female 32
They can work with your surroundings
Participants described the benefits of being in their own environment, as opposed to a ‘sterile room’.
At home, the therapist can see what they have to work with and can improvise and adjust exercises;
they can be creative and adaptive to individual goals in a real-life setting:
I have always maintained that physio[therapy] is best given in your own home because then people can
see what you’re working with . . . [my] house is small . . . and that’s quite hard to explain when you say,
‘Oh, I live in a little house.’. People think, ‘Oh well, she can still walk around in a figure of 8,’ well you
can’t, cos there isn’t enough room? . . . They can actually see what you’ve got and what you’re coping with
. . . we went for a walk one day with the dog . . . huge confidence boost that was . . . they came here and
looked at everything . . . I could see them looking . . . they’ve got to see what you’ve got and what you get
round . . . you’re working with your surroundings, that’s why it worked so successful and it was such a
good idea because . . . you were working with what that person has to live with every day.
Female 29
. . . knowing what your home environment is like and what you’re going to be able to do of those exercises
. . . if they give you something sort of running for 10 yards or something inside, that’s not gonna work
if you’re in a confined area, or if you can’t manage these stairs or you know if you’ve got nothing, no
space, I mean we’re fairly compact here, there’s not a large area, just seeing that I think, and how you
can manage the exercises in your home environment . . . Rather than . . . you get home and you think,
‘Well, how do I do that?’.
Female 32
I wouldn’t have done it on my own
This describes the confidence gained by being overseen by a health professional who tailors the
exercises to the individual. Patients did not feel that they had the capability to progress in this way
on their own:
They check you as to whether you were able to do this exercise or not and so . . . they were able to
actually tailor the exercises to the way you were progressing. . . . now I wouldn’t have been able to do
that on my own . . . [they] came in a couple of times as well and check that my knees were, my knee
was flexible enough you know . . . without the contact there isn’t the progress.
Male 33
I found [exercises at home] very comforting because he was there and he was telling me what it’s for and




NIHR Journals Library www.journalslibrary.nihr.ac.uk
62
Participants described how knowing that someone would be coming to ‘check-up’ on them was a
motivation to keep doing the exercises, and this motivation got them into the habit. There was a sense
of duty towards the therapist who had come ‘all that way’; they did not want to let the therapist down:
It was, it was beneficial because I knew he was coming . . . which made me do the exercises . . . that was the
main thing actually it kept me going . . . I feel that I’m so active because he came here . . . because he came,
I felt I had to do them because I didn’t want to let him down coming all this way . . . I wouldn’t be as active.
I am convinced that I would not be . . . ‘cos I am a lazy person . . . I probably wouldn’t be where I am now . . .
whereas because I knew [name] was coming, it made me do them. You know, it’s as simple as that really.
Female 25
I think if he hadn’t have come I wouldn’t have bothered doing it . . . there was somebody there to make you
do it too . . . which of course got me into the habit of doing it . . . I think if I’d just been given the sheets I
would have thought, ‘Yeah, that’s alright, I’ll do that when I’ve got a spare minute,’ [laughs] . . . I mean I was
a bit miffed at the time and thought, ‘Oh blow, I got to do that’ . . . once you get into a routine it’s not so
bad, it’s just part of the day then, your ritual . . . I think we’re all people of habit aren’t we?
Female 31
There is nothing like company
Finally, participants describe the social benefits of a therapist coming to their own house. This social
aspect facilitated exercise:
[I was] quite pleased to see her when she came . . . If you’re a bit younger and more active perhaps you
might think differently, but in my position I was glad to see someone, I’m glad to see anyone that breaks
the day up a little bit . . . for someone of my age and my way of life now, it was a welcome break to have
someone come round and chat to you for 10 minutes, quarter of an hour. Umm, it’s got a bit of a social
benefit I think.
Male 28
It did two things to me in my circumstances: it meant I had someone to talk to . . . So that was good,
and not only that . . . I quite look forward to someone coming in . . . if you’ve got two people together one
encourages the other . . . I mean you can go to these sports centres and . . . but I don’t think that’s the
answer . . . it’s team sports you need isn’t it? . . . It’s also the social side that goes with it, isn’t it? . . .
There’s nothing like company . . . I can vouch for that, there’s nothing like company.
Male 33
Challenges of having treatment at home
Participants also described two challenges of having treatment at home: they put me through my paces
and feeling at sea now that it is over.
They put me through my paces
Participants felt a bit surprised about the pace and duration of exercises and felt exhausted:
Some days if I had gone through all the exercises I would have been doing them 24 hours a day . . . if I’d
have been a sort of 40-year-old I would probably have coped with them, but being an 80-year-old was
slightly different and I don’t know whether that was really taken into consideration.
Male 30
I was surprised how intensive it was . . . he did put me through my paces . . . pulling my leg up and
stretching it out, that kind of thing . . . that really hurt and . . . the ones I’m doing is the lifting one which
I find quite hard to do on this chair . . . and on the bed I can lift my leg up quite nicely and the bend of
course, the bloody bend . . . which isn’t bad but it’s not brilliant, but it does hurt.
Female 25
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I do feel a bit a sea now it’s over
Participants also described being worried about what would follow: they felt a bit abandoned.
There was a sense that something should follow on, even if they had to organise it themselves:
I do feel a bit at sea, I’m thinking, ‘Hmm.’. And I know it’s gonna be up to me and sometimes I can think,
‘Oh’. But I think I need to see if I can find some . . . NHS physio[therapy] . . . Quite how I go about that I
haven’t got a clue but I’ll think about it when I got my head . . . my head’s not quite in the right place yet
. . . it’s something else you got to think about and organise.
Female 29
I done my 8 weeks or 6 weeks . . . and I think there’s a thing that, you can get a referral to the gym down
in the town . . . I don’t know, I’ll have to make enquiries . . . who I’d have to get referred by . . . so, I don’t
see them again then? . . . I want to know what’s going on . . . you get a lot of support in that first
6 months, but then there doesn’t seem to be anything . . . you feel as if right you’ve had your 6 months –
bang that’s the end of it.
Male 30
Factors that might have effect outcome
Participants describe factors that might have an impact on their outcome from treatment: my get up
and go has got up and gone; a variable social life; if you take to the person it goes a long way; and a
lot would shirk from putting on a pair of running shoes.
If you take to the person it goes a long way
Participants described an effective health-care interaction as hinging on ‘taking to the person’.
Personality factors were described as integral to being good health-care professionals and none of the
participants was negative about being treated by an assistant therapist:
He’s [not a physiotherapist] bless him . . . but he’s also had injuries himself so he knows, he knows what
it’s like to have a lot of pain . . . he’s an extraordinarily empathetic young man.
Female 29
A therapist should be kind, understanding, empathetic and be able to put people at ease. They should
also be able to have a bit of fun and to know what ‘makes people tick’. They should not appear
disinterested or ‘perfunctory’:
[Previous treatment] was perfunctory . . . it was done by the book . . . they’ve got to tick certain boxes . . .
a lot of physio[therapy] workis personality . . . you can log-on to that personality with someone, you’ll get
far more out of them . . . a lot of physio[therapy] is how you interact with people . . . it was a personal
thing . . . interpersonal skills are just crucial. You’ve got to be able to talk to people on any level really . . .
got to be able to relate to what that person is telling them . . . you have to have empathy . . . you have to
be able to cotton on to what makes them tick really . . . the best ones put an element of fun, they get on
your wave length you know, pretty quickly . . . It’s just building up a relationship . . . you have to do it
very quickly don’t you . . . so you have to have the innate ability to build up a fairly good relationship
with somebody.
Female 29
[He] was wonderful, he really was . . . everybody has been very, very kind and all gone over the top with
me, let's put it that way if you like, with the helpfulness . . . I can’t fault anything. I really can’t. . . . I liked
[name], you know, she kind of put me at my ease, never put any pressure on me at all . . . I think if you
take to the person that’s talking to you it goes a long way to anything, you know.
Female 25
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One woman made a comparison to palliative care therapists:
I used to listen to [palliative care] physio[therapist]s all day, getting people to go up and down these stairs,
who didn’t want to . . . they were dying, they didn’t want to know about it but she was gonna get them up.
And the way she did it was amazing, because, because of her personality . . . cos it’s not about dying, it’s
about making the most of living really . . . I think they’re quite similar actually . . . the empathy and the
relating to people . . . I mean, you’ve got to have all those qualities haven’t you? You’ve got to have the
same qualities.
Female 29
My get up and go has got up and gone
Participants describe other health issues with advancing age that might have an impact on recovery,
including high blood pressure, chronic arthritis, hip replacements, diabetes, heart attacks, itching,
chronic cough, hearing loss, sight loss and incontinence. Some described this as ‘just old age’ or ‘my get
up and go has got up and gone’:
I developed diabetes . . . then I got angina 3 years later, I had a heart attack . . . now I’ve got a terrible
blasted itch I’ve had it for 4 years, no one knows what it is. . . . It makes my life an absolute misery.
. . . Another thorn of mine: hearing, I’m completely deaf in this ear . . . and I’ve had this cough since about
December I suppose but that’s the least of my problems. I think most of my troubles are just age . . .
Lack of stamina compared to when I was young . . . put it another way: my get up and go has got up and
gone . . . I mean age has to catch up with everyone doesn’t it eventually, unless you’re gonna die in your
sleep at 50, that’s luck . . . I can’t die young can I now? I think that’s really the basic trouble: age. I think so.
Male 28
I do have other health problems . . . I used to enjoy swimming a lot and I’ve not been able to do that for
about 5 years . . . that was partly my knee but . . . it’s the eyesight issue as much as anything . . . vision
certainly affects what I decide to do.
Female 32
A variable social life
Some participants described a diminished social life that could have a profound impact on their motivation
and recovery. Two men had quite recently lost their wives and described the impact of this loss:
I think my mental thing is, is more related to the loss of my wife in many ways . . . Because I’m in a house
on my own . . . I don’t have anybody to talk to . . . I get up in the morning to have my breakfast . . . but
some days I don’t bother to have any food at all, because I can’t be bothered. We always used to lay the
table up here for lunch, you know, and we would sit down and have a chat; television was turned off,
radio was turned off, we used to talk at lunchtimes always . . . that’s the big issue with me mentally . . .
Now whether that’s had an impact on the way I’ve, I’ve recovered I don’t know . . . but I feel it has had
an effect . . . I still talk to my wife [laughs].
Male 33
I don’t do much really. Umm, my daughter has every Friday off and does the housework and this that and
the other, she looks after me quite a lot when she’s here, but she’s not here a great deal. Umm, I don’t get
out a lot at all . . . I watch the television mostly in the evening; I haven’t succumbed to daytime television
yet . . . all my friends have died really . . . And you do lose a lot of friends when you stop work. But once
again they’ve all died off one by one; almost the longest survivor I think.
Male 28
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Others described a more active participation in life with friends and family:
I play Bridge a lot . . . I teach Bridge . . . I enjoy doing that . . . they wanted to learn over at the club . . .
So I said to the girls, ‘Do you want me to do it?’. ‘Oh yes please’ sort of thing, and so I, I started them from
scratch and that was 14 years ago . . . and we’re still learning [laughs]. Yes, once a week. And then I’d go
with one or two of them to different clubs, a couple of clubs to get them used to going out and joining
clubs and that, yeah they enjoy it, it’s nice.
Female 31
I have two sons and a daughter and that family with the grandchildren and their partners and I’ve begged
one of them to give me a wedding [laughter] . . . they’ve all got partners, two step grandchildren, great
grandchildren . . . they’ve been together 10 years and they’re just expecting their first child together . . .
I'm very proud of them all, they've all got homes, jobs and if they’re not buying a home they're renting one.
Female 25
A lot would shirk putting on a pair of running shoes
Personal motivation to exercise was described as a factor that might influence adherence and, therefore,
outcome. Participants described the ‘exercise type’ or ‘not the exercise type’:
I do have to give myself a good talking to . . . you’re talking to the wrong person, cos I am literally the
laziest person, I hate exercise. Yes. And you know I have a lovely place to walk in, you know, I used to say
that to myself before, ‘I don’t live in a tower block where I’ve got to walk round and round the sofa’, you
know I just have to step out the door and this time of year it’s beautiful, you know. And I don’t even have
to go very far, I can just walk down the village and stop for a cup of tea down the other end and come
back again. You know, I have no excuses other than the fact that I am just bone idle and I hate exercise.
Female 29
They’ve probably never exercised in the first place . . . a lot of individuals that I know would shirk putting
on a pair of running shoes [laughs] . . . My wife was a townie . . . She’s never been interested in sport.
She’s never done any sport at all in her life . . . When I was at school we had . . . form games . . . school
games . . . and then you had the school represented teams . . . so I’ve always been physical as it were.
But I mean my son he’s, he, he’s not physical, he doesn’t do exercises, he would blow a gasket if you asked
him to do some exercises.
Male 33
Discussion
Implications for clinical practice and education
Physiotherapists and assistants
We found that both physiotherapists and rehabilitation assistants were positive about working with
each other in the community and that themes cut across both groups.
Our findings indicate that there are personal skills that are integral to good clinical practice that extend
beyond professional knowledge: seeing the person in their own world, developing people skills and
thinking outside the cubicle. We found that the home therapy environment encouraged clinicians
to develop these skills, and the clinicians indicated that they would transfer these skills to other
clinical settings.
Our findings also suggest that there are barriers to developing personal skills that should be considered.
It can be a challenge to tread the fine line between being a friend and being a patient, and there can be
times that you feel outside your comfort zone. Physiotherapists and assistants described the need for a
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support network to help them to meet these challenges. Having successfully managed these challenges,
clinical staff described the ‘above and beyond’ – getting to know the patient and, therefore, having an
impact on their lives – that made their role rewarding in the long term.
Patients
We found that the interviewed participants were extremely positive about the CORKA home-based
intervention. Benefits included good, effective use of their time (‘It was a relief not to travel’ and ‘I got
an hour’s work done in an hour’), being able to tailor the intervention to their own environment and
having someone to oversee exercise progression. Home therapy was described as a social benefit that
contributed to exercise adherence and motivation.
The challenges of home therapy included the intense nature of home treatment (where you got an
hour’s work done in an hour). For some, this intensity could become burdensome. Participants also
described feeling abandoned after the intervention was over.
Our findings highlighted factors that might affect the outcome of trial interventions. These included
personal circumstances, such as physical health, social life and personal feelings about exercise. They
also included the personality and social skills of the therapist, which participants described as integral
to adherence and motivation. This supports findings from the clinician interviews.
Strengths and limitations of the study
The sampling strategy successfully recruited participants with a range of ages and experience.
Qualitative research is an interpretive methodology that does not aim to be statistically representative
of the whole: it aims to distil ideas from the essence of collected data. Thus, the rigour of our qualitative
study hinged on our collaborative approach to analysis and the experience of the qualitative researcher.
It is not possible to precisely estimate an appropriate sample size for qualitative studies when projects
require numbers of participants and resources to be estimated in advance to be granted funding, and
the number of participants in qualitative studies ranges widely. Further research exploring the issue of
saturation would be useful. Our study has distilled ideas that would be useful in developing clinical
practice for frail older adults undergoing joint replacement and for clinical education.
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Chapter 7 Screening tool development
Introduction
This chapter describes the development of the screening tool to identify participants at risk of a poor
outcome after TKA, who would then be suitable for recruitment into the CORKA trial. During trial
design, we identified that no existing screening tool existed to identify patients at risk of a poor
outcome after KA. It is reported following the Transparent Reporting of Multivariable Prediction
Models for Individual Prognosis or Diagnosis statement.105,106
Study population
The data used to develop the screening tool came from the Knee Arthroplasty Trial (KAT) data set.107
The KAT was a pragmatic, multicentre RCT designed to determine whether or not a metal-backed plate
for the tibial component was more effective and cost-effective than a single high-density polyethylene
component or resurfacing the patella, and whether or not a mobile bearing between the tibial and
the femoral components was associated with better outcomes than standard designs without a
mobile bearing.107
The KAT involved 116 surgeons at 34 UK sites. All patients under the care of a collaborating surgeon
were potentially eligible for inclusion in the trial if a decision had been made to have primary knee
replacement surgery. A patient was ineligible for the trial if their surgeon considered that a particular
type of operation was clearly indicated, for example if a patient required a highly constrained knee
replacement to replace function of the collateral ligaments. A participant remained eligible only if
their surgeon was convinced that there was no indication for one of the trial surgeries. For example,
a patient with a very thin patella would not be eligible for the patellar resurfacing comparison because
patellar resurfacing would not be suitable for them.108
Knee Arthroplasty Trial data collection
The KAT data collection was carried out using standard forms to record pre-operative, peri-operative
and post-operative information. Data describing functional status and QoL were collected in forms
that were sent to the participants by mail. These follow-up forms were meant to be completed by
participants around 3 months, 1 year and 2 years after the surgery.
If follow-up questionnaires were not returned after a mail reminder, the trial team gave a telephone
reminder and offered participants the option of completing the form over the telephone. Further
details of the KAT design and data collection can be found elsewhere.107
The KAT time points and the data collected at each are described in Table 27.
Individual patient data used to develop the screening tool
The KAT data set contained individual participant information at baseline and 3-month, 1-year and
2-year follow-up, which was collected from 2318 participants randomised to receive one of the three
KAT interventions.
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To develop the CORKA screening tool, we excluded data from KAT participants aged ≤ 55 years (n = 115)
to match the CORKA trial exclusion criteria. We also excluded data from KAT participants with a BMI of
> 50kg/m2 (n = 9). The final development data set comprised information from 2194 KAT participants.
Available variables and initial selection of candidate predictors
Of the variables available in the KAT data set, those measuring sociodemographic indicators (e.g. age,
gender and BMI), pre-surgery QoL, physical function, current mobility levels and pain status were
considered potentially useful for identifying KA patients at risk of a poor surgery outcome.We selected
eight of these variables as a priori candidate predictors for testing for inclusion in the screening tool.
These candidate predictors were selected based on their clinical importance, existing statistical evidence
and relevance to the patient. The initial selection was made internally by the research team, taking into
account the literature and the team’s expertise.
Table 28 lists the pre-selected candidate predictor variables, what type of variable they are, how they
were collected and the number of missing data. The table also includes information for height and
weight, which were used to calculate the eighth variable, BMI.
Outcome definition
The outcome of interest for the predictive tool was functional status 1 year after TKA, measured by the
OKS. To identify the participants who would most benefit from the CORKA home-based intervention,
we defined an OKS score of 26 or less as the threshold for a poor outcome.
The OKS was the primary outcome measure in KAT. Table 29 presents a summary of the available
outcome data in the KAT data set, the number of participants with a good or poor outcome and the
number of missing data.
TABLE 27 Time points and data collected in the KAT
Time point Information collected Questionnaires
1. First contact with patients
(emergency department presentation)
Baseline characteristics, clinical assessment,
health on the day of the interview, general
health and health problems caused by the knee
l Contact details
l Demographics
l Surgeon’s assessment form




2. Follow-up at 3 months post surgery Health on the day of the interview, general
health, health problems caused by the knee





3. Follow-up at 1 and 2 yearsa Health on the day of the interview, general




SF-12, Short Form questionnaire-12 items.
a Only data from 1-year follow-up were used in the statistical analysis presented in this chapter.
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Exploratory analysis and data transformation
The baseline characteristics of the candidate predictors in the KAT data set were summarised using means
and SDs for continuous variables, and frequencies and percentages for binary and categorical variables.
Binary and categorical predictors were tabulated against the outcomes to check for empty or low cell
counts (n < 5). Where empty or low counts were found, categorical variables were re-categorised by
joining some of the categories together if it made clinical sense to do so.
Although most of the KAT participants had their Short Form questionnaire-12 items (SF-12) assessment
performed with version 2.0 of the questionnaire, some were assessed with version 1.0. The two predictors
that were based on questions from this instrument were re-categorised to ensure data consistency.
The list of manipulated variables and the changes made for each are presented in Table 30.
TABLE 28 Pre-selected candidate predictor variables from emergency department presentation and baseline assessment
Type Variable name Categories/units Questionnaire
Missing
values, n (%)
Binary Gender Male, female Participant details form 0 (0)
Categorical
or ordinal
ASA classification grade Completely fit and healthy; some
illness but has no effect on
normal activity; symptomatic
illness present, but minimal
restriction; symptomatic illness
causing severe restriction
Baseline questionnaire 109 (5)
Have you accomplished less
than you would like as a
result of your physical health?
(SF-12 question 6)
All of the time; most of the time;
a good bit of the time; some of
the time; a little of the time; none
of the time
Baseline questionnaire 148 (6)
Have you felt downhearted
and low? (SF-12 question 11)
All of the time; most of the time;
a good bit of the time; some of
the time; a little of the time; none
of the time
Baseline questionnaire 141 (6)
Pain on the knee (OKS
question 1)
None; very mild; mild; moderate;
severe
Baseline questionnaire 113 (5)
Mobility (EQ-5D-5L question 1) No problems in walking about;
some problems in walking about;
confined to bed
Baseline questionnaire 94 (4)
Continuous Age Years Participant details form 0 (0)
Height Metres Participant details form 148 (6)
Weight Kilograms Participant details form 107 (5)
BMI kg/m2 Not on questionnaire
(calculated)
157 (7)
SF-12, Short Form questionnaire-12 items.
TABLE 29 Outcome rate and percentage of missing data in the KAT data set
Outcome
Good outcome/no
event (OKS of > 26)
Poor outcome/event
(OKS of ≤ 26) Missing data Total
Functional status outcome 1 year after TKA 1319 (56.9%) 389 (16.8%) 610 (26.3%) 2318
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Handling missing data
The percentage of missing data in the CORKA screening tool development data set was presented
for each candidate predictor variable in Table 28 and the outcome in Table 29. To conform to current
guidelines, multiple imputation for all participants with at least one missing value was performed.109
As several predictor variables of different types had missing data (binary, categorical and continuous),
multiple imputation by chained equations was carried out using the mi impute chained function in Stata 15.
We used the option logit for binary variables, mlogit for categorical variables and truncreg for continuous
variables, setting the lower and upper limits for imputed values as the correspondent scale limits.
We assumed that all missing data were missing at random and that the imputation models included
all available observed characteristics for the predictors of interest, predictors of predictors (e.g. weight
and height for BMI) and outcomes, as recommended by White et al.109 There were low rates of missing
data, with no more than 6% missing for any one candidate predictor. Based on the number of missing data
for the variable with the highest rate of missing observations, we produced 10 complete imputed data sets.
We did not perform data transformations on continuous predictor variables before imputing missing
observations.
Despite using the augmented-regression approach,110 some categorical predictors were excluded during
imputation owing to perfect prediction.111 Perfect prediction occurs when one of the categories in a
categorical explanatory variable is always observed with one of the possible outcomes, for example if
all women had a good outcome. Perfect prediction is a problem because it leads to infinite coefficients
with infinite standard errors, causing instability during estimation and preventing the imputation model
from achieving convergence. It is often resolved by discarding the observations corresponding to the
offending covariate patterns or by discarding the independent variables that perfectly predict the
TABLE 30 Format and categories/units of the candidate predictor variables in the original KAT data set and after
data manipulation
Variable
In the original data set
After exploratory analysis/data
manipulation
Type Categories/units Type Categories/units
Age Continuous Years Binary l 56–65 years
l ≥ 66 years
BMI Continuous kg/m2 Categorical l Normal weight (< 25 kg/m2)
l Overweight (25–29.9 kg/m2)
l Obese (≥ 30 kg/m2)
ASA classification grade Categorical l Fit/healthy
l Some illness




Binary l Fit/healthy or some illness





less than you would like
as a result of your
physical health?
Categorical l All the time
l Most of the time
l Some of the time
l A little of the time
l None of the time
Binary l All the time or most of
the time
l Some of the time or a little of
the time or none of the time





Binary l None or very mild or mild
l Moderate or severe
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outcome during estimation. We decided to keep all of the observations in the data set and discard the
variables that caused perfect prediction from the multiple imputation model. As a result, we discarded
two baseline variables: ‘mobility’ and ‘have you felt downhearted or low’.
Sample size considerations
Sample size requirements for logistic regression are based on the concept of events per variable (EPV).
It is widely recommended that a data set contains a minimum of 10 EPV to avoid overfitting the
model.112–117
As the KAT database contained 389 events of a poor outcome 1 year after surgery (see Table 30), we
could examine up to 39 (389/10) candidate predictor variables in the model. After excluding two of the
preselected candidate predictors owing to perfect prediction, only six of our baseline candidate predictors
remained for testing. We, therefore, had 65 EPV available, making overfitting unlikely.
Data modelling
As the outcome was binary (poor outcome after TKA: yes/no), the screening tool was developed using
a logistic regression modelling framework with the logit probability of an adverse outcome as the
response variable. We removed candidate predictors that were not statistically significantly associated
with the outcome. The remaining candidate predictors were included in the final logistic regression.
As we had 65 EPV, we did not shrink the regression coefficients.
To aid implementation of the screening tool, we simplified the final multivariable model by assigning
integers to the predictors based on the final model. The integers can be summed to obtain a total to
identify participants who are likely to have a poor outcome 1 year after TKA.
Predictive accuracy
The performance of the CORKA screening tool was characterised by evaluating its discrimination.
Calibration was not assessed, as the aim of the screening tool was to generate a score for an individual
and not predict the probability of the outcome.
Discrimination measures the screening tool’s ability to correctly rank individuals. The overall discriminatory
ability was summarised by the area under the receiver operating characteristic (AUROC) curve (c-index),
with 95% CIs. The AUROCwas classified as follows: 0.5 to < 0.6 poor, 0.6 to < 0.7 fair, 0.7 to < 0.8 moderate,
0.8 to < 0.9 good and 0.9–1 excellent. Owing to the large number of EPV, we did not carry out a formal
internal validation of the model using bootstrapping or cross-validation, for example.
Results
Table 31 summarises the candidate predictor data available for modelling in the KAT data set before
and after exclusions and multiple imputation. Multiple imputation and excluding KAT participants with
characteristics that would not meet the inclusion and exclusion criteria for the CORKA trial from the
model development data set did not greatly alter the sample’s characteristics. For example, average
age changed from approximately 69.99 ± 8.38 years before to 71.01 ± 7.22 years after exclusion and
multiple imputation, and BMI changed from 29.70 ± 5.47 kg/m2 before to 29.53 ± 4.88 kg/m2 after
exclusion and multiple imputation.
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We kept continuous variables in their original format without data transformation for multiple
imputation of missing data.
A summary of the unadjusted and fully adjusted multivariable models’ estimates (odds ratios with
95% CIs and p-values) is presented in Table 32. In the unadjusted analysis, all remaining candidate
predictors were significantly associated with the outcome, except for gender. In the fully adjusted
multivariable model with the predictors, all variables remained statistically significant. Age was
negatively associated with the likelihood of a poor outcome 1 year after TKA. The research team
made the pragmatic decision to omit this variable from the final multivariable model, as we did not
have a plausible clinical explanation for the observed direction of association.
A summary of the final multivariable logistic regression model (odds ratios, 95% CIs and p-values) is
presented in Table 33.
As all of the odds ratios were greater than 1, the CORKA screening tool was developed by rounding
the observed odds ratios for each predictor or predictor category. Any patient with a score of 5 or
more would be classified as being at increased risk of a poor outcome after 1 year and likely to benefit
from the CORKA home-based intervention. The threshold score of 5 was a pragmatic choice taken
TABLE 31 Summary of the baseline characteristics of the candidate predictors in the KAT data set before and after
exclusions and multiple imputation
Variable Before multiple imputation After multiple imputation
Age (years), mean (SD) 69.99 (8.38) 71.01 (7.22)
Height (m), mean (SD) 1.65 (9.89) 1.65 (9.85)
Weight (kg), mean (SD) 81.00 (16.45) 80.54 (15.57)
BMI (kg/m2), mean (SD) 29.70 (5.47) 29.53 (4.88)
Gender, n (%)
Male 1014 (43.74) 955 (43.53)
Female 1304 (56.26) 1239 (56.47)
Pain on the knee, n (%)
None 5 (0.23) 5 (0.23)
Very mild 31 (1.41) 33 (1.5)
Mild 97 (4.42) 94 (4.28)
Moderate 953 (43.38) 968 (44.12)
Severe 1111 (50.57) 1094 (49.86)
ASA classification grade, n (%)
Fit/healthy 367 (17.10) 367 (16.73)
Some illness 1324 (61.70) 1350 (61.53)
Symptomatic illness with minimal restriction 440 (20.50) 460 (20.97)
Symptomatic illness causing severe restriction 15 (0.70) 17 (0.77)
During the past 4 weeks, have you accomplished less than you would like as a result of your physical health? n (%)
None or very mild or mild 1759 (81.06) 1781 (81.18)
Moderate or severe 411 (18.94) 413 (18.82)
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by the research team based on forecasted numbers of individuals declared as at high risk of a poor
outcome. The final CORKA screening tool is presented in Table 34.
The model performance was assessed in terms of discrimination. The model had a fair overall discriminatory
ability to predict a poor outcome 1 year after TKA (apparent performance), as measured by the AUROC
curve (0.66, 95% CI 0.64 to 0.69).
TABLE 32 Summary of the full unadjusted and adjusted multivariable logistic regression models including all six
remaining candidate predictors of a poor outcome 1 year after TKA
Variable
Unadjusted analysis Full multivariable model
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Age (56–65 years) 1.55 (1.24 to 1.92) < 0.001 1.55 (1.24 to 1.95) < 0.001
Gender (female) 1.10 (0.88 to 1.37) 0.399 – –
BMI
Overweight (25–29.9 kg/m2) 1.41 (1.03 to 1.94) 1.39 (1.01 to 1.93)
Obesity (≥ 30 kg/m2) 2.05 (1.50 to 2.79) < 0.001 1.80 (1.31 to 2.48) < 0.001
OKS
Moderate/severe pain on the knee 2.8 (1.59 to 4.91) < 0.001 3.61 (2.47 to 4.63) 0.001
ASA classification grade
Symptomatic illness with minimal restriction/
symptomatic illness causing severe restriction
2.63 (2.10 to 3.28) < 0.001 2.60 (2.07 to 3.26) < 0.001
SF-12
Accomplishing less than would like as a result of
physical health all the time/most of the time
2.19 (1.74 to 2.76) < 0.001 2.04 (1.60 to 2.59) < 0.001
Estimates of candidate predictors that were not statistically significant are in bold. Although age was a statistically
significant predictor, we decided not to include this variable in the final model as it was not clinically plausible that
older patients are less likely to present a poor outcome 1 year after TKA than younger patients.
TABLE 33 Estimates of the final multivariable model for the prediction of a poor outcome 1 year after TKA
Variable Odds ratio (95% CI) p-value
BMI
Overweight (25–29.9 kg/m2) 1.44 (1.04 to 1.99) < 0.001
Obesity (≥ 30 kg/m2) 1.93 (1.41 to 2.66)
OKS (moderate/severe pain on the knee) 3.63 (1.49 to 5.67) < 0.001
ASA classification grade (symptomatic illness with minimal
restriction/symptomatic illness causing severe restriction)
2.49 (1.99 to 3.13) < 0.001
SF-12 (accomplishing less than would like as a result of physical
health all the time/most of the time)
2.04 (1.61 to 2.59) < 0.001
Intercept 0.05 (0.03 to 0.10) < 0.001
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Discussion
The CORKA screening tool was developed to be a simple-to-use tool that identified participants likely
to be at increased risk of a poor outcome 1 year after TKA and, therefore, most likely to benefit from
the CORKA home-based intervention. As the screening tool was developed using a large existing data
set with a small number of candidate predictors, we were not concerned about overfitting the model.
The apparent performance of the model was fair, as measured by its discrimination.
The research team was confident that the developed screening tool would help to identify most
patients at an increased risk of a poor outcome and most likely to benefit from the CORKA home-
based intervention, owing to the quality of the development data set, data optimisation with missing
data multiple imputation and model building strategy.
We did not conduct any cross-validation or internal validation because EPV is a marker of the potential for
overfitting, with an EPV value of < 10 widely considered to be the level at which concerns may be raised.
Our EPV for model development was very large at an EPV of 65. Simulation studies118,119 illustrate that
once EPV is > 20, the bias owing to any overfitting is negligible/eliminated, such that the apparent
performance (reported in the monograph) converges to the true underlying large sample performance.118,119
We chose to use the KAT data set and the OKS as an indicator of poor outcome because of the
availability of a large data set. The use of clinical trial data is potentially challenging, particularly if
there is a large treatment effect observed in the trial. The potential of using clinical trial data has
recently been described by Pajouheshnia et al.120 Options are to include treatment (if the effect is
large) in the model or to use the control arm only (particularly if the arm was a placebo arm). The KAT
observed no differences in OKS between the treatment arms, which reinforced our justification
of using the entire trial data. Furthermore, available data following the natural course of patients
are uncommon, individuals will usually have received specific treatments during follow-up,
i.e. confounding by indication.120
TABLE 34 The CORKA scoring system (screening tool) for the risk of a poor outcome 1 year after TKA
Variable Categories Points
BMI Normal weight (< 25 kg/m2) 0
Overweight (25–29.9 kg/m2) 1
Obesity (≥ 30 kg/m2) 2
OKS question 1:a during the past 4 weeks, how would you
describe the pain you usually have in your knee?
None or very mild or mild 0
Moderate or severe 4
ASA classification grade Fit/healthy 0
Some illness or symptomatic illness with
minimal restriction or symptomatic
illness causing severe restriction
2
SF-12 question 6:b in the past 4 weeks, have you been limited in
the kind of work you do or other regular activities you carry out
as a result of feeling anxious or depressed?
All the time or most of the time 2
Some of the time or a little of the time
or none of the time
0
a Do you feel pain on your knee?
b Have you accomplished less than you would like as a result of your physical health?
Note
A score of 5 or more would classify the patient as likely to present a poor outcome 1 year after TKA, defined as an
OKS of ≤ 26.
SCREENING TOOL DEVELOPMENT
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Chapter 8 Discussion
This discussion summarises the trial findings and the issues associated with its internal and externalvalidity, and provides interpretation for clinical practice in the NHS.
Overview of the trial findings and key messages
Knee arthroplasty is one of the most commonly performed musculoskeletal operations. Although it
effectively reduces pain and improves physical function for most patients and has good reported cost-
effectiveness, around 15% of patients report dissatisfaction with their post-operative outcome.7,121,122
In the short term, KA results in substantial loss of quadricep strength and decreased range of knee
motion and function, compared with the pre-operative status.123 Pain, reduced function, decreased
mobility and resulting falls cause significant morbidity for those patients with a poor KA outcome.
However, there is evidence to support the use of functional exercises by physiotherapists to improve
the range of joint motion and QoL.18 Draft clinical guidelines from the National Institute for Health and
Care Excellence (NICE) recommended targeted physiotherapy interventions for patients at higher risk
of a poor outcome for whom a self-managed exercise programme at home may not be suitable.124
The CORKA trial was a large multicentre RCT that targeted patients who were at risk of poor
outcomes after KA. We randomised 621 participants: 312 to usual care and 309 to home-based
rehabilitation. Most participants had a screening tool score of 5 or 6, all met the criteria of moderate
or severe knee pain and most were overweight or obese. The two treatment groups were well
balanced at baseline. The average age of the trial participants was 70.5 years.
Approximately one-quarter of participants received a UKA. TKA has been the traditional treatment of
choice for older patients with knee pain and limited activity because of arthritis. Undertaking UKA
is possible for some of these patients, but the indications outlined by Kozinn and Scott125 in 1989
suggested that the procedure was not suitable for patients with higher degrees of comorbidity.
The original indications for UKA included arthritis isolated to the medial compartment in patients
under 60 years of age with low levels of physical activity and weighing under 82 kg. This was thought
to be around 6–12% of patients undergoing knee replacement surgery.126 However, more recently,
Campi et al,126 reported that surgeons have widened the indications, especially for weight, age and
activity, and up to 50% of patients may now be eligible for UKA.
The recent TOPKAT trial127 compared TKA with UKA, and demonstrated that both were effective
options for patients with medial knee arthritis with similar clinical outcomes. However, participants
receiving a UKA had slightly better outcomes in terms of lower surgery costs and follow-up health
costs in the first 5 years. The lower costs of surgery for UKA may be a result of the increasing use of
enhanced recovery pathways, which are having a positive effect on outcomes.121 These pathways can
adopt rehabilitation strategies that encourage early mobilisation and discharge.128 Within the CORKA
trial, the same post-operative intervention was used irrespective of implant. However, both treatment
options may have been shorter and less intense for the UKA patients, who rarely struggle to regain
their range of movement.
There was no difference in evidence of the benefit between usual care and home-based rehabilitation
in terms of LLFDI function score at 12 months post randomisation (ITT multiple imputation difference
0.49, favouring CORKA; 95% CI –0.89 to 1.88; p = 0.48), 6 months post randomisation (ITT multiple
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imputation difference 0.66; 95% CI –0.70 to 2.03; p = 0.34) or based on any sensitivity analysis.
As previously discussed, this may be in part because participants in the usual-care group received
more treatment sessions than anticipated. Treatment effects varied substantially by site and showed
some relation to the average number of sessions of usual care and home-based rehabilitation received
at each site.
There were also no significant differences between the two groups in terms of any of the secondary
PROMs or physical measures for the ITT population using available cases. Sensitivity analyses of
the key secondary PROMs (LLFDI disability frequency and limitation, OKS and KOOS QoL subscale)
identified one significant difference between the two groups, for LLFDI disability limitation using the
ITT population and multiple imputation. However, we do not believe that this is a difference that is
explicable by the package tested and think that it is more likely to arise from the number of tests
performed than being a true finding when considered in the context of all the other tests, physical
and self-reported, that were conducted with no statistically or clinically significant differences. The
number of participants experiencing a serious adverse event was small in both the usual-care arm
(14/312, 4.5%) and the home-based rehabilitation arm (18/309, 5.8%), with no significant difference
between them (risk difference 1.3%, 95% CI –2.1% to 4.8%; p = 0.45).
Over the 1 year of the CORKA trial, we found a small non-significant difference in QALYs favouring
the CORKA home-based intervention (0.003 QALYs, 95% CI –0.017 to 0.023 QALYs). The CORKA
intervention itself was cheaper, but the participants in the CORKA arm reported higher use of other
NHS resources in that year than participants in the usual-care arm. This cost was offset by lower
societal costs, with more CORKA participants returning to the workplace and using less social services
than usual-care participants.
The participant diaries that were used to capture health and societal costs showed that participants
in the CORKA arm had less time off work and returned to work sooner than participants in the
usual-care arm. We do not believe that this is a spurious finding. We can only speculate on the reason
for this. The CORKA intervention was much more functionally focused, with individual goal-setting
aiming to return to activities that the participants had selected as important to them. Conventional
physiotherapy has a more biomechanical approach focusing on strength and mobility. We believe
that the more individually tailored functional approach of the CORKA intervention may have been a
factor in a larger number of people returning to work. Overall, however, because of the age of most
participants, a relatively small number of participants in both groups returned to work.
Usual care used a traditional clinic-based or hospital-based model of outpatient physiotherapy delivered
by qualified, registered physiotherapists. By contrast, the CORKA home-based intervention was
multidisciplinary in content, was delivered in participants’ own homes and used a staffing model of
rehabilitation assistants supervised by a qualified physiotherapist or occupational therapist. The trial
data suggest that the two treatments were similarly effective and safe in this population.
Interviews with patients who received and therapists who delivered the CORKA home-based
intervention showed that it was acceptable to both patients and clinicians. Being treated at home
facilitated a holistic rather than biomedical approach that underpinned a collaborative partnership.
Internal validity and methodological limitations
The CORKA trial was pragmatic in the context of the funding envelope available for physiotherapy
within the UK. It sought to estimate the effect of treatment strategies based on clinic-based or
home-based treatment using different staffing models. It used a range of recognised measures with
a 12-month follow-up, which is longer than many previous trials.
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We recruited 621 participants. Based on our published statistical analysis plan,46 the sample size
calculation required data from a minimum of 620 participants, assuming a moderately small standardised
effect size of 0.275, or 3 points on the LLFDI function score, with a power of 90% and an alpha of 0.05.
This allowed for a withdrawal rate of 10%.
The availability of follow-up data in this trial was very good. Primary outcome data were available for
92% of participants in the usual-care group and 89.4% of participants in the home-based rehabilitation
group at 12-month follow-up. Rates of withdrawals (34/621, 5.5%) and deaths (3/621, 0.5%) were very
low, resulting in a loss to follow-up rate lower than the 10% we had allowed for. We had primary
outcome data at 12 months for 566 participants (91.1%), providing sufficient statistical power to
detect a difference between the groups as originally specified.
Randomisation was conducted by a central facility at the Oxford Clinical Trials Research Unit and was
stratified by site using variable block lengths, preventing research staff from anticipating or influencing
treatment allocation for any given participant and resulting in two well-matched arms. Owing to
stratification by recruiting site when allocating participants to the groups, the numbers recruited were
not divided into exactly equally sized groups, but did not differ significantly. Demographic data, self-
reported functional measures, clinical impairment measures and disease stability were all very similar.
Owing to the nature of physiotherapy interventions, it was not possible to blind participants to their
treatment allocation. However, we endeavoured to ensure that outcome assessors remained blinded
throughout the trial. This was hard to achieve, with a high risk of inadvertent unblinding by participants
to research staff. We used a number of strategies to reduce the risk of unblinding, including explicitly
instructing participants not to inform their research physiotherapist of their group allocation at every visit.129
Barker et al.130 have previously reported that using these strategies resulted in successfully maintaining
blinding in 81–91% of the assessments, meeting the expected level for a successfully blinded trial, as defined
by Minns Lowe et al.129 and Boutron et al.131 As the primary outcome measure was self-reported by the
participants, it was unlikely to have been influenced by unblinding of the outcome assessors.
Compliance with home-based rehabilitation was prespecified as receipt of at least four treatment
sessions, and the compliance rate was high (269/309, 87.1%). The average number of treatment
sessions in each group was similar, with participants in the usual-care group receiving a median of
four sessions (IQR two to six sessions) and participants in the home-based rehabilitation group receiving
a median of five sessions (IQR four to seven sessions). The number of treatment sessions received in the
usual-care group was larger than anticipated, which may have affected the observed treatment effect.
There was also wide variability in the number of usual-care treatment sessions offered to participants
(range 0–27). The median number of usual-care sessions differed substantially by site, ranging from
two at site 13 to six at site 1. This suggests that there is a lack of standardisation in usual rehabilitation
offered to these patients across the country.
The interventions in both of the treatment arms were well received by participants according to the
qualitative study results.
Quality assurance checks and observation visits determined that the therapists delivered the content
well, although there was variation in the number of sessions delivered.
The treatment logs and assurance visits demonstrated that exercise progression was delivered as
planned. In designing the interventions, incremental progression of exercises and activity levels were
considered important to achieve the underlying physiological changes required to improve strength
and balance. There was good evidence from the content analysis of treatment logs that participants
had progressed the quantity and difficulty of the programme content, incrementally increasing the
amount of activity expected throughout the course of the treatment programme.
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The trial team achieved a high level of data completeness for the primary outcome, with over 90%
complete. The completeness for the physical measures was slightly lower at 89.2% for the F8WT,
89.4% for the 30SCST and 89.9% for the SLS, but was still close to the desired level of 90%, reflecting
that the physical outcome tests required a visit to the site. The pragmatic approach to collecting
outcome data by post or telephone when participants were unable or unwilling to attend face-to-face
assessments resulted in a higher completion of the questionnaire data.
A small proportion of participants (5.8%) withdrew and were distributed evenly across the two treatment
arms. There were no significant baseline differences between those retained and those lost to follow-up.
Only three participants (0.5%) were lost to the trial because of death. This was lower than expected
considering that, on average, participants were over 70 years of age and had a BMI of over 31, and
81% were categorised as being in an ASA classification category of mild or moderate systemic disease
at baseline.
An internal pilot study was conducted at one site (Oxford) to review the recruitment feasibility and
confirm the intervention package. The 15 participants randomised during this pilot study were used in
the final analysis, as no changes were made to the interventions or assessment tools between the pilot
and the main trial.
External validity/generalisability of findings
Overall, we believe that the generalisability of the findings of the trial is good. We recruited sites
across a number of NHS trusts, resulting in variation in trust size and a range of site sizes and
geographical locations. The training burden on qualified therapists and rehabilitation assistants was
relatively small because the core principles underpinning the programme were already within the
skill set and expertise of most NHS therapy staff. Thus, we believe that the intervention could be
implemented in other NHS sites relatively easily, particularly where a model for community care
already exists.
Post-operative physiotherapy: case of need
Although physiotherapy is generally regarded to be a key component in achieving optimal results
following KA, there is considerable international variation in the rehabilitation provided. In the UK,
inpatient rehabilitation is of short duration, with patients typically discharged 3–5 days following
arthroplasty after an accelerated recovery pathway. The key criteria for discharge home from hospital
are safe mobilisation and adequate knee flexion. Patients are usually referred to receive further
physiotherapy input through individual or group-based outpatient physiotherapy.
It is assumed that increased physiotherapy provision correlates with better outcomes. However, the
benefits of post-operative physiotherapeutic interventions are poorly established, with no consensus as
to whether or not outpatient therapy provides superior outcomes over other service delivery models.
The content, intensity and duration of existing physiotherapy programmes delivered in the outpatient
setting have been shown to vary widely.132–135 Rehabilitation provision following discharge varies widely
and no definitive guidelines for rehabilitation post knee replacement exist. The generally held assumption
is that increased therapist contact enhances the rehabilitation provision.
One of the interesting but potentially expected results from the CORKA trial was the variation seen
in usual care. Participants in the usual-care arm received an average of four treatment sessions, with
a range of 0 to 27 sessions. Provision of rehabilitation following KA varies in what is provided, where
it is provided and for how long it lasts.124 As the ultimate aim of rehabilitation is to improve patients’
outcomes, it is reasonable to consider how best to deliver rehabilitation after KA.
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Previous studies33,136 have investigated how much supervision is required in the rehabilitation process
following KA and whether or not self-management is sufficient. NICE recently reviewed the evidence
comparing self-directed outpatient rehabilitation and supervised outpatient rehabilitation.124 No
clinically important differences were found in QoL, PROMs or functional outcomes between group-
based or individually based supervision and self-directed rehabilitation. In the light of this evidence,
we suggest that self-directed rehabilitation makes sense for many people, with some caveats. As some
patients may benefit from supervised rehabilitation, a tool that identifies them from those who can
rely on self-directed rehabilitation would be useful, similar to that developed in Chapter 7. There may
also be benefits to supervised rehabilitation that are not captured by the current evidence or the
outcome measures used in existing studies. For example, participants in our embedded qualitative
study were very positive about the CORKA home-based intervention and the supervision provided
by therapists and rehabilitation assistants (see Chapter 6).
A significant amount of evidence suggests that patients benefit from rehabilitation after KA regardless
of where it takes place, how it is delivered and who supervises it. There are many potential pathways
for rehabilitation that seem to result in positive outcomes for patients. This could be positive for those
who design, implement and commission rehabilitation services. As patients seem to do well regardless
of how rehabilitation is delivered, rehabilitation pathways could be directed by local or subgroup
needs. However, some meta-analyses have highlighted that post-operative physical therapy applied
uniformly to all following TKA does not effectively improve patients’ outcomes after 1 year.134
As most patients report a good result after TKA, some might benefit from a targeted intervention;
for example, the CORKA trial focused on patients at risk of poor outcomes.
The CORKA home-based intervention could benefit patients who find it difficult to travel a significant
distance to a larger hospital, for example owing to frailty. Using the CORKA trial combination of
qualified therapists and rehabilitation assistants might make sense for certain areas of the UK or
other countries because of the large geographical areas covered by therapists. It may be important to
consider how we identify and focus resources on those subgroups that may benefit from supervised or
more closely monitored rehabilitation.
Although many studies have compared outpatient physiotherapy with supervised home exercises,
no RCTs have compared physiotherapy after KA with no treatment. Both patients and surgeons have
concerns that the absence of physiotherapy would lead to poor outcomes and potentially further
surgery for manipulation under anaesthesia.
The CORKA intervention
While developing the CORKA trial, in particular the CORKA home-based intervention, we considered the
breadth of potential improvements that rehabilitation could facilitate after KA. One way to categorise how
disability, or in this case KA, might affect people is to use the World Health Organization International
Classification of Functioning, Disability and Health constructs of impairment, activity restriction and
limited participation.137 Impairment is related to body functions or structure, activity refers to difficulties
in undertaking tasks or actions, and participation refers to difficulties experienced within life situations.
Knee arthroplasty rehabilitation tends to focus on physical impairment and activity,138 which the
CORKA home-based intervention accounted for. However, the intervention was also designed to
consider social participation, reflected by the CORKA primary outcome measure: the LLFDI.37,139 The
LLFDI assesses function, which records the participant’s ability to perform discrete tasks or activities,
and disability, which measures the participant’s ability to undertake socially defined life tasks.
It was reported as early as 2011 that rehabilitation programmes after arthroplasty need to focus on
more than just physical impairment. Davis et al.140 investigated the trajectory of symptom improvement,
daily activities and participation for 1 year after total hip or knee replacement. They concluded that KA
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rehabilitation programmes should target physical impairments, the ability to undertake activities and
social participation.
Wylde et al.138 recognised that outcome measures recorded post arthroplasty tended to focus on
impairment or activity, but less so on limited participation. They aimed to investigate the importance
of and difficulty in participating in leisure activities before and after knee or hip arthroplasty. They
found that roughly one-quarter of all participants and almost one-third of KA participants were
unable to carry out their leisure activities after surgery. The study concluded that leisure activities
are important to people undergoing knee or hip arthroplasty and that limitations in participation
should be measured after surgery. Maxwell et al.141 explored the predictors and extent of participation
restriction for patients after TKA. They also found that approximately 30% of study participants
reported limitations in carrying out activities after TKA. They reported modifiable factors associated
with participation restriction and suggested that these could be targeted in rehabilitation programmes.
Other evidence has suggested that patients can return to leisure pursuits after KA, referring to the
activity and participation categories of the International Classification of Functioning, Disability and
Health framework. For example, a systematic review suggested that patients are able to return to
athletic activities after lower limb arthroplasty, although sometimes at a lower intensity than before
surgery.142 In the light of this body of evidence, it was important that the CORKA home-based
intervention was developed considering impairment, activity and participation.
The CORKA trial was designed to include participants who were at risk of a poor outcome. One aspect of
the intervention that could help to achieve a better outcome, particularly for those at risk of a poorer
outcome, was that it was designed to be an individually tailored programme for each participant. This
approach is in line with a recent study by Barker et al.,143 which aimed to determine what functional or
leisure activities were most important to those undergoing KA and to compare the actual time to return
to these activities with patients’ expectations before surgery. The authors discussed the factors that could
influence a return to activities valued by patients and recommended a tailored, personalised approach.
These considerations helped direct the development of the CORKA intervention. The full process is
outlined in Chapter 3. The intervention was an individually tailored package consisting of range of
movement, strengthening and balance exercises; gait skills; a graduated walking programme; practising
functional tasks of relevance to the individual; information provision; adherence strategies; and the
provision of appropriate aids and equipment. A breadth of components was included to target
impairment, activity and participation.
The CORKA intervention took some steps to considering spousal support, such as asking participants
who might be able to help them with achieving their exercise goal, as part of a behavioural contract.
Future interventions should consider an ecological approach, considering not just the individual patient
and clinical staff but other relevant agents in the environment, in particular the support of spouses or
family. For example, it has been shown in physical activity promotion, that increases in an individual’s
physical activity level positively affects a spouse’s physical activity engagement.144 It may be that if the
CORKA intervention targeted couples or families more specifically there may have been a difference in
adherence with exercise programmes.144
Workforce model: rehabilitation assistants
Our trial design used a workforce model based on experienced rehabilitation assistants supervised by
a qualified therapist. This is an emerging service delivery model in the UK and elsewhere, where the
need to provide greater levels of care to meet the needs of an ageing population is set against a
backdrop of insufficient commissioned training places for students.145 This model works well in
the USA, where trials comparing the delivery of the Otago falls programme by qualified physical
therapists and physical therapy assistants supervised by qualified physical therapists have
demonstrated good outcomes.146
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Published guidance from professional bodies on competency training and roles that may be allocated
to assistant staff can support advanced or experienced rehabilitation assistants to deliver effective
protocol-driven care.147 This will free up qualified staff for complex care and management of the overall
patient pathway. This model is more advanced in speech and language therapy. Several RCTs have
compared the roles of speech therapy assistants and qualified therapists undertaking speech therapy
for children in schools and for swallowing practice.148,149
In preparing the CORKA intervention, we were aware of the need to map the proposed tasks in the
programme to the competencies and experience of advanced rehabilitation assistants. We drew on
the work of Moran et al.150 to prepare a programme that optimised the chances of effectiveness by
establishing clear communication and supervision structures and resourcing training and pay to reflect
the responsibility being undertaken.
Our findings showed that a model of supervision by a qualified therapist who acted as a consultant
available to discuss and evaluate patients’ needs and who reviewed patients at two time points to ensure
adequate progression was safe and as effective as a traditional model using qualified practitioners.
Qualitative study
Our qualitative findings indicate positive outcomes from CORKA that extended beyond the trial.
Clinician interviews indicated that working with participants in their own homes facilitated a holistic
rather than biomedical approach. It encouraged clinicians to develop people skills and flexibility when
prescribing exercise and planning. These skills were transferable beyond the trial and into other clinical
settings. Clinicians described the long-term personal rewards of going ‘above and beyond’, which may
affect staff retention.
Our findings indicate areas of focus for clinical education. How do we help clinicians to balance the
need to build rapport with the need to remain professional at all times, both of which are integral to
effective outcomes? How do we help clinical line managers balance their need to provide support with
assistants’ freedom to work independently and develop clinical skills?
In interviews, patient participants indicated that they did not object to having treatment delivered
by physiotherapy assistants. Rather, our findings suggest that an individualised approach alongside a
collaborative relationship enhances the effectiveness of exercise therapy. Our findings also highlight
the social benefits of home therapy, particularly for those who are socially isolated. Future research
should consider effects beyond physical intervention.
In a synthesis of 13 qualitative studies on patients’ perceptions of physical activity, Smith et al.151
highlighted the facilitators of and barriers to physical activity before and after joint replacement.
They found that the focus of physical activity after joint replacement is a desire for a new lease
of life, being able to participate and enjoy life and being able to do ‘obligatory activities’ (such as
personal care). Patients did not seem to be focused on public health or improving health. Smith et al.151
suggested that external engagement and support to undertake exercise facilitated physical activity
after joint replacement surgery, which resonates with our findings. They highlighted the importance
of social contact, particularly postoperatively when social networks can be lost. Enjoying and taking
part in physical exercise may supersede health as a global aim. Similar to our findings under the theme
‘I would not have done it on my own’, Smith et al.151 suggested that a significant barrier to physical
activity following TKA is fear of not ‘doing the right thing’. They highlighted a window of opportunity
to encourage physical activity immediately following surgery as ‘motivating time for people to undergo
rehabilitation and may therefore be a captive period to engagement in physical activity education’.151
We have added that exercise should be individualised and relevant to the person and that exercise
should be sociable and mutually supported.
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Our qualitative findings also highlighted the cost benefits of the CORKA trial for patients, with regard
to travel time and ‘getting an hour’s work done in an hour’. These costs should be considered in
health-care provision and trials.
Critique of methods
We designed our trial to test interventions that could be delivered in routine NHS physiotherapy
practice within the current commissioning constraints of the number of sessions remunerated by
most care commissioning groups. The trial showed that it was practicable and successful to deliver
the intervention content in both clinical and community settings.
Late Life Function and Disability Index
Our primary outcome measure was the function component of the LLFDI. This is a PROM designed to
assess change, particularly in older adults. The scale is made up of an overall function domain and three
subdomains: advanced lower extremity function (e.g. getting up from the floor), basic lower extremity
function (e.g. walking within the home) and upper extremity function (e.g. putting on and taking off a
coat). Each domain is calibrated on a 0–100 scale on which 0 indicates the worst functional level and 100
indicates the best functional level. It asks patients to report their current level of difficulty in performing
32 physical tasks on a typical day without assistance. It has good reported reliability and sensitivity to
change.152 We felt that the LLFDI encompassed the range of activities that were pertinent after
arthroplasty, with a basic and advanced subsection that could capture changes in patients who achieved
a good or poor outcome from surgery. We chose the function subscale over the disability subscale
because self-reported functional difficulties in elderly patients are strongly predictive of disability.153,154
Beauchamp et al.155 reported the minimal clinically important difference for the function component
of the LLFDI. They reported that substantial changes are reflected in a 5-point change in the overall
function scale, a 6-point change in the basic lower extremity subscale and a 9-point change in the
advanced lower extremity subscale. They reported that small but meaningful changes are reflected in a
2-point change in the overall function scale, a 3-point change in the basic lower extremity subscale and
a 4-point change in the advanced lower extremity subscale.
We found substantial changes from baseline to 1 year in both groups. The CORKA home-based
intervention resulted in an overall change of 8.9 points and usual care resulted in an average
change of 8.7 points, indicating that the combined effect of surgery and rehabilitation was a highly
significant improvement in function. Although most of this improvement was probably because of
the surgical procedure, it may not have been so large without appropriate, effective rehabilitation.
We cannot quantify the contribution of one without the other.
Secondary outcome measures
Despite recruiting only those at risk of poor outcomes to CORKA, the mean 52-week OKS achieved by
both treatment arms was within the 4-point minimal clinically important difference of the wider UK
average OKS following KA (35 points). The actual method of delivering physiotherapy may therefore be
comparatively unimportant.
Study limitations
There are limitations to our work. We developed a screening tool to identify the patients in the worst
half for predicted outcome. To make this pragmatic, we based the key questions on those already
collected as standard practice in most pre-operative assessment clinics or collected as part of the
standard national PROMs data set for KA. This may have resulted in a tool that was insufficiently
sensitive to identify the patients most at risk of a poor outcome that could be addressed by
rehabilitation after surgery. In developing our screening tool, we made an assumption that participants
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with an OKS of 26 or less would be more likely to benefit from the home intervention than from
traditional physiotherapy. We recognise that this assumption was informed by the consensus opinion of
groups of orthopaedic physiotherapy practitioners that we consulted in developing our research study
and interventions and that it is not self-evident or based on hard evidence.
As we compared the multidisciplinary home-based intervention with the current UK best practice of
outpatient physiotherapy, we cannot comment on the effect of the treatment arms compared with no
treatment. The research available to date focuses on the efficacy of different types of physiotherapy
following KA, with a lack of consensus. However, physiotherapy remains an accepted component of
the treatment pathway for KA in the UK. A control group withholding all post-operative outpatient
physiotherapy was not possible, as it was judged unacceptable to surgeons (who would not allow their
patients to enter into such a trial) and unethical to deny physiotherapy to patients already highlighted
as being at risk of poor outcomes.
We chose the LLFDI as the primary outcome measure, which is not an outcome tool specifically designed
to capture change in outcome after KA. It was selected as it maps to the World Health Organization’s
International Classification of Functioning, Disability and Health, and allows analysis of function, activity
and participation. It has also been used in other rehabilitation trials of older adults. It is arguable that a
more specific measure targeted at KA may have been a better choice.We included the OKS as a secondary
measure to address this potential limitation. The results of the LLFDI and OKS were well-matched.
Owing to the nature of this therapy trial, it was not feasible to blind patients or therapists to treatment
allocation. To ensure generalisability, we compared physiotherapy interventions that are deliverable
within the current standard commissioning envelope for NHS physiotherapy, setting physiotherapy
provision to approximately six sessions of individual physiotherapy.
Our cost-effectiveness analysis has several limitations, including missing data on resource use and
EQ-5D-5L. We accounted for missing data using multiple imputation, which assumed that the data
were missing at random conditional on modelled covariates.103 We found no strong evidence to
contradict this assumption and found that multiple imputation and complete cases analysis gave the
same results about the cost-effectiveness of the CORKA intervention.
Implications for clinical practice and policy
The NHS 5 Year Forward Plan156 has identified the need for further productivity and efficiency in
health-care delivery. It has also identified that the demands on health services are growing owing to
an ageing population with more long-term conditions and greater patient expectations. Part of the
NHS plan is to decentralise services, with greater community provision and less emphasis on care
provided in large acute trusts where that is not clinically mandated.
We suggest that the CORKA home-based intervention is a model that meets this strategy as it targets care
to those at higher risk who most need it, within participants’ own homes and communities. It addresses the
issue of workforce shortage by using an innovative workforce model of advanced rehabilitation assistants,
moving UK service provision closer to that which has been proven to be effective in North America, where
the use of physical therapy assistant graded staff is well embedded.
Patient and public involvement
We benefited from the support of highly engaged patient and public involvement (PPI) representatives
at various stages of the trial. Before the trial began we were supported by the Biomedical Research Unit
PPI officer, who helped in the recruitment of a PPI representative as a co-applicant and fully voting
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member of the CORKA Trial Steering Committee. This PPI representative had previously undergone KA
surgery with a relatively poor outcome. They, therefore, understood the rationale behind the CORKA
trial, in addition to the aim of the intervention to help those at risk of a poor outcome. The trial team
were able to update the PPI member throughout the study, with feedback welcomed.
Patient and public involvement engagement also occurred in the development of the intervention used for
the CORKA trial. In the development and piloting phase, changes were made to participant materials and
intervention procedures based on comments and advice from people who had undergone KA surgery;
these are covered in more detail in Chapter 3. More informally, we were extensively supported by members
of our local research engagement group and by former and current patients undergoing physiotherapy
following KA. Their generous time and comments were hugely influential in shaping the trial, designing
the intervention, and producing the patient information and documentation to support the trial. The PPI
representative supported the write up of the CORKA monograph by reading the chapters that they were
involved in and PPI groups will be used to help disseminate the results of the CORKA trial.
Further research
The findings from the cost-effectiveness analysis are important and consistent with the findings of the
trial: there is no meaningful difference in costs and QoL between the CORKA intervention and the
usual-care arm at the 12-month follow-up time point, although there is some evidence that CORKA
may be cost-effective from an NHS and societal perspective. Further work to review the relative
importance of NHS and societal costs in this population may be important, particularly if health care
moves towards a more centrally funded health and social care integrated model.
It is suggested that further research should focus on developing a screening tool that is more sensitive
in identifying those patients who will benefit from additional input, as recommended by the draft NICE
guidance.124 The NICE committee did not feel that self-directed rehabilitation without further supervision
was adequate, and did not recommend supervised rehabilitation for all. However, they commented that ‘it
would be very useful if a tool existed that indicated those who would benefit from supervised rehabilitation
or required adaptations to self-directed rehabilitation’ [reproduced with permission from NICE124 © NICE
2020 Joint replacement (primary): hip, knee and shoulder. Available from www.nice.org.uk/guidance/ng157
All rights reserved. Subject to Notice of rights NICE guidance is prepared for the National Health Service in
England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no
responsibility for the use of its content in this publication].
The screening tool developed in the CORKA trial identified the population most at risk of a poor outcome
after KA. It could be further developed to identify factors linked to engagement with rehabilitation.
The CORKA home-based intervention was delivered by rehabilitation assistants supervised by qualified
therapists in a ratio of five sessions to two sessions. To the best of our knowledge, the use of different
workforce models and particularly a hybrid model of assistants supervised at a distance by qualified
therapists has not been researched in any depth in the UK.With projected deficits in health-care staffing
from NHS England, modelling further work looking at different workforce models and interventions
using rehabilitation assistants may form an important subject for further research. The use of a different
staffing model is also worthy of exploration in terms of overall costs and affordability, making good
quality rehabilitation affordable to all, particularly with the anticipated continued growth in the number
of KA procedures performed each year.
Research to explore the relative benefits of alternative ways of delivering interventions would also be
useful, particularly if this improved adherence. Similarly, it would be of interest to explore the reasons
that older people do not engage fully with treatment interventions to improve the delivery of future
programmes using strategies to enhance engagement.
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Appendix 1 Late Life Function and Disability
Instrument effect by screen score
For patients with a score of 5 or more, continue to screen for eligibility onto the study. For patientswith a score below 5, stop the screening process and record this in the screening log.
–20 –15 –10 –5 0 5 10 15 20
Favours usual care Favours home-based rehabilitation







   1.91 (–0.34 to 4.15)
–0.48 (–2.25 to 1.29)
   0.11 (–3.70 to 3.92)
   1.38 (–2.70 to 5.46)
–5.79 (–23.03 to 11.45)
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Appendix 2 Health economics unit costs





Clinic, one to one £55.90 NHS Reference Cost schedule 2017–18,90 tab total outpatient attendances,
service code 650
Clinic, group
Home, one to one £57.26 NHS Reference Cost schedule 2017–18,90 community health services,
currency code A08A1
Community, one to one
Community, group £48.48 NHS Reference Cost schedule 2017–18,90 community health services,
currency code A08AG
CORKA programme £35.31 Weighted average of costs for physiotherapist at home (£57.26; see above)
and physiotherapy assistants (£26.53) with a ratio of 2 : 5. Physiotherapy
assistant cost derived by applying NHS Agenda for Change grade 3 salary
(£18,813) to band 4 community staff costs from section 9 of PSSRU 2018.91
Assume 1 hour per patient including travel time




GP: surgerya £34.30 Cost per minute of GP time: PSSRU 201891 (see table 10.3b)
GP: homea £76.39 Cost per minute of GP time: PSSRU 201891 (see table 10.3b). Average
consultation length of 9.2 minutes;93 assume average 12 minutes travel
time for home visits: PSSRU 2009157
GP: telephonea £15.10 Cost per minute of GP time: PSSRU 201891 (see table 10.5)
Practice nurse: surgery £14.90 PSSRU 2018,91 table 10.6 (practice nurse). Mean hourly cost is £56 for
face-to-face contact (£57.70 at current prices). Average consultation is
15.5 minutes: 2006–7 GP workload survey158
District nurse: home £38.45 NHS Reference Cost schedule 2017–18,90 tab CHS, currency code N02AF
Physiotherapist: clinic £55.90 NHS Reference Cost schedule 2017–18,90 tab total outpatient attendances,
service code 650
Physiotherapist: home £57.26 NHS Reference Cost schedule 2017–18,90 tab CHS, currency code A08A1
Occupational therapist: clinic £73.25 NHS Reference Cost schedule 2017–18,90 tab total outpatient attendances,
service code 651
Occupational therapist: home £81.31 NHS Reference Cost schedule 2017–18,90 tab CHS, currency code A06A1
A&E £160.32 NHS Reference Cost schedule 2017–18,90 tab AE, weighted average of all
service codes
Fracture clinic: hospital £123.94 NHS Reference Cost schedule 2017–18,90 tab total outpatient attendances,
service code 110 (trauma and orthopaedics)
Outpatient clinic £125.01 NHS Reference Cost schedule 2017–18,90 tab total outpatient attendances,
weighted average of all service codes
continued
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Outpatient, not face to face £90.83 NHS Reference Cost schedule 2017–18,90 tab total consultant led, non
face-to-face, follow-up outpatient attendances, weighted average of all
service codes
Counsellor/psychologist £170.27 NHS Reference Cost schedule 2017–18,90 tab total outpatient attendances,
service code 656 (clinical psychology)
Hydrotherapy £29.93 Cost per session in UK 2000 prices is £17.19.97 Inflated to 2018 prices
using HCHS index from PSSRU 201891
Social services £84.00 PSSRU 2018,91 table 11.1 (social care worker, adult services). Use cost per
hour of client-related work.
Falls prevention programme £21.81 NICE CG1613,98 appendix K. Unit cost per non-acute admitted patient
Acupuncture £139.44 NHS Reference Cost schedule 2017–18,90 tab OPROC, service code 191
(pain management), currency code AB23Z
Chiropractor £55.90 Assumed same as NHS physiotherapy clinic
Osteopath £55.90 Assumed same as NHS physiotherapy clinic
Private complimentary
therapies
£55.90 Assumed same as NHS physiotherapy clinic
Pharmacy £6.75 Cost per hour: PSSRU 2018,91 table 9 (band 66). Assume mean consultation
same as for GP, i.e. 9.2 minutes93
X-ray £31.49 NHS Reference Cost schedule 2017–18,90 directly accessed diagnostic
services, direct access plain film (currency code DAPF)
Ultrasound £51.38 NHS Reference Cost schedule 2017–18,90 diagnostic imaging, direct access;
weighted average cost of currency code RD4
CAT scan £88.87 NHS Reference Cost schedule 2017–18,90 diagnostic imaging, direct access;
weighted average cost of currency code RD2
MRI scan £132.81 NHS Reference Cost schedule 2017–18,90 diagnostic imaging, direct access;
weighted average cost of currency code RD0
Echocardiogram £76.65 NHS Reference Cost schedule 2017–18,90 directly accessed diagnostic
services, currency code EY50Z
Day surgery £139.59 NHS Reference Cost schedule 2017–18,90 weighted average of all
outpatient procedures
Cost per bed-day £345.76 NHS Reference Cost schedule 2017–18,90 weighted average of all excess
bed-day costs
Cost per day in critical care £1049.23 NHS Reference Cost schedule 2017–18,90 tab CC, weighted average of
service code CCU03
CAT, calibrated automated thrombography; CHS, Community Health Service; HCHS, Hospital and Community Health
Service; GP, general practitioner; MRI, magnetic resonance imaging; OPROC, outpatient procedures; PSSRU, Personal
Social Services Research Unit.
a Excluding direct care staff costs and including qualification costs.
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TABLE 37 Unit costs per item for medications by British National Formulary chemical name
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TABLE 37 Unit costs per item for medications by British National Formulary chemical name
(continued )
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TABLE 37 Unit costs per item for medications by British National Formulary chemical name
(continued )






Other emollient preparationsa £6.87




















b Long-term use only if patient is also prescribed opioid painkillers.
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TABLE 38 Unit costs of equipment items

































Walker (3 wheels) £62.99
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TABLE 38 Unit costs of equipment items (continued )





Unit costs are from the Co-operative Mobility website.99




Cost per hour of informal care £7.93 UK national minimum wage 2
Cost per week away from paid employment £556.43 The mean weekly gross wage of £16.76 multiplied by the
average number of hours worked per week, i.e. 33.2 hours95
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Appendix 3 Health economics resource use
TABLE 40 Mean number of intervention contacts related by treatment
allocation and contact type
Treatment received Mean number of contacts
Usual care (n = 312) 4.46
Clinic, one to one 2.92
Clinic, group 0.88
Home, one to one 0.60
Community, one to one 0.05
Community, group 0.02
CORKA intervention (n= 309) 5.21
TABLE 41 Mean number of health-care visits by type, treatment allocation and follow-up period






Total, n 264 263 273 273
NHS health care
GP 1.35 1.42 0.38 0.46
Nurse 1.42 1.65 0.15 0.19
Physiotherapist 1.56 0.81 0.27 0.36
Outpatient 0.80 0.93 0.29 0.27
A&E 0.14 0.16 0.02 0.05
Other 0.74 0.65 0.20 0.17
Medications 2.42 2.22 0.90 0.85
Equipment 2.02 2.05 0.31 0.32
Private health care
Physiotherapist 0.25 0.33 0.10 0.12
Other 0.13 0.04 0.05 0.07
Medications 0.25 0.24 0.13 0.10
Equipment 0.32 0.41 0.10 0.13
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TABLE 42 Mean number of hospital admissions and days in hospital by treatment allocation and follow-up period






Total, n 264 263 273 273
Number of hospital admissions 0.11 0.10 0.08 0.11
Days in hospital (excluding critical care) 0.46 0.57 0.24 0.42
Days in critical care 0.02 0.01 0.00 0.01
TABLE 43 Patient-reported data on informal care and time away from paid employment by treatment allocation and
follow-up period







Any care (%) 50.4 44.1 4.0 7.0
Hours of care 54.7 44.3 2.6 7.1
Time away from paid employment
Any time (%) 17.8 12.9 2.2 1.8
Weeks off 1.8 1.1 0.2 0.2
TABLE 44 Response-level data for EQ-5D questionnaires at each follow-up time point by treatment allocation








Total, n 308 308 281 275 286 278
Mobility
No problems 5 4 38 41 44 47
Slight problems 18 18 29 29 24 26
Some problems 52 51 21 15 19 11
Severe problems 25 27 3 4 4 6
Extreme problems 0 0 0 0 0 1
Self-care
No problems 54 58 73 72 71 74
Slight problems 31 27 12 13 14 11
Some problems 14 11 5 2 6 5
Severe problems 1 3 1 2 0 1
Extreme problems 0 0 0 0 0 0
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TABLE 44 Response-level data for EQ-5D questionnaires at each follow-up time point by treatment allocation (continued )









No problems 15 17 49 50 50 56
Slight problems 30 31 24 26 25 21
Some problems 38 34 13 11 13 9
Severe problems 15 15 3 2 3 2
Extreme problems 2 3 0 0 1 1
Pain
No problems 1 1 24 23 31 32
Slight problems 11 11 42 45 38 40
Some problems 54 53 20 16 18 12
Severe problems 28 28 4 4 5 4
Extreme problems 7 6 1 1 0 2
Anxiety/depression
No problems 62 63 66 65 67 67
Slight problems 25 20 15 18 16 13
Some problems 9 13 7 4 6 9
Severe problems 3 2 1 1 1 1
Extreme problems 1 3 1 0 1 0
TABLE 45 Data values for EQ-5D-5L utility and costs for each follow-up period following imputation








EQ-5D-5L utility 0.520 (0.220) 0.518 (0.228) 0.750 (0.436) 0.754 (0.441) 0.765 (0.445) 0.767 (0.475)
Total NHS costs (£) – – 794 (32) 805 (44) 221 (26) 284 (33)
Intervention costsa – – 250 (14) 184 (8) 0 (0) 0 (0)
Total subsequent
NHS costs
– – 544 (31) 621 (44) 221 (26) 284 (33)
Total private health
care (£)
– – 88 (21) 57 (15) 15 (7) 31 (13)
Informal care (£) – – 414 (40) 352 (34) 27 (13) 61 (19)
Time off work (£) – – 1015 (84) 643 (63) 90 (31) 101 (31)
Total societal costs (£) – – 2312 (94) 1856 (75) 353 (37) 476 (42)
a No missing data, estimated based on all randomised participants.
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